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Cannabis use initiated during adolescence may precipitate lasting consequences 
on the brain and behavioral health of the individual. However, research on the risk factors 
for cannabis use during adolescence has been largely cross-sectional in design. Despite 
the few prospective studies, even less is known about the neurobiological predictors. This 
dissertation improves on the extant literature by leveraging a large longitudinal study to 
uncover the predictors of cannabis use in adolescent samples collected prior to exposure. 
All data were drawn from the IMAGEN study and contained a large sample of 
adolescents studied at age 14 (N=2,224), and followed up at age 16 and 19. Participants 
were richly characterized using psychosocial questionnaires, structural and functional 
MRI, and genetic measurements. Two hypothesis-driven studies focused on amygdala 
reactivity and two data-driven studies across the feature domains were completed to 
characterize cannabis use in adolescence.  
The first study was cross-sectional and identified bilateral amygdala hyperactivity 
to angry faces in a sample reporting cannabis use by age 14 (n=70). The second study 
determined this amygdala effect was predictive of cannabis use by studying a sample of 
cannabis-naïve participants at age 14 who then used cannabis by age 19 (n=525). A dose-
response relationship was observed such that heavy cannabis users exhibited higher 
amygdala reactivity. Exploratory analyses suggested amygdala reactivity decreased from 
age 14 to 19 within the cannabis sample, although statistical significance was not found.  
In the third study, data-driven machine learning analyses predicted cannabis 
initiation by age 16 separately for males (n=207) and females (n=158) using data from all 
feature domains. These analyses identified a sparse set of shared psychosocial predictors, 
whereas the identified brain predictors exhibited sex- and drug-specificity. Additional 
analyses predicted initiation by age 19 and identified a sparse set of psychosocial 
predictors for females only (n=145). The final study improved on drug-specificity by 
performing differential prediction analyses between matched samples of participants who 
initiated cannabis+binge drinking vs. binge drinking only by age 16 (males n=178; 
females n=148). A sparse subset of psychosocial predictors identified in the third study 
was reproduced, and novel brain predictors were identified. Those analyses were unique 
as they compared two machine learning algorithms, namely regularized logistic 
regression and random forest analyses.  
These studies substantiated the use of both hypothesis- and data-driven prediction 
analyses applied to large longitudinal datasets. They also addressed common issues 
related to human addiction research by examining sex-differences and drug-specificity. 
Critically, these studies uncovered predictors of use in samples collected prior to 
cannabis-exposure. The identified predictors are therefore disentangled from 
consequences of use. Results from all studies inform etiological mechanisms influencing 
cannabis use in adolescence. These findings can also be used to stratify risk in vulnerable 
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parameter estimates for the paths into and out of the ROI (a and b 
paths) are in line with the lower GMV exhibited by the dysregulated 




















CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
Drug use is one of the most common and chronic behavioral health issues facing 
society, yet little is know about the neurobiological, genetic, and psychosocial predictors 
of use. Individuals who struggle with substance use disorders typically begin drug 
experimentation in adolescence. Therefore, it is important to identify predictive profiles 
during this period of development when individuals are most vulnerable to initiating drug 
use. Here, the literature specifically concerning adolescent cannabis use will be reviewed 
in light of the psychosocial and neurobiological changes that occur during adolescence. 
Special focus will be given to the animal and human studies that reported on the 
correlates and consequences of cannabis use in adolescence. In light of those studies, it is 
suggested that cannabis initiation during early adolescence is related to differences in the 
neurobiology and psychosocial functioning later in life.  
 Cannabis use has become a topical matter of public health in light of the risks 
associated with early initiation and chronic use. Recreational cannabis use for adults is 
now legalized in many different parts of the United States and abroad. Moreover, recent 
trends in adolescent use indicated that cannabis is now the second most popular drug used 
by adolescents (as indicated by any lifetime use), surpassing cigarettes in 2011 (Johnston 
et al., 2018). Despite these trends, the scientific evidence related to the biobehavioral 
predictors of cannabis use remains unclear. An important gap in the literature is the lack 
of longitudinal studies with multimodal assessments aimed at uncovering the predictors 




initiation, stratify risk in vulnerable adolescents, and supply targets for proactive 
interventions tailored to mitigate use and attenuate the consequences of use.  
1.1 Adolescent Development 
Psychosocial Development 
The World Health Organization defines adolescence as the period of development 
between ages 10-19 (www.who.init), although some argued for an extension into age 24 
(Sawyer et al., 2018). Adolescence is a developmental period characterized by substantial 
psychosocial and neurobiological changes (Spear, 2000a). Throughout this period, 
adolescents experiment with various new behaviors, environments, and reinforcers in 
order to learn new skills necessary for independence. Childhood behavioral patterns that 
previously sustained the individual are replaced by adult-like behaviors developed 
through experimentation with independence.  
Adolescents also experience a drive to emigrate from the natal family 
environment, incorporate more peers into their social networks, and increase time spent 
outside of adult supervision (Spear, 2000a). Increased interactions with peers provide 
opportunities for the adolescent to experiment with and learn social skills necessary for 
adulthood. And from an evolutionary biology perspective, motivation to emigrate from 
the home to associate with peers is advantageous in facilitating the identification of 
reproductive partners.   
Opportunities to engage in risky behaviors are likely during this phase of 
development when adolescents spend more time engaged with their social network of 




reinforcement for adolescents (Kaplan et al., 1987) and can boost self-esteem (Shedler 
and Block, 1990). Adolescents also reported they approach risky situations in order to 
satisfy curiosity and augment the sense of arousal, intensity, and complexity of novel 
experiences (Lipsett and Mitnick, 1991). While risk-taking behaviors are a common 
feature of adolescence, moderating the frequency and severity of these behaviors is an 
important skill that must also be learned during this period (Galvan et al., 2007).  
 
Structural Neurodevelopment 
Across early development and into adulthood, the brain undergoes a series of 
changes including global and focal volume changes, increased myelination, synaptic 
pruning, and receptor proliferation until the stable adult form is reached (Spear, 2000b, 
2013). Throughout this process, the neural architecture supporting cognitive, affective, 
motor, and sensory functions reach maturity.  
From gestation to late childhood, the brain generates an excess of neurons and 
synaptic connections to supply individuals with an overabundance of neural resources 
(Huttenlocher and Dabholkar, 1997; Oppenheim, 1991). Following this overabundance, 
synaptic pruning results in considerable gray matter volume loss as a healthy means to 
promote functional neuronal efficiency. During this process, the important neural 
connections established from prior experience and learning are preserved, while 
redundant connections are terminated (Casey et al., 2008).  
In addition to synaptic pruning, neuronal myelination also proliferates during 




specifically characterized by a marked increase in the myelination of the corticospinal 
tracts supporting voluntary movements, and the frontotemporal tracts supporting 
language (Paus, 1999). Pruning and myelination processes are especially active in the 
prefrontal cortex (PFC) (Gogtay et al., 2004; Whitford et al., 2007).  
Work by Giedd and colleagues uncovered separate neural developmental 
trajectories by sex (Giedd et al., 1999). Total brain and total gray matter volume (but not 
white matter) exhibited an inverted U shape trajectory from childhood to adolescence. 
Volumes increased throughout childhood and approached an inflection point that 
triggered a decline in brain volume, most likely driven by pruning processes. On average, 
females reached peak total brain volume at age 11 years while males peaked at age 15. In 
terms of white matter volume, research by Lenroot and colleagues suggested white matter 
increased steadily throughout the lifespan, but at a much faster rate in adolescence for 
males than females (Lenroot et al., 2007). In a related study of white matter development 
by Perrin and colleagues, authors postulated white matter sex-differences may be due to 
axonal diameter, rather than myelination, as testosterone up-regulates expression of 
axonal microtubules (Perrin et al., 2008). 
 
Functional Neurodevelopment 
Durston and colleagues argued that spatial-extent of brain activity characterizes 
functional maturity (Durston et al., 2006). Compared to immature diffuse activity, 




the strengthening of relevant connections via long-term potentiation. As such, spatial-
extent is an important way to characterize functional between-group differences.  
In terms of the functional network structure, brain activation networks develop 
into organized distributed processes from adolescence into adulthood, and prioritize 
sparse “small world” network structures (i.e., spatially distant regions of the brain are 
connected by a small number of connections). In a study of resting state network 
structures by Fair and colleagues, a-priori defined regions of interests for the default 
mode network were studied at two stages of development (Fair et al., 2009). Findings 
indicated distant network nodes exhibited weak interconnectivity at age 7, but then 
shifted to strong interconnectivity at age 21. For example, authors reported modest 
correlated activity between the medial prefrontal cortex and the lateral parietal cortex at 
age 7. After functional development, these regions exhibited strong correlated activity. 
This example of functional integration among distant cortical regions is a hallmark of 
functional development and reflects mature functional efficiency grounded in the changes 
to the structural architecture (Churchwell et al., 2010; Giedd et al., 1999; Lenroot et al., 
2007; Perrin et al., 2008). 
 
Brain Development and Adolescent Behavior  
The current framework of adolescent neurodevelopment in relation to drug use 
behaviors postulates that a divergent rate of maturation between the subcortical and 
prefrontal regions of the brain might drive reward-seeking behaviors (Casey et al., 2000; 




positively correlated activity between the ventral striatum and medial prefrontal regions, 
whereas adults exhibit a developmental switch to anti-correlated activity (Fareri et al., 
2015). This effect is also evident in the connectivity between the amygdala and mPFC 
(Gee et al., 2013). As such, anti-correlated activity is interpreted as a sign of top-down 
cognitive control whereby the prefrontal cortex down-regulates subcortical activity.  
A developmental functional MRI (fMRI) study by Galvan and colleagues 
indicated the bottom-up mesocortical and mesostriatal dopaminergic projections of the 
midbrain reached functional maturity prior to the opposing top-down prefrontal 
projections (Galvan et al., 2006). This finding is supported by animal models that 
indicated dopaminergic projections to the PFC reached high levels during adolescence 
(Kalsbeek et al., 1988; Leslie et al., 1991; Rosenberg and Lewis, 1994). Animal models 
have also identified the three major dopamine receptor subtypes, D1, D2, and D4, reach 
peak concentrations in the striatum during adolescence, whereas the concentrations in 
cortical regions continued to rise throughout adulthood (Tarazi and Baldessarini, 2000). 
While more research is needed, functional MRI studies of reward processing found 
heightened blood-oxygen level dependent (BOLD) signals in the striatum and 
ventromedial prefrontal cortex (vmPFC) specific to adolescents during receipt of reward 
(Cohen et al., 2010; Leijenhorst et al., 2010). Furthermore, another study by Galvan and 
colleagues reported a positive correlation between ventral striatum activation and a self-
reported measure of risk-taking behaviors (Galvan et al., 2007). In sum, these findings 
support the hypothesis that dopaminergic hyperactivity in adolescence may potentiate 





1.2 Substance Use in Adolescence 
Current Prevalence Rates of Alcohol, Cannabis, and Cigarette Use in Adolescence 
 
Current prevalence rates of drug use in adolescence can be derived from the most 
recent report of the Monitoring the Future Study (“MTF”, Johnston et al., 2018). The 
MTF study surveyed US classroom students in grades 8 (age 13-14), 10 (age 15-16), and 
12 (age 17-18) on their patterns of drug use. For the 2017 report, roughly 43,700 
teenagers in 360 schools across the United States were studied. This nationally 
representative dataset provides context for the need to study drug use in adolescence.  
Alcohol is currently (and historically) the most commonly used substance in 
adolescence. As of 2017, 23%, 42%, and 62% of teens in grade 8, 10, and 12 respectively 
reported any lifetime alcohol use. Conversely, binge drinking (defined by the MTF study 
as consuming five or more drinks) prevalence has reached it’s historic low and currently 
stands at roughly 9%, 25%, and 45% of grades 8, 10, and 12. Despite this historic low, it 
is troubling that nearly half of adolescents initiated at least one binge drinking episode 
before finishing 12th grade.  
Following alcohol, cannabis is the second most commonly used drug (surpassing 
cigarettes in 2011) with any lifetime use reported in 14%, 31%, and 45% of grades 8, 10, 
and 12. These rates have been stable over the past 10 years (2007 – 2017), and 
demonstrate an improvement relative to the past 20 years when rates peaked at 23%, 
42%, and 50% in 1997.  Nonetheless, rates of use are consequential in that about 10% of 




In terms of the availability of the drug, roughly 65% of 10th graders in 2017 reported that 
cannabis was “fairly easy” or “very easy” to obtain. For comparison, roughly 63% said 
the same for cigarettes, indicating that cannabis is remarkably within reach for these 
adolescents. It is also important to note that cannabis risk perception is at a historic low, 
with only 40% of 10th graders who perceived “great risk” in regular cannabis use, and 
only 20% who perceived “great risk” for occasional use (Johnston et al., 2018).  
The MTF study also provided estimates on the differences in prevalence between 
years 2016 and 2017. For binge drinking, there was no significant difference in use rates 
from 2016—2017, providing very early evidence for the stabilization of the historically 
low levels of adolescent binge drinking. For cannabis, a significant 1.3% increase in use 
was observed from 2016—2017, but only when considering all grades combined. No 
significant differences were observed for each grade in isolation, although trends 
indicated subtle increases (Johnston et al., 2018). Thus, the significant increase across the 
grades is a small effect that only reached significance with a large sample.  
Finally, cigarette use is common in adolescence, although rates have declined 
over time. Current prevalence of lifetime cigarette use stands at 9%, 16%, and 26% for 
grades 8, 10 and 12. These numbers are a major improvement relative to 1997 when rates 
were 47%, 60%, and 65% (Johnston et al., 2018). Within the context of cannabis use, 
alcohol and tobacco use are highly correlated with cannabis, in addition to being highly 
correlated with each other (Moss et al., 2014a). Given this association, some researchers 
posit the lack of an anticipated increase in cannabis use was driven in part by the decline 





Psychosocial Outcomes Associated with Drug Use in Adolescence 
 Developmental patterns of cannabis use have indicated that early initiation is 
correlated with higher levels of cannabis dependence (DSM-IV) in adulthood (Hall & 
Degenhardt, 2009; Moss, Chen & Yi, 2009). Correlations have also been identified 
between adolescent cannabis use and diminished socio-economic attainment (Fergusson 
& Boen, 2008), and although this effect is presumably bi-directional (low-SES predicts 
cannabis use), carefully controlled models have suggested a causal mechanism for 
cannabis use (Melchior et al., 2017). Many of the psychosocial consequences of cannabis 
use may be attenuated by delaying cannabis use until later in life (Lisdahl et al., 2013). 
Therefore, the ability to predict and inform prevention strategies for cannabis use is of 
substantial value to minimize psychosocial consequences later in life.  
The literature linking cannabis use to mental health outcomes is inconclusive. An 
earlier study reported that roughly 10% of males and 22% of females who used cannabis 
in adolescence experienced depression and anxiety as adults  (Patton, 2002). However, a 
recent meta-analysis by Gobbi and colleagues offered an updated perspective on the 
associations between adolescent cannabis use conferring risk for depression, anxiety, and 
suicidality. Authors reported that adolescent use was associated with a 1.4 increase in the 
odds for developing depression, 1.2 increase for anxiety (although not statistically 
significant), 1.5 increase for suicidal ideation, and finally a 3.5 increase for a suicide 
attempt (Gobbi et al., 2019). These findings should be interpreted within in the context of 




graders). And although those odds ratios are modest, a different meta-analysis reported 
stronger odds for both depression and suicide attempt when considering more frequent 
use (Silins et al., 2014). Therefore, preventing cannabis use is hypothesized to partially 
lower the incidence of these disorders and experiences.  
 Lastly, the relationship between adolescent cannabis use and schizophrenia or 
psychotic like disorders has been an active area of research. The Swedish Conscript study 
(Andréasson et al., 1987), and Dunedin, NZ study (Arseneault et al., 2002) were 
instrumental in catalyzing interest in these associations. Those studies each supplied 
evidence that higher frequency of use (Andréasson et al., 1987) and earlier age of onset 
(Arseneault et al., 2002) predicted the likelihood of developing psychosis. Since those 
reports, more recent papers adjusted their risk models for confounding variables like 
other drug use, family histories, and prodromal symptomology, and concluded the risk 
for these disorders is still valid (Gage et al., 2016; Mustonen et al., 2018). Future studies 
are needed to examine the extent to which interventions or decreasing prevalence rates of 
cannabis use correlate with psychotic like disorder diagnoses.  
 
1.3 Predictors and Correlates of Cannabis Use in Adolescence 
Psychosocial Predictors 
Substance use in adolescence is predicted by a set personality traits and 
environmental factors. To start, novelty-seeking personality levels typically peak during 
adolescence (Maggs et al., 1995; Moffitt, 1993), and are also highly predictive of 




also tend to discount delayed rewards in favor of immediate rewards (Steinberg, 2008) 
and display insensitivities to the aversive properties of some drugs (Cauffman et al., 
2010; Doremus-Fitzwater et al., 2010; Schramm-Sapyta et al., 2006). Taken together, 
these behavioral characteristics make adolescents vulnerable to engage drug use.  
For environmental factors, numerous studies have identified frequency of early 
life stress (Barrett and Turner, 2006), as well as perceived level of stress (Baer et al., 
1987; Deykin et al., 1987; Johnson and Pandina, 1993; Tschann et al., 1994) as strong 
predictors of drug use in adolescence. More specifically, studies indicated that physical 
and/or sexual abuse during childhood is more frequent in females than males, but 
nonetheless strongly predicted drug use later in life for both sexes (Liebschutz et al., 
2002). For males, severity of later drug use was inversely correlated with age at first 
abuse, such that the younger the age of physical and/or sexual abuse, the more severe 
substance abuse problems later in life. This dose response relationship was not evident in 
females, as any history of abuse during childhood strongly predicted substance use 
problems in adulthood (Liebschutz et al., 2002).  
Taken together, prior life stress might promote the generation of maladaptive 
coping strategies that include substance use. And while stress more generally precipitates 
drug use (DeWit et al., 1999; Sinha, 2008; Tschann et al., 1994; Wills, 1986) the exact 
mechanism driving this association are actively being studied (Milivojevic and Sinha, 
2018). Drugs and drug-seeking behaviors may potentiate perceptual and biological 
reactivity to stress (Cinciripini et al., 1989; Cobb and Van Thiel, 1982; D’Souza et al., 




impair capacity for impulse control, which is hypothesized to contribute to the 
maintenance of substance use disorders  (Sinha, 2009). Therefore, various forms of life 
stress are key predictors to be studied as well as how they might influence the 
neurobiology to confer risk for use.  
 
Parental and Peer Influences 
Correlations between adolescent cannabis use and lifetime cannabis use of the 
parent has been identified (Duncan et al., 1995; Kerr et al., 2015). A recent paper by 
Sokol and colleagues reported that any maternal lifetime cannabis use shifted the age of 
initiation two years earlier in their adolescent offspring relative to adolescents from 
parents without cannabis use histories (Sokol et al., 2018). Furthermore, O’Loughlin and 
colleagues reported adolescents with one parent endorsing any lifetime use were roughly 
twice as likely to use cannabis, while adolescents with two parents endorsing any lifetime 
use were eight times more likely to use cannabis, relative to their peers whose parents do 
not report lifetime use (O’Loughlin et al., 2018). Hence, the influence of parental lifetime 
cannabis use on the initiation of use for their child is remarkable. While many factors 
may partially contribute to parent-offspring transmission of drug use, possible 
mechanisms include shared genetic and neurobiological predispositions.  
Peer influences are also strong indicators of cannabis use. At a very basic level, an 
adolescent is more likely to use cannabis if they are involved in a network of peers who 
use cannabis. This finding has been consistent throughout the literature (Ali et al., 2011; 




are hypothesized to be related to the individual differences in the reinforcing properties of 
both the drug and the social context (Caouette and Feldstein Ewing, 2017). For example, 
some adolescents may not find pleasure in drug use but enjoy the social reinforcement 
achieved by engaging in cannabis use behaviors with their peers. In contrast, some 
adolescents may not enjoy social situations but they are necessary as a means to obtain 
drugs. Evidence for both these scenarios are reported in the literature. Lee and colleagues 
studied motives for cannabis use in high school graduates and reported that 26% 
endorsed social enhancement and bonding as their primary motive for use (Lee et al., 
2007). Buckner and colleagues designed an instrument to measure the likelihood of 
cannabis use in different social situations and reported that adolescents with social 
anxieties avoided social situations where cannabis is unavailable (Buckner et al., 2012). 
Therefore, it is important to consider relationships with peers and social contexts as 
contributing factors for cannabis use in adolescence.  
 
Cognitive Associations with Cannabis Use 
In studies on cognition in adolescent cannabis users, findings are relatively 
inconclusive, with more evidence pointing to cognitive deficits in teens with heavy or 
earlier onset of use. Research by Tapert and colleagues examined cognitive development 
in relation to cannabis use in a longitudinal study of teens. Early reports found a decrease 
in composite attention scores with cannabis use (Tapert et al., 2002). These findings were 




associated with a decrease in complex attention, slow processing speeds, and reduced 
verbal learning and sequencing skills (Jacobus and Tapert, 2014; Medina et al., 2007a). 
In a longitudinal study by Hanson and colleagues, researchers assessed verbal 
learning, working memory, visual attention, and time estimation at three time points 
across one month of monitored abstinence in cannabis using teens compared to controls. 
Across all measures, cannabis users showed worse performance than controls, however, 
users showed a recovery effect following three-weeks monitored abstinence for all 
measures except attention. These findings provided evidence that cannabis related insult 
only to attention might persist into adulthood, or, at least require protracted periods of 
abstinence to recover (Hanson et al., 2010). These findings have been corroborated by 
Fontes and colleagues (Fontes et al., 2011), and Gruber and colleagues qualified this 
finding and reported attentional deficits negatively correlated with age of initiation 
(Gruber et al., 2012). Therefore, cannabis might partially impair attentional capacities in 
individuals who initiate cannabis earlier than their peers.   
As reflected above, an ongoing area of research is the extent to which adolescent 
cognitive differences persist into adulthood. In early studies, Schwartz and colleagues 
reported short-term memory impairments persist at least six-weeks after monitored 
abstinence (Schwartz et al., 1989). However, in a prospective study by Fried and 
colleagues, researchers analyzed cognitive performance in current users, former users, 
and never-using controls, while accounting for performance levels prior to drug use. 
Investigators measured IQ, memory, processing speed, and attention using an extensive 




users across all domains. However, former users had performance levels similar to never-
users despite initiating use earlier and using more cannabis than the current users. 
Although that study was confounded as former users also had the highest socioeconomic 
status (SES) compared to the two comparison groups (Fried et al., 2005).  
Lastly, Lane and colleagues assessed motivation in adolescent cannabis users 
using a reward task that allowed subjects to switch task difficulties for smaller monetary 
reinforcement. Heavy users switched task difficulties at an earlier rate than non-using 
peers, and earned a greater proportion of earnings from the smaller reward level. 
Proportion of earnings correlated with the amount of cannabinoids present in urine 
samples on the day of testing (Lane et al., 2005). This finding was also exhibited by 
adults tested under acute intoxication of smoked cannabis compared to placebo (Lane and 
Cherek, 2002). Thus, cannabis use is associated with impaired motivation and sensitivity 
to reward, at least under acute and lingering effects. Authors concluded cannabis use 
might disrupt healthy motivational processes that coordinate favorable behavioral 
adaptations (Lane et al., 2005).  
It is worth noting there were studies that did not find differences in cognitive 
abilities related to cannabis use in adolescence (Tait et al., 2011; Takagi et al., 2011; 
Teichner et al., 2000). However, the prevalence of papers that reported cannabis use 
compromises cognition outnumbers those reports. Scott and colleagues reviewed the 
literature on adolescent cannabis use and cognition (Scott et al., 2018). Authors reported 
modest impairments on learning, working memory, delayed memory, inhibition, and 




that those differences generally abated following a minimum of three days monitored 
abstinence (Scott et al., 2018). This conclusion was also reported in an earlier meta-
analysis adult cannabis use and cognition (Grant et al., 2003). Together, these findings 
indicated that cannabis cessation interventions would likely produce beneficial effects on 
cognitive ability in adolescents who initiated cannabis use. 
 
Cannabinoid Psychopharmacology & Insights from Animal Models 
The primary cannabinoid (CB1) receptor is a metabotropic Gi-protein coupled 
receptor located throughout the brain, with high concentrations in the cerebellum, 
hippocampus (especially the CA1/CA3 and dentate gyrus), basal ganglia and amygdala 
(Glass et al., 1997; Herkenham et al., 1991; Katona et al., 2001). Within these regions, 
the CB1 receptor is found on presynaptic terminals of both GABAergic and 
glutamatergic interneurons and participates in neuromodulatory functioning. The 
endogenous ligands for these receptors are anandamide and 2‐arachidonoylglycerol, 
while the primary exogenous cannabinoid responsible for psychoactive effects is delta-9-
tetrahydrocannabinol (THC) (Gaoni and Mechoulam, 1964; Pertwee, 2008). When the 
CB1 receptor is bound by these ligands, neurotransmission is attenuated through the 
inhibition of cyclic adenosine monophosphate (cAMP) and subsequent signal 
transduction pathways, including the inhibition of pre-synaptic Ca2+ channels to regulate 
vesicular release of neurotransmitters (Wilson et al., 2001).   
Animal models have provided valuable evidence that linked adolescent 




Dalton & Zavitsanou exposed adolescent rats to a CB1-repcetor agonist at different doses 
and frequencies of infusion (one time use, light use, chronic use). Results indicated a 
dose-response decrease in CB1 receptor densities by dose and frequency of use relative to 
control animals. Lower CB1 receptor densities were reported across the brain with 
dramatic effects in the substantia nigra and CA1 subfield of the hippocampus (Dalton and 
Zavitsanou, 2010). Those results were in line with a previous study that showed similar 
effects on the amygdala, ventral tegmental area, and nucleus accumbens (Rubino et al., 
2008). Related lines of inquiry indicated that THC might be neurotoxic to both cortical 
(Downer et al., 2001) and hippocampal neurons (Lawston et al., 2000; Quinn et al., 
2008b) as measured by differences in tissue characterizations and metabolic changes. 
Together, these findings support the hypothesis that exposure to exogenous cannabinoids 
during adolescence disrupts typical neurodevelopment and might be partially related to 
phenotypic differences in those youths.   
Animal studies have also reported on the functional neurobiological and 
behavioral differences following exposure to cannabinoids in adolescence. Renard and 
colleagues identified impaired long term potentiation in pretreated rats relative to controls 
by probing network activity between the hippocampus (CA1/subiculum) and prefrontal 
(prelimbic) cortex (Renard et al., 2016). Those findings elucidated previous studies that 
showed deficits in domains dependent on hippocampal-PFC circuits including object-
recognition (O’Shea, 2004) and spatial learning (Cha et al., 2006). 
Lastly, animal models have supported the link between adolescent use and mood 




adolescence and identified more depressive-like behaviors in adulthood as indexed by a 
forced swim test and a sucrose preference test (Rubino et al., 2008). Those findings are in 
line with work by Bambico and colleagues who reproduced those two findings and also 
reported evidence for elevated anxiety-like behaviors as indexed by a novelty-suppressed 
feeding test in pretreated rats (Bambico et al., 2010). It is important to stress that all of 
these studies suggested adolescent, but not adult, exposure to cannabinoids precipitated 
structural, functional, and behavioral differences. These results underscore the need to 
predict cannabis use in human samples to minimize the likelihood of adolescents 
developing these brain and behavioral differences.  
 
Genetic Associations with Cannabis Use 
In a recent GWAS study using a very large sample (N=184,765), researchers 
identified eight single nucleotide polymorphisms (SNPs) that explained 11% of the 
variance of lifetime cannabis use. The top three SNPs were on a gene coding for 
CADM2, a cell adhesion molecule that is expressed widely in the brain. Authors reported 
this gene was previously affiliated with alcohol consumption and risk taking behaviors 
(Pasman et al., 2018). 
There were two GWAS for cannabis use dependence (DSM-IV). The first study 
identified three SNPs having an association with cannabis use dependence. One SNP was 
found on an antisense transcription region (RP11-206M11.7, rs143244591) whose 
function was unknown. The other SNPs were found on a gene coding for a protein that 




coding for a protein that regulates neuronal inflammation (CSMD1, rs77378271; Sherva 
et al., 2016). In the earlier GWAS study, none of their SNPs passed significance levels 
appropriate for GWAS studies (p < 1.0 x 10-8; Agrawal et al., 2011).  However, authors 
suggested a candidate-gene approach using neurotransmitter receptor genes (e.g., 
cannabinoid, opioid, dopamine), and relevant enzymes (e.g., fatty-acid amide hydrolase, 
FAAH) might better uncover associations with cannabis use (Agrawal and Lynskey, 
2009). Therefore, a GWAS approach might not yield the most clear or robust findings 
despite their potential for identifying novel biological predictors of cannabis use. 
 
Structural Brain Correlates of Adolescent Drug Use  
Recently, Orr and colleagues compared a sample of very light cannabis users at 
age 14 to a closely matched sample of controls and reported greater gray matter volumes 
(GMV) across many subcortical regions like the amygdala, hippocampus, and striatum 
with extent into the surrounding cortical regions (Orr et al., 2019). However, there is 
mixed evidence in the literature. Ashtari and colleagues identified bilateral hippocampal 
volume reductions in adolescent cannabis users compared to controls when scanned after 
1 month of monitored abstinence. Self-reported levels of use were also inversely 
correlated with the right hippocampus, suggesting a dose response in volume reduction 
(Ashtari et al., 2011). Similarly, Yücel and colleagues reported GMV reductions in the 
bilateral amygdala in adolescent users compared to controls (Yucel et al., 2008). In a 
study of young adults, GMV was greater in the anterior cerebellum of heavy cannabis 




and right amygdala volumes, and negative correlation between weekly cannabis use and 
bilateral hippocampal GMV was identified (Cousijn et al., 2012).  
Generally, those studies provided convering evidence on medial temporal lobe 
structures. All authors interpreted their finding in the context of the CB1 densities in 
those regions and concluded cannabis use in adolescence might be toxic to those tissues. 
Furthermore, those studies were inline with the animal models that reported neurotoxic 
effects of exogenous cannabinoids on the hippocampus mentioned above.  
 
Structural Brain Predictors of Cannabis Use 
As the above studies were cross-sectional, they were unable to infer a causal 
relationship between cannabis use and structural differences. Next, the few prospective 
studies will be surveyed. Starting with a study by Cheetham and colleagues, researchers 
studied an adolescent sample pre- and post-cannabis use. Findings indicated less GMV in 
the orbital frontal cortex (OFC) at age 12 predicted cannabis use by age 16 (Cheetham et 
al., 2012a).  These findings are in line with work by Volkow & Fowler who reported 
hypoactivity in the OFC using fMRI and positron emission tomography (PET) 
characterized individuals with drug dependence (Volkow and Fowler, 2000). These two 
studies suggest a propensity for drug use is partially predicted by differences in structure 
and function of the OFC, a region putatively involved in relevant functions like reinforcer 
evaluation (Noonan et al., 2012) and behavioral regulation (Bryden and Roesch, 2015).  
Jacobus and colleagues investigated cortical thickness before (age 13) and after 




thickness across many prefrontal regions, including the left precentral and superior 
frontal gyri, predicted the future alcohol+cannabis group relative to alcohol-only, and less 
thickness in right middle frontal gyrus predicted the alcohol+cannabis group relative to 
controls (Jacobus et al., 2016). This study also contained repeated measures on some 
neurocognitive and mental health screeners. Results indicated lower performance on 
working memory tasks, and, higher externalizing scores at baseline predicted the 
alcohol+cannabis initiating group relative to the others. These results suggested a 
preexisting working memory deficit is continued (if not exacerbated) through prolonged 
cannabis exposure in adolescence. These findings also indicate that a combination of 
behavioral and neuroimaging measures yields a predictive profile of cannabis use in 
adolescence.  
In light of these two studies, findings generally indicated lower gray matter 
volumes in prefrontal regions preceded cannabis use in adolescence. The interpretations 
regarding these effects are challenging, although they might signal precocious 
development as normative adolescent neurodevelopment is characterized by volume 
reductions. Exhibiting lower volumes relative to their peers at the same age might 
indicate an accelerated neurodevelopment, which in turn, facilitates maladaptive 
psychosocial development involving cannabis use.  
 
Functional Brain Correlates of Adolescent Cannabis Use  
Cannabis use in adolescence has been largely understudied using fMRI. Work by 




without cannabis use histories after 1 month of monitored abstinence. Despite not 
observing behavioral task differences, higher and more diffuse cortical activations during 
successful inhibition trials were observed in many prefrontal regions including bilateral 
superior and middle frontal gyri in the cannabis using group relative to controls (Tapert et 
al., 2007a). These findings indicated cannabis use might have partially induced lasting 
functional differences as indexed by the lack of functional efficiency relative to their non-
using peers.  
Similar studies also indicated that adolescent cannabis users did not differ on 
cognitive task performance measures relative to controls following one-month of 
abstinence. Instead, they were characterized by more diffuse brain activations throughout 
parietal regions on a spatial working memory task (Padula et al., 2007; Schweinsburg et 
al., 2008). Similar studies reported diffuse prefrontal activations during working memory 
(Jager et al., 2010), and attention tasks (Abdullaev et al., 2010). Lastly, one study 
identified more diffuse activity during a verbal working memory task correlated with an 
earlier age of cannabis initiation (Becker et al., 2010). The consistency of these effects all 
supports the interpretation that adolescent cannabis users may have compromised healthy 
functional development as characterized by diffuse patterns of functional activations. 
However, these studies did not evaluate their samples prior to cannabis initiation, so 
causal interpretations are speculative.  
 




 Cannabis use elicits positively and negatively valenced mood altering properties 
for the user, yet few investigators have used fMRI to study emotional processing in these 
samples. Green and colleagues reviewed studies on the self-reported subjective 
experiences related to acute cannabis use. Relaxation was the most common experience 
reported by 91% of cannabis users. Negatively valenced experiences were also reported 
as 40% of users reported anxiety and 27% reported depression (Green et al., 2003). 
Together with the animal and human findings related to the emotional correlates and 
consequences of cannabis use, these effects motivate a need to study cannabis use from 
an affective neuroscience perspective. Furthermore, there is a gap in the literature for 
studies using fMRI to illuminate differences in affective processing in adolescents. 
However, the adult literature offers some insights.   
 The amygdala is a key brain region involved in visual threat detection systems 
(Fox et al., 2015; Pessoa and Adolphs, 2010) and is commonly implicated during fMRI 
studies of social affective processing (Adolphs, 2010). Amygdala reactivity has only been 
studied in light of cannabis use for adults. A pharmacological fMRI study by Phan and 
colleagues reported that acute administration of THC was associated with lower 
amygdala reactivity during angry face processing relative to placebo (Phan et al., 2008). 
Outside of the acute period, Gruber and colleagues corroborated this affect by reporting 
that adults with chronic cannabis use displayed lower amygdala reactivity to angry faces 





In adolescents, one study by Heitzeg and colleagues probed for differences using 
an emotional word processing task. In that study, researchers compared adolescents with 
heavy cannabis use histories to a sample of very light cannabis using controls. Results 
indicated that heavy users demonstrated lower bilateral amygdala activations when 
processing both positively and negatively valenced words (Heitzeg et al., 2015).  
Together with the adult studies, these reports indicated that cannabis use is correlated 
with differences in affective processing, with converging evidence on amygdala 
reactivity. Lower amygdala reactivity generally followed acute and protracted use 
histories. It will be important to assess if emotional processing differences preceded use, 
as it is hypothesized that higher emotional reactivity partially influences individuals to 
use cannabis for the relaxing (anxiolytic) effects.  
 
Functional Brain Predictors of Drug Use  
 There is a lack of prospective studies that examined functional brain activations 
prior to cannabis use in adolescence. After searching the literature, a single report by 
Tervo-Clemmens and colleagues was identified (Tervo-Clemmens et al., 2018). In that 
study, researchers scanned children at age 12 and 15 using a working memory paradigm. 
Results indicated that higher frontoparietal activations and lower visual cortex activations 
during high task load in a sample of cannabis-naïve children predicted cannabis use by 
age 15. A dose-response effect was also found in the cuneus, such that lower activations 
predicted heavier use. Additionally, lower spatial planning scores from a cognitive test 




limited by a small outcome group (n=22 future cannabis users), therefore, replication and 
larger studies are needed.  
Reasons for the shortage of prospective fMRI results are unclear, but might be 
related to publication bias. And although speculative, the structural studies reported by 
Jacobus and Cheetham likely came from a larger project with fMRI as neuroimaging 
batteries usually contain both structural and functional assessments. The lack of 
publications on fMRI data from these groups might suggest no functional differences 
were identified. And again, as this is speculative, the functional predictors of cannabis 
use are likely to be small effects, which necessitates a large sample. As a final thought, it 
might be the case that a non-linear or machine learning approach might be better suited to 
identify neurobiology predictors as Jacobus and Cheetham and colleagues used 
traditional mass-univariate approaches. To date, machine learning approaches are in their 
infancy, as few longitudinal machine learning studies have been reported. This sparse 
literature will be reviewed at the end of the following section. 
 
1.4 Predictive Modeling of Drug Use 
Predictive Modeling Overview 
As outlined by Whelan & Garavan, predictive modeling is a technically 
challenging pursuit with many opportunities for methodological errors leading to inflated 
interpretations (Whelan and Garavan, 2014). These issues are pertinent to the field of 
psychiatric neuroimaging (or any field with feature-rich datasets) as the number of 




a phenotype exceeds the sample size. In this scenario, estimating a multiple regression 
model yields perfect fit to the data. In general, model fit statistics increase as the number 
of parameters increases, and/or the number of subjects decreases (Babyak, 2004). In these 
scenarios, an uninformed researcher might become overoptimistic and interpret the 
results of an overfit model (Whelan and Garavan, 2014).  
The ultimate goal for prediction analyses is to yield a model that accurately 
predicts novel observations. The gold standard for predicting novel observations is to test 
a model on a completely independent external dataset. However, the researcher might not 
have this option with a limited sample size. To overcome the lack of an external dataset, 
and to address the challenges in estimating a model with an excessive number of 
variables, we will consider two remedies that can be used in parallel— cross-validation 
and regularization (or feature selection more generally).  
 
Cross-Validation 
Cross-validation is a procedure commonly used to partition the original dataset 
into subsamples of observations (Wong, 2015). A model is then estimated on one 
subsample of the dataset (“training data”), and then evaluated using the observations in 
the subsample not used (“test data”) during model estimation. A common practice is to 
initially set aside a percentage of the data as the validation set, say 10%, and estimate a 
predictive model on the remaining 90%. Thus, the researcher is able to evaluate how well 
their predictive model generalizes to the set aside 10%. Generalizability may be 




under the curve of the receiver-operating characteristic (ROC AUC) from logistic 
models, returned from evaluating the model on the test data.  For these two statistics, 
values closer to 1 reflect superior prediction.  
ROC curves plot the trade off between sensitivity and 1-specificity at all 
probability thresholds provided by the classifier (i.e., the logistic model) (Hanley and 
McNeil, 1982). For ROC AUCs, values from 0.99 – 0.51 reflect diminishing returns, with 
0.50 reflecting chance performance. These values reflect the probability of a randomly 
chosen “case” being ranked higher than a control. To help with interpretation, work by 
Rice and Harris has shown that the ROC AUC can be equated Cohen’s d and Pearson’s 
point-biserial correlation, such that a medium effect size Cohen’s d=0.5, and r=0.243, is 
equivalent to a ROC AUC=.639 (Rice and Harris, 2005). 
One specific form of cross-validation is k-fold cross-validation, where k = number 
of partitions (or, “folds) of the original dataset (Wong, 2015). Each fold contains a 
similar amount of unique samples from the original dataset (i.e., when k = 10 and N=100, 
each kth fold will have 10 observations). k-fold cross-validation then becomes an iterative 
process whereby a single fold is set aside as the test sample (“test fold”), and a model is 
estimated on the remaining k-1 folds. The model estimated on the k-1 folds is then 
evaluated on the set aside test fold, thereby insuring the independence of the final test 
sample. This process is repeated k times, resulting in k final models. In doing so, each 






Regularization is statistical technique used during regression model estimation 
that attempts to minimize the amount of overfit to the data. (Zou and Hastie, 2005) 
Similarly to model estimation using ordinary least squares, regularized regression 
techniques seek to minimize the error between the predicted and observed outcome while 
also minimizing the magnitude of the regression coefficients. It is important that all 
independent variables are standardized prior to regularization so that coefficient 
penalization is consistent across independent variables. Here, two specific forms of 
regularization will be considered, LASSO (Least Absolute Shrinkage and Selector 
Operator; Tibshirani, 1996), and Ridge regression (Hoerl and Kennard, 1970).  
LASSO regression rejects complex models in favor of parsimonious models by 
minimizing the sum of the absolute values of the coefficients (Tibshirani, 1996). In doing 
so, the LASSO estimator solves for the 𝓵𝟏-norm of the design matrix. During LASSO 
estimation, predictors that are weakly correlated with the outcome measure are assigned a 
regression coefficient equal to zero, effectively removing them from the final model. The 
predictors remaining in the model are therefore more important to the outcome measure 
than the predictors set to zero. LASSO regression is one technique available to 
researchers when the number of predictors is immense, as the estimation procedure 
performs feature selection while fitting a model.  
Ridge regression seeks to solve problems arising from multicolinearity among 
predictor variables (Hoerl and Kennard, 1970). The Ridge estimator minimizes the sum 
of the squared values of the regression coefficients during model fit. In doing so, the 




during ridge regression (unlike LASSO) but are assigned smaller coefficients to reduce 
their fit. As such, correlated predictor variables are given similar regression coefficients 
and allowed to coexist in the model. Therefore, Ridge regression might be especially 
valuable in modeling inherently correlated predictor variables common to neuroimaging 
and psychological research (e.g., neighboring or functionally co-activating brain data; 
alcohol and tobacco use levels).   
In scenarios with excessive independent variables, and modeling correlated 
variables might be of theoretical interest, a hybrid approach balancing LASSO and Ridge 
regression, termed “elastic-net” regularization (Zou and Hastie, 2005), can be used. In 
elastic-net regularization, LASSO and Ridge are combined using a mixing parameter, α 
that balances the contribution of the LASSO to Ridge estimation methods. In addition to 
the α parameter, a second parameter, λ controls the magnitude of the shrinkage applied to 
the coefficients.  
During elastic-net model estimation, the α and the λ values can be tuned within a 
cross-validation procedure in order to identify the optimal set of parameter values that 
minimize the test error returned from evaluating model fit on an independent sample of 
observations. These tuning parameters are always non-negative values, such that 0 ≤ α ≤ 
1 and 0 ≤ λ. It can be shown that when α approaches 1, the LASSO estimator is favored, 
and when α approaches 0, the Ridge estimator is favored (Zou and Hastie, 2005). 






Most regression models are an extension of the general linear model and assume 
independent variables (IVs) combine in some linear fashion to predict the dependent 
variable (DV). However, this might not always be a safe assumption when modeling an 
excessive number of IVs from disparate sources, as many of these features might exhibit 
non-linear effects when predicting the DV. In parallel, attempting to include interaction 
terms (or other non-linear terms) for an already excessive number of IVs would be 
prohibitive. Regression models also attempt to model the average (singular) relationship 
between the IVs and DV (See Lemon et al. 2003, for comparison of regression to tree-
estimation) (Lemon et al., 2003). However, it is hypothesized that the observations in a 
sample reach the same outcome through different pathways. Different pathways are 
especially viable when the outcome is a behavioral measure. Therefore, estimating 
regression models may not be the optimal way to leverage a large dataset or to probe 
individual differences. 
 To address these concerns, non-linear modeling procedures like decision trees 
and random forests (Breiman, 2001) can serve as candidate models to predict cannabis 
use initiation. These tree-based models are more easily understood and interpretable non-
linear models relative to support vector machines or neural networks. A decision tree 
consists of series of logical if-then rules that effectively partition the feature space to 
group observations together (Quinlan, 1986). The optimal set of rules divides the feature 
space until the observations are adequately separated into their respective outcomes. 




impurity or squared error within each partition. In the case of predicting drug use, trees 
can be constructed to partition all future cannabis users separately from their naïve peers.   
An extension of the decision tree is a random forest (Breiman, 2001). During 
model estimation, a single decision tree is estimated on a randomly selected set of 
features. This procedure is then repeated many times until many trees built off randomly 
selected features comprise a “forest”. Random forests are ideal for feature rich datasets as 
it is equally likely for any feature to be randomly selected during the construction of a 
tree in the forest. And due to the random selection of features, random forests effectively 
account for multi-colinearity. And while all randomly selected features (usually restricted 
to the square root of the total number of features) are considered during tree estimation, 
only those that separate the classes when split are assigned an if-then rule.  
The forest can then be used to predict new observations by taking the majority 
vote across all trees. Looking across the trees in the forest, one can also determine the 
features that best predicted the outcome measure when split. A summary decision tree 
may then be estimated using only those features. Therefore, a predictive profile informed 
by a tree-based estimator conveys a unique pathway towards the outcome measure, 
whereas a profile informed from a regression provides a singular pathway for the average 
individual.  
One caveat to this method is the high risk of overfitting, as a decision tree can 
quickly become complex enough to exactly classify each observation (Schaffer, 1993). 
Therefore, techniques to resist overfitting must be applied when predicting out of sample 




minimum number of observations present in a terminal leaf node. In doing so, these rules 
stop the decision tree from completely isolating each single observation. 
 
Predictive Modeling of Binge-Drinking by Age 16 
Whelan and colleagues implemented cross-validated regularized regressions to 
classify adolescent binge-drinkers at age 14, and, predict binge-drinking by age 16 from 
data collected age 14. In applying these methods to a wealth of neuroimaging, 
psychometric, and candidate SNP data, findings indicated highly significant classification 
(AUC=0.90) and prediction (AUC=0.75). Hence, these methods yielded models that 
performed well in classifying and predicting independent samples.  
When probing the models further, the most reliable features that both classified 
and predicted adolescent binge drinking were more frequent sexual life experiences and 
higher novelty seeking, disorderly, and extravagant personalities, and lower 
conscientiousness personality traits. The brain features that classified age 14 binge 
drinking included lower GMV of the vmPFC, and lower activations in the left putamen 
and hippocampus during reward anticipation, and right hippocampus during reward 
outcome. The brain features that predicted binge drinking were lower activations in pre- 
and post-central gyri during failed response inhibitions. In sum, the classification was 
driven by lower activity in regions serving appetitive processing, while the prediction 
was driven by lower activity in sensory motor areas during failed response inhibitions.  
Finally, Squeglia and colleagues recently published a machine learning study 




report, researchers used random forests on data collected at age 12-14 to predict moderate 
to heavy alcohol use by age 18, relative to a sample of consistently alcohol naïve peers. 
Three separate models were generated using an increasing number of feature domains 
(demographics only; demographics + neurocognitive; demographics + neurocognitive + 
neuroimaging). The prediction accuracies increased with the inclusion of each domain, as 
indexed by sensitivity  (.60, .67, .74) and specificity (.64, .70, .73) to alcohol initiation. 
The most important features driving prediction were largely from the neuroimaging 
domain, including lower thickness of the left supramarginal gyrus, lower activation in the 
right posterior cingulate and superior temporal gyrus during a working memory task.  
Aside from the neuroimaging data, sex, socioeconomic status (SES), and 
cognitive measures were also selected as predictors of adolescent alcohol use. The lack of 
consistency with Whelan and colleagues are likely due to differences in measurement 
(Whelan used voxel-wise data, Squeglia used ROIs). Nonetheless, these results indicated 
the highest prediction was achieved with the combination of behavioral and 
neuroimaging data. And in keeping with the prediction study by Whalen and colleagues, 
significant and meaningful predictions can be made using a machine learning approach to 
leverage multi-domain data to uncover profiles predicting drug use in adolescence.  
 
1.5 Overview of the IMAGEN study 
 The IMAGEN study (Schumann et al., 2010) is large longitudinal study of 
adolescent development conducted across eight different sites in Europe (Paris, Dublin, 




europe.com). Study procedures included a comprehensive neuroimaging (MRI) battery 
and blood assays for genetic measurements of the adolescent. Both the adolescent and 
their parent also completed many psychosocial questionnaires. The study was designed to 
address many different scientific aims (Schumann et al., 2010) but broadly seeks to 
understand the relationship between adolescent psychosocial and neurobiological 
development, and how those data characterize and predict behavioral health issues.  
The study employed a convenient community sampling method by targeting the 
local school systems. Efforts were made to stratify enrollment to capture differences in 
ethnic and socioeconomic backgrounds. Baseline enrollment started at age 14, and youths 
were reassessed at ages 16 and 19. At the baseline visit, study protocols were explained 
to the family, written informed consent was obtained from the parent, and the child 
provided assent. Local ethics committees at all participating sites approved the study 
protocols. There were N=2,224 participants enrolled in the baseline sample.  
At the baseline visit, parents completed a set of self-report questionnaires related 
to their personality, drug use levels, and family histories. They also completed a mental 
health screener for which they reported on their child. The mental health questionnaire 
used in IMAGEN was the Development and Well-Being Assessment (“DAWBA”) and 
the affiliated brief screener, the Strengths and Difficulties Questionnaire (“SDQ”) 
(Goodman, 1997; Goodman et al., 2000).  
The adolescent also provided self-report on many of the same questionnaires. 
Personality was measured via the NEO, TCI, and SURPS questionnaires (Cloninger, 




measured on an ordinal scale using the European School Survey Project on Alcohol and 
Other Drugs instrument (ESPAD) (Hibell et al., 1997). Frequencies and valence ratings 
for various stressful life events was measured via the life events questionnaire (Newcomb 
et al., 1981). Various cognitive measures were also recorded (Kirby et al., 1999; 
MacLeod et al., 1986; Robbins et al., 1994) including their performance and verbal IQ 
levels (Wechsler, 2003).  
Blood assays were performed at baseline from which DNA was extracted. 
Genotype information was collected at 582,892 markers using the Illumina 
HumanHap610 and HumanHap660 Genotyping BeadChips (San Diego, CA). The 1000 
Genomes project reference set of markers (www.internationalgenome.org) was used for 
imputation after reducing the markers to ~13 million SNPs for European populations.  
Adolescents without any MRI contra-indications received a neuroimaging scan. 
For brain structure, a high-resolution whole-brain anatomical scan (MPRAGE), and a 
diffusion-tensor imaging (DTI) scan for white-matter fiber tractography were collected. 
For brain function, three fMRI tasks were administered. The stop signal task measured 
motor response inhibition (Rubia et al., 2005). The monetary incentive delay task 
measured reward anticipation and reward outcomes (Knutson et al., 2000). Lastly, a face 
processing scan that involved passive viewing of angry and neutral faces was collected 
(Grosbras, 2005). Standardization efforts were in place to ensure all sites used similar 
acquisition techniques, and all data were submitted to identical preprocessing pipelines.   
Adolescents were then followed up at age 16 and 19. The age 16 assessment 




home using an online portal (Psytools, Delosis, London, UK). The age 19 visit also 
included a follow up using the psychosocial questionnaires, and another neuroimaging 
scan that was identical to the baseline visit. See www.imagen-europe.com for all standard 
operating procedures as well as a selection of papers that previously reported on 
IMAGEN data.    
1.6 Current Report 
This dissertation contains a collection of studies that uncover the correlates and 
predictors of cannabis use in adolescence by leveraging data from the IMAGEN study.  
The first study  (in Chapter 2) tested for cross-sectional differences in the neurobiology of 
adolescents who reported any lifetime cannabis use at baseline (age 14). As informed by 
the animal and human studies, the face processing task was selected for use as it was 
hypothesized that adolescents using cannabis would exhibit hyperactivity to social threat 
processing cues. This study also adds to the apparent gap in the literature relating 
adolescent cannabis use to the functional neurobiology supporting affective functions.  
After characterizing those differences, the longitudinal nature of the IMAGEN 
dataset was interrogated to determine if the differences observed in Chapter 2 preceded 
cannabis use in adolescence. Hence, Chapter 3 begins the prediction theme of this 
dissertation by predicting cannabis use levels at age 19 using a sample of individuals who 
were cannabis-naïve at age 14. As such, the baseline data was disentangled from the 
consequences of cannabis exposure.  
The remaining studies in Chapters 4 & 5 better characterize a predictive profile 




in the IMAGEN study. Cannabis naïve samples at baseline were identified and machine 
learning was used to identify the predictors of cannabis initiation by age 16 and 19. 
Prediction models were executed separately by sex in light of the sex-differences 
discussed above. Post-hoc analyses tested if the predictors were specific to each sex or 
generalized to the opposite sex. Finally, drug-specificity was assessed by evaluating the 
identified predictors of cannabis use on an independent sample of binge drinkers. As 
cannabis use and binge drinking were found to be highly co-occuring, drug-specificity 
was evaluated again by executing similar machine learning analysis predicting future 
cannabis use versus future binge drinking.  
Results from theses analyses uncovered the predictive profiles of cannabis use in 
adolescence. These profiles can be used to both stratify risk and inform intervention 
strategies designed to mitigate use. For instance, the level of risk for cannabis use can be 
determined by how closely an adolescent aligns with the predictive profiles uncovered 
here. The psychosocial and neurobiological predictors uncovered here inform treatment 
strategies. As the literature indicated cannabis use in adolescence is associated with 
psychosocial, cognitive, and neurobiological differences, the knowledge gained from this 
dissertation will be translated to help lower cannabis use in adolescence through 







Abdullaev, Y., Posner, M.I., Nunnally, R., and Dishion, T.J. (2010). Functional MRI 
evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behav. 
Brain Res. 215, 45–57. 
Adolphs, R. (2010). What does the amygdala contribute to social cognition? Ann. N. Y. 
Acad. Sci. 1191, 42–61. 
Agrawal, A., and Lynskey, M.T. (2009). Candidate genes for cannabis use disorders: 
findings, challenges and directions. Addiction 104, 518–532. 
Agrawal, A., Lynskey, M.T., Hinrichs, A., Grucza, R., Saccone, S.F., Krueger, R., 
Neuman, R., Howells, W., Fisher, S., Fox, L., et al. (2011). A genome-wide association 
study of DSM-IV cannabis dependence. Addict. Biol. 16, 514–518. 
Ali, M.M., Amialchuk, A., and Dwyer, D.S. (2011). The Social Contagion Effect of 
Marijuana Use among Adolescents. PLoS ONE 6, e16183. 
Andréasson, S., Allebeck, P., Engström, A., and Rydberg, U. (1987). Cannabis and 
schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2, 1483–1486. 
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., and Moffitt, T.E. (2002). 
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. 
BMJ 325, 1212–1213. 
Ashtari, M., Avants, B., Cyckowski, L., Cervellione, K.L., Roofeh, D., Cook, P., Gee, J., 
Sevy, S., and Kumra, S. (2011). Medial temporal structures and memory functions in 
adolescents with heavy cannabis use. J. Psychiatr. Res. 45, 1055–1066. 
Baer, P.E., Garmezy, L.B., McLaughlin, R.J., Pokorny, A.D., and Wernick, M.J. (1987). 
Stress, coping, family conflict, and adolescent alcohol use. J. Behav. Med. 10, 449–466. 
Bambico, F.R., Nguyen, N.-T., Katz, N., and Gobbi, G. (2010). Chronic exposure to 
cannabinoids during adolescence but not during adulthood impairs emotional behaviour 
and monoaminergic neurotransmission. Neurobiol. Dis. 37, 641–655. 
Barrett, A.E., and Turner, R.J. (2006). Family structure and substance use problems in 
adolescence and early adulthood: examining explanations for the relationship. Addict. 
Abingdon Engl. 101, 109–120. 
Becker, B., Wagner, D., Gouzoulis-Mayfrank, E., Spuentrup, E., and Daumann, J. (2010). 
The impact of early-onset cannabis use on functional brain correlates of working 




Block, R.I., O’Leary, D.S., Ehrhardt, J.C., Augustinack, J.C., Ghoneim, M.M., Arndt, S., 
and Hall, J.A. (2000). Effects of frequent marijuana use on brain tissue volume and 
composition. Neuroreport 11, 491–496. 
Breiman, L. (2001). Random Forests. Mach. Learn. 45, 5–32. 
Bryden, D.W., and Roesch, M.R. (2015). Executive Control Signals in Orbitofrontal 
Cortex during Response Inhibition. J. Neurosci. 35, 3903–3914. 
Buckner, J.D., Heimberg, R.G., Matthews, R.A., and Silgado, J. (2012). Marijuana-
related problems and social anxiety: The role of marijuana behaviors in social situations. 
Psychol. Addict. Behav. 26, 151–156. 
Caouette, J.D., and Feldstein Ewing, S.W. (2017). Four Mechanistic Models of Peer 
Influence on Adolescent Cannabis Use. Curr. Addict. Rep. 4, 90–99. 
Casey, B.J., Giedd, J.N., and Thomas, K.M. (2000). Structural and functional brain 
development and its relation to cognitive development. Biol. Psychol. 54, 241–257. 
Casey, B.J., Jones, R.M., and Hare, T.A. (2008). The Adolescent Brain. Ann. N. Y. Acad. 
Sci. 1124, 111–126. 
Cauffman, E., Shulman, E.P., Steinberg, L., Claus, E., Banich, M.T., Graham, S., and 
Woolard, J. (2010). Age differences in affective decision making as indexed by 
performance on the Iowa Gambling Task. Dev. Psychol. 46, 193–207. 
Cha, Y.M., White, A.M., Kuhn, C.M., Wilson, W.A., and Swartzwelder, H.S. (2006). 
Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol. 
Biochem. Behav. 83, 448–455. 
Cheetham, A., Allen, N.B., Whittle, S., Simmons, J.G., Yücel, M., and Lubman, D.I. 
(2012). Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-
year longitudinal and prospective study. Biol. Psychiatry 71, 684–692. 
Chilcoat, H.D., and Anthony, J.C. (1996). Impact of parent monitoring on initiation of 
drug use through late childhood. J. Am. Acad. Child Adolesc. Psychiatry 35, 91–100. 
Churchwell, J.C., Lopez-Larson, M., and Yurgelun-Todd, D.A. (2010). Altered Frontal 
Cortical Volume and Decision Making in Adolescent Cannabis Users. Front. Psychol. 1. 
Cinciripini, P.M., Benedict, C.E., Van Vunakis, H., Mace, R., Lapitsky, L., Kitchens, K., 
Nezami, E., and Gjika, H.B. (1989). The effects of smoking on the mood, cardiovascular 
and adrenergic reactivity of heavy and light smokers in a non-stressful environment. Biol. 




Cloninger, C.R. (1999). The temperament and character inventory-revised. St Louis MO 
Cent. Psychobiol. Personal. Wash. Univ. 
Cobb, C.F., and Van Thiel, D.H. (1982). Mechanism of ethanol-induced adrenal 
stimulation. Alcohol. Clin. Exp. Res. 6, 202–206. 
Cohen, J.R., Asarnow, R.F., Sabb, F.W., Bilder, R.M., Bookheimer, S.Y., Knowlton, 
B.J., and Poldrack, R.A. (2010). A unique adolescent response to reward prediction 
errors. Nat. Neurosci. 13, 669–671. 
Conrod, P.J., Pihl, R.O., Stewart, S.H., and Dongier, M. (2000). Validation of a system of 
classifying female substance abusers on the basis of personality and motivational risk 
factors for substance abuse. Psychol. Addict. Behav. J. Soc. Psychol. Addict. Behav. 14, 
243–256. 
Costa Jr., P.T., and McCrae, R.R. (1995). Domains and Facets: Hierarchical Personality 
Assessment Using the Revised NEO Personality Inventory. J. Pers. Assess. 64, 21–50. 
Cousijn, J., Wiers, R.W., Ridderinkhof, K.R., van den Brink, W., Veltman, D.J., and 
Goudriaan, A.E. (2012). Grey matter alterations associated with cannabis use: results of a 
VBM study in heavy cannabis users and healthy controls. NeuroImage 59, 3845–3851. 
Dalton, V.S., and Zavitsanou, K. (2010). Cannabinoid effects on CB1 receptor density in 
the adolescent brain: An autoradiographic study using the synthetic cannabinoid HU210. 
Synapse 64, 845–854. 
DeWit, D.J., MacDonald, K., and Offord, D.R. (1999). Childhood stress and symptoms 
of drug dependence in adolescence and early adulthood: social phobia as a mediator. Am. 
J. Orthopsychiatry 69, 61–72. 
Deykin, E.Y., Levy, J.C., and Wells, V. (1987). Adolescent depression, alcohol and drug 
abuse. Am. J. Public Health 77, 178–182. 
Doremus-Fitzwater, T.L., Varlinskaya, E.I., and Spear, L.P. (2010). Motivational systems 
in adolescence: possible implications for age differences in substance abuse and other 
risk-taking behaviors. Brain Cogn. 72, 114–123. 
Downer, E., Boland, B., Fogarty, M., and Campbell, V. (2001). Delta 9-
tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via 
activation of the CB1 receptor. Neuroreport 12, 3973–3978. 
D’Souza, D.C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., 
Braley, G., Gueorguieva, R., and Krystal, J.H. (2004). The psychotomimetic effects of 
intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for 





Duncan, G.J., Boisjoly, J., Kremer, M., Levy, D.M., and Eccles, J. (2005). Peer Effects in 
Drug Use and Sex Among College Students. J. Abnorm. Child Psychol. 33, 375–385. 
Duncan, T.E., Duncan, S.C., Hops, H., and Stoolmiller, M. (1995). An Analysis of the 
Relationship Between Parent and Adolescent Marijuana Use Via Generalized Estimating 
Equation Methodology. Multivar. Behav. Res. 30, 317–339. 
Durston, S., Davidson, M.C., Tottenham, N., Galvan, A., Spicer, J., Fossella, J.A., and 
Casey, B.J. (2006). A shift from diffuse to focal cortical activity with development. Dev. 
Sci. 9, 1–8. 
Fair, D. A., Cohen, A. L., Power, J. D., Dosenbach, N. U., Church, J. A., Miezin, F. M., 
... & Petersen, S. E. (2009). Functional brain networks develop from a “local to 
distributed” organization. PLoS computational biology, 5(5), e1000381. 
 
Fareri, D.S., Gabard-Durnam, L., Goff, B., Flannery, J., Gee, D.G., Lumian, D.S., 
Caldera, C., and Tottenham, N. (2015). Normative development of ventral striatal resting 
state connectivity in humans. NeuroImage 118, 422–437. 
Fontes, M.A., Bolla, K.I., Cunha, P.J., Almeida, P.P., Jungerman, F., Laranjeira, R.R., 
Bressan, R.A., and Lacerda, A.L.T. (2011). Cannabis use before age 15 and subsequent 
executive functioning. Br. J. Psychiatry 198, 442–447. 
Fox, A.S., Oler, J.A., Tromp, D.P.M., Fudge, J.L., and Kalin, N.H. (2015). Extending the 
amygdala in theories of threat processing. Trends Neurosci. 38, 319–329. 
Fried, P.A., Watkinson, B., and Gray, R. (2005). Neurocognitive consequences of 
marihuana--a comparison with pre-drug performance. Neurotoxicol. Teratol. 27, 231–
239. 
Gage, S.H., Hickman, M., and Zammit, S. (2016). Association Between Cannabis and 
Psychosis: Epidemiologic Evidence. Biol. Psychiatry 79, 549–556. 
Galvan, A., Hare, T.A., Parra, C.E., Penn, J., Voss, H., Glover, G., and Casey, B.J. 
(2006). Earlier development of the accumbens relative to orbitofrontal cortex might 
underlie risk-taking behavior in adolescents. J. Neurosci. Off. J. Soc. Neurosci. 26, 6885–
6892. 
Galvan, A., Hare, T., Voss, H., Glover, G., and Casey, B. j. (2007). Risk-taking and the 
adolescent brain: who is at risk? Dev. Sci. 10, F8–F14. 
Gaoni, Y., and Mechoulam, R. (1964). Isolation, Structure, and Partial Synthesis of an 
Active Constituent of Hashish. J. Am. Chem. Soc. 86, 1646–1647. 
Gee, D.G., Humphreys, K.L., Flannery, J., Goff, B., Telzer, E.H., Shapiro, M., Hare, 




to negative connectivity in human amygdala-prefrontal circuitry. J. Neurosci. Off. J. Soc. 
Neurosci. 33, 4584–4593. 
Giedd, J.N., Blumenthal, J., Jeffries, N.O., Castellanos, F.X., Liu, H., Zijdenbos, A., 
Paus, T., Evans, A.C., and Rapoport, J.L. (1999). Brain development during childhood 
and adolescence: a longitudinal MRI study. Nat. Neurosci. 2, 861–863. 
Glass, M., Dragunow, M., and Faull, R.L. (1997). Cannabinoid receptors in the human 
brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal 
and adult human brain. Neuroscience 77, 299–318. 
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., 
Marmorstein, N., Cipriani, A., Dendukuri, N., et al. (2019). Association of Cannabis Use 
in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A 
Systematic Review and Meta-analysis. JAMA Psychiatry. 
Gogtay, N., Giedd, J.N., Lusk, L., Hayashi, K.M., Greenstein, D., Vaituzis, A.C., Nugent, 
T.F., Herman, D.H., Clasen, L.S., Toga, A.W., et al. (2004). Dynamic mapping of human 
cortical development during childhood through early adulthood. Proc. Natl. Acad. Sci. U. 
S. A. 101, 8174–8179. 
Goodman, R. (1997). The Strengths and Difficulties Questionnaire: A Research Note. J. 
Child Psychol. Psychiatry 38, 581–586. 
Goodman, R., Ford, T., Richards, H., Gatward, R., and Meltzer, H. (2000). The 
Development and Well-Being Assessment: Description and Initial Validation of an 
Integrated Assessment of Child and Adolescent Psychopathology. J. Child Psychol. 
Psychiatry 41, 645–655. 
Grant, I., Gonzalez, R., Carey, C.L., Natarajan, L., and Wolfson, T. (2003). Non-acute 
(residual) neurocognitive effects of cannabis use: a meta-analytic study. J. Int. 
Neuropsychol. Soc. JINS 9, 679–689. 
Green, B., Kavanagh, D., and Young, R. (2003). Being stoned: a review of self-reported 
cannabis effects. Drug Alcohol Rev. 22, 453–460. 
Grosbras, M.-H. (2005). Brain Networks Involved in Viewing Angry Hands or Faces. 
Cereb. Cortex 16, 1087–1096. 
Gruber, S.A., Rogowska, J., and Yurgelun-Todd, D.A. (2009). Altered affective response 
in marijuana smokers: An FMRI study. Drug Alcohol Depend. 105, 139–153. 
Gruber, S.A., Sagar, K.A., Dahlgren, M.K., Racine, M., and Lukas, S.E. (2012). Age of 
Onset of Marijuana Use and Executive Function. Psychol. Addict. Behav. J. Soc. 




Hale, R.L., Whiteman, S., Muehl, K., and Faynberg, E. (2003). Tridimensional 
Personality Traits of College Student Marijuana Users. Psychol. Rep. 92, 661–666. 
Hall, W., and Pacula, R.L. (2003). Cannabis use and dependence: public health and 
public policy (Cambridge university press). 
Hanley, J.A., and McNeil, B.J. (1982). The meaning and use of the area under a receiver 
operating characteristic (ROC) curve. Radiology 143, 29–36. 
Hanson, K.L., Winward, J.L., Schweinsburg, A.D., Medina, K.L., Brown, S.A., and 
Tapert, S.F. (2010). Longitudinal study of cognition among adolescent marijuana users 
over three weeks of abstinence. Addict. Behav. 35, 970–976. 
Hawkins, J.D., Graham, J.W., Maguin, E., Abbott, R., Hill, K.G., and Catalano, R.F. 
(1997). Exploring the effects of age of alcohol use initiation and psychosocial risk factors 
on subsequent alcohol misuse. J. Stud. Alcohol 58, 280–290. 
Heesch, C.M., Negus, B.H., Keffer, J.H., Snyder, R.W., Risser, R.C., and Eichhorn, E.J. 
(1995). Effects of cocaine on cortisol secretion in humans. Am. J. Med. Sci. 310, 61–64. 
Heitzeg, M.M., Cope, L.M., Martz, M.E., Hardee, J.E., and Zucker, R.A. (2015). Brain 
activation to negative stimuli mediates a relationship between adolescent marijuana use 
and later emotional functioning. Dev. Cogn. Neurosci. 16, 71–83. 
Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., Costa, B. de, and Rice, K.C. 
(1991). Characterization and localization of cannabinoid receptors in rat brain: a 
quantitative in vitro autoradiographic study. J. Neurosci. 11, 563–583. 
Hibell, B., Andersson, B., Bjarnason, T., Kokkevi, A., Morgan, M., and Narusk, A. 
(1997). The 1995 ESPAD report. Alcohol Drug Use Stud. In 26. 
Hoerl, A.E., and Kennard, R.W. (1970). Ridge Regression: Biased Estimation for 
Nonorthogonal Problems. Technometrics 12, 55–67. 
Huttenlocher, P.R., and Dabholkar, A.S. (1997). Regional differences in synaptogenesis 
in human cerebral cortex. J. Comp. Neurol. 387, 167–178. 
Hyman, S.M., Garcia, M., Kemp, K., Mazure, C.M., and Sinha, R. (2005). A gender 
specific psychometric analysis of the early trauma inventory short form in cocaine 
dependent adults. Addict. Behav. 30, 847–852. 
Jacobus, J., and Tapert, S.F. (2014). Effects of Cannabis on the Adolescent Brain. Curr. 




Jager, G., Block, R.I., Luijten, M., and Ramsey, N.F. (2010). Cannabis use and memory 
brain function in adolescent boys: a cross-sectional multicenter functional magnetic 
resonance imaging study. J. Am. Acad. Child Adolesc. Psychiatry 49, 561–572, 572.e1-3. 
Johnson, V., and Pandina, R.J. (1993). A longitudinal examination of the relationships 
among stress, coping strategies, and problems associated with alcohol use. Alcohol. Clin. 
Exp. Res. 17, 696–702. 
Johnston, L.D., O’Malley, P.M., Bachman, J.G., and Schulenberg, J.E. (2011). 
Monitoring the Future National Survey Results on Drug Use, 1975-2010. Volume I, 
Secondary School Students. Inst. Soc. Res. 
Johnston, L.D., Miech, R.A., O’Malley, P.M., Bachman, J.G., Schulenberg, J.E., and 
Patrick, M.E. (2018). Monitoring the Future national survey results on drug use: 1975-
2017: Overview, key findings on adolescent drug use. (The University of Michigan: Ann 
Arbor: Institute for Social Research.). 
Kalsbeek, A., Voorn, P., Buijs, R.M., Pool, C.W., and Uylings, H.B. (1988). 
Development of the dopaminergic innervation in the prefrontal cortex of the rat. J. Comp. 
Neurol. 269, 58–72. 
Kaplan, H.B., Johnson, R.J., and Bailey, C.A. (1987). Deviant Peers and Deviant 
Behavior: Further Elaboration of a Model. Soc. Psychol. Q. 50, 277–284. 
Katona, I., Rancz, E.A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., and Freund, T.F. 
(2001). Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in 
the Control of GABAergic Transmission. J. Neurosci. 21, 9506–9518. 
Kerr, D.C.R., Tiberio, S.S., and Capaldi, D.M. (2015). Contextual risks linking parents’ 
adolescent marijuana use to offspring onset. Drug Alcohol Depend. 154, 222–228. 
Kirby, K.N., Petry, N.M., and Bickel, W.K. (1999). Heroin addicts have higher discount 
rates for delayed rewards than non-drug-using controls. J. Exp. Psychol. Gen. 128, 78–
87. 
Knutson, B., Westdorp, A., Kaiser, E., and Hommer, D. (2000). FMRI visualization of 
brain activity during a monetary incentive delay task. NeuroImage 12, 20–27. 
Koob, G.F., and Le Moal, M. (2008). Neurobiological mechanisms for opponent 
motivational processes in addiction. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 363, 3113–
3123. 
Kuntsche, E., and Jordan, M.D. (2006). Adolescent alcohol and cannabis use in relation 




Lane, S.D., and Cherek, D.R. (2002). Marijuana Effects on Sensitivity to Reinforcement 
in Humans. Neuropsychopharmacology 26, 520–529. 
Lane, S.D., Cherek, D.R., Pietras, C.J., and Steinberg, J.L. (2005). Performance of heavy 
marijuana-smoking adolescents on a laboratory measure of motivation. Addict. Behav. 
30, 815–828. 
Lawston, J., Borella, A., Robinson, J.K., and Whitaker-Azmitia, P.M. (2000). Changes in 
hippocampal morphology following chronic treatment with the synthetic cannabinoid 
WIN 55,212-2. Brain Res. 877, 407–410. 
Ledoux, S., Miller, P., Choquet, M., and Plant, M. (2002). Family Structure, Parent–
Child Relationships, and Alcohol and Other Drug Use Among Teenagers in France and 
the United Kingdom. Alcohol Alcohol 37, 52–60. 
Lee, C.M., Neighbors, C., and Woods, B.A. (2007). Marijuana motives: Young adults’ 
reasons for using marijuana. Addict. Behav. 32, 1384–1394. 
Leijenhorst, L.V., Zanolie, K., Meel, C.S.V., Westenberg, P.M., Rombouts, S.A.R.B., 
and Crone, E.A. (2010). What Motivates the Adolescent? Brain Regions Mediating 
Reward Sensitivity across Adolescence. Cereb. Cortex 20, 61–69. 
Lemon, S.C., Roy, J., Clark, M.A., Friedmann, P.D., and Rakowski, W. (2003). 
Classification and regression tree analysis in public health: Methodological review and 
comparison with logistic regression. Ann. Behav. Med. 26, 172–181. 
Lenroot, R.K., Gogtay, N., Greenstein, D.K., Wells, E.M., Wallace, G.L., Clasen, L.S., 
Blumenthal, J.D., Lerch, J., Zijdenbos, A.P., Evans, A.C., et al. (2007). Sexual 
dimorphism of brain developmental trajectories during childhood and adolescence. 
NeuroImage 36, 1065–1073. 
Leslie, C.A., Robertson, M.W., Cutler, A.J., and Bennett, J.P. (1991). Postnatal 
development of D1 dopamine receptors in the medial prefrontal cortex, striatum and 
nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a 
quantitative autoradiographic analysis. Brain Res. Dev. Brain Res. 62, 109–114. 
Lieb, R., Merikangas, K.R., Höfler, M., Pfister, H., Isensee, B., and Wittchen, H.-U. 
(2002). Parental alcohol use disorders and alcohol use and disorders in offspring: a 
community study. Psychol. Med. 32, 63–78. 
Liebschutz, J., Savetsky, J.B., Saitz, R., Horton, N.J., Lloyd-Travaglini, C., and Samet, 
J.H. (2002). The relationship between sexual and physical abuse and substance abuse 
consequences. J. Subst. Abuse Treat. 22, 121–128. 





Lisdahl, K.M., Gilbart, E.R., Wright, N.E., and Shollenbarger, S. (2013). Dare to Delay? 
The Impacts of Adolescent Alcohol and Marijuana Use Onset on Cognition, Brain 
Structure, and Function. Front. Psychiatry 4. 
MacLeod, C., Mathews, A., and Tata, P. (1986). Attentional bias in emotional disorders. 
J. Abnorm. Psychol. 95, 15–20. 
Maggs, J.L., Almeida, D.M., and Galambos, N.L. (1995). Risky Business The 
Paradoxical Meaning of Problem Behavior for Young Adolescents. J. Early Adolesc. 15, 
344–362. 
Malmberg, M., Kleinjan, M., Vermulst, A.A., Overbeek, G., Monshouwer, K., Lammers, 
J., and Engels, R.C.M.E. (2012). Do Substance Use Risk Personality Dimensions Predict 
the Onset of Substance Use in Early Adolescence? A Variable- and Person-Centered 
Approach. J. Youth Adolesc. 41, 1512–1525. 
Medina, K.L., Hanson, K.L., Schweinsburg, A.D., Cohen-Zion, M., Nagel, B.J., and 
Tapert, S.F. (2007). Neuropsychological functioning in adolescent marijuana users: 
subtle deficits detectable after a month of abstinence. J. Int. Neuropsychol. Soc. JINS 13, 
807–820. 
Melchior, M., Chastang, J.-F., Mackinnon, D., Galéra, C., and Fombonne, E. (2010). The 
intergenerational transmission of tobacco smoking—The role of parents’ long-term 
smoking trajectories. Drug Alcohol Depend. 107, 257–260. 
Miech, R., Johnston, L., and O’Malley, P.M. (2017). Prevalence and Attitudes Regarding 
Marijuana Use Among Adolescents Over the Past Decade. Pediatrics 140. 
Milivojevic, V., and Sinha, R. (2018). Central and Peripheral Biomarkers of Stress 
Response for Addiction Risk and Relapse Vulnerability. Trends Mol. Med. 24, 173–186. 
Moffitt, T.E. (1993). Adolescence-limited and life-course-persistent antisocial behavior: a 
developmental taxonomy. Psychol. Rev. 100, 674–701. 
Moss, H.B., Chen, C.M., and Yi, H. (2014). Early adolescent patterns of alcohol, 
cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a 
nationally representative sample. Drug Alcohol Depend. 136, 51–62. 
Mustonen, A., Niemelä, S., Nordström, T., Murray, G.K., Mäki, P., Jääskeläinen, E., and 
Miettunen, J. (2018). Adolescent cannabis use, baseline prodromal symptoms and the risk 
of psychosis. Br. J. Psychiatry 212, 227–233. 
Naqvi, N.H., and Bechara, A. (2010). The insula and drug addiction: an interoceptive 




Newcomb, M.D., Huba, G.J., and Bentler, P.M. (1981). A Multidimensional Assessment 
of Stressful Life Events among Adolescents: Derivation and Correlates. J. Health Soc. 
Behav. 22, 400. 
Noonan, M.P., Kolling, N., Walton, M.E., and Rushworth, M.F.S. (2012). Re-evaluating 
the role of the orbitofrontal cortex in reward and reinforcement. Eur. J. Neurosci. 35, 
997–1010. 
O’Loughlin, J.L., Dugas, E.N., O’Loughlin, E.K., Winickoff, J.P., Montreuil, A., 
Wellman, R.J., Sylvestre, M.-P., and Hanusaik, N. (2018). Parental Cannabis Use Is 
Associated with Cannabis Initiation and Use in Offspring. J. Pediatr. 
Oppenheim, R.W. (1991). Cell Death During Development of the Nervous System. 
Annu. Rev. Neurosci. 14, 453–501. 
O’Shea, M. (2004). Chronic cannabinoid exposure produces lasting memory impairment 
and increased anxiety in adolescent but not adult rats. J. Psychopharmacol. (Oxf.) 18, 
502–508. 
Padula, C.B., Schweinsburg, A.D., and Tapert, S.F. (2007). Spatial Working Memory 
Performance and fMRI Activation Interactions in Abstinent Adolescent Marijuana Users. 
Psychol. Addict. Behav. J. Soc. Psychol. Addict. Behav. 21, 478–487. 
Palermo, D.S. (2014). Coping With Uncertainty: Behavioral and Developmental 
Perspectives (Psychology Press). 
Patton, G.C. (2002). Cannabis use and mental health in young people: cohort study. BMJ 
325, 1195–1198. 
Patton, G.C., Carlin, J.B., Coffey, C., Wolfe, R., Hibbert, M., and Bowes, G. (1998). 
Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am. J. 
Public Health 88, 1518–1522. 
Paulus, M.P., Tapert, S.F., and Schulteis, G. (2009). The role of interoception and 
alliesthesia in addiction. Pharmacol. Biochem. Behav. 94, 1–7. 
Paus, T. (1999). Structural Maturation of Neural Pathways in Children and Adolescents: 
In Vivo Study. Science 283, 1908–1911. 
Perrin, J.S., Hervé, P.-Y., Leonard, G., Perron, M., Pike, G.B., Pitiot, A., Richer, L., 
Veillette, S., Pausova, Z., and Paus, T. (2008). Growth of white matter in the adolescent 





Pertwee, R.G. (2008). Ligands that target cannabinoid receptors in the brain: from THC 
to anandamide and beyond: Ligands that target cannabinoid receptors in the brain. 
Addict. Biol. 13, 147–159. 
Pessoa, L., and Adolphs, R. (2010). Emotion processing and the amygdala: from a “low 
road” to “many roads” of evaluating biological significance. Nat. Rev. Neurosci. 11, 
773–782. 
Phan, K.L., Angstadt, M., Golden, J., Onyewuenyi, I., Popovska, A., and de Wit, H. 
(2008). Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in 
Humans. J. Neurosci. 28, 2313–2319. 
Quinn, H.R., Matsumoto, I., Callaghan, P.D., Long, L.E., Arnold, J.C., Gunasekaran, N., 
Thompson, M.R., Dawson, B., Mallet, P.E., Kashem, M.A., et al. (2008). Adolescent 
Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater 
Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following 
Exposure. Neuropsychopharmacology 33, 1113–1126. 
Rakic, P., Bourgeois, J.-P., and Goldman-Rakic, P.S. (1994). Synaptic development of 
the cerebral cortex: implications for learning, memory, and mental illness. In Progress in 
Brain Research, (Elsevier), pp. 227–243. 
Renard, J., Rosen, L.G., Loureiro, M., De Oliveira, C., Schmid, S., Rushlow, W.J., and 
Laviolette, S.R. (2016). Adolescent Cannabinoid Exposure Induces a Persistent Sub-
Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the 
Prefrontal Cortex. Cereb. Cortex bhv335. 
Rice, M.E., and Harris, G.T. (2005). Comparing effect sizes in follow-up studies: ROC 
Area, Cohen’s d, and r. Law Hum. Behav. 29, 615–620. 
Robbins, T.W., James, M., Owen, A.M., Sahakian, B.J., McInnes, L., and Rabbitt, P. 
(1994). Cambridge Neuropsychological Test Automated Battery (CANTAB): A Factor 
Analytic Study of a Large Sample of Normal Elderly Volunteers. Dement. Geriatr. Cogn. 
Disord. 5, 266–281. 
Rose, J.S., Chassin, L., Presson, C.C., and Sherman, S.J. (1996). Demographic factors in 
adult smoking status: Mediating and moderating influences. Psychol. Addict. Behav. 10, 
28–37. 
Rosenberg, D.R., and Lewis, D.A. (1994). Changes in the dopaminergic innervation of 
monkey prefrontal cortex during late postnatal development: a tyrosine hydroxylase 
immunohistochemical study. Biol. Psychiatry 36, 272–277. 
Rubia, K., Smith, A.B., Brammer, M.J., Toone, B., and Taylor, E. (2005). Abnormal 
Brain Activation During Inhibition and Error Detection in Medication-Naive Adolescents 




Rubino, T., Vigano’, D., Realini, N., Guidali, C., Braida, D., Capurro, V., Castiglioni, C., 
Cherubino, F., Romualdi, P., Candeletti, S., et al. (2008). Chronic Δ9-
Tetrahydrocannabinol During Adolescence Provokes Sex-Dependent Changes in the 
Emotional Profile in Adult Rats: Behavioral and Biochemical Correlates. 
Neuropsychopharmacology 33, 2760–2771. 
Sawyer, S.M., Azzopardi, P.S., Wickremarathne, D., and Patton, G.C. (2018). The age of 
adolescence. Lancet Child Adolesc. Health 2, 223–228. 
Schaffer, C. (1993). Overfitting Avoidance as Bias. Mach. Learn. 10, 153–178. 
Schramm-Sapyta, N.L., Morris, R.W., and Kuhn, C.M. (2006). Adolescent rats are 
protected from the conditioned aversive properties of cocaine and lithium chloride. 
Pharmacol. Biochem. Behav. 84, 344–352. 
Schumann, G., Loth, E., Banaschewski, T., Barbot, A., Barker, G., Büchel, C., Conrod, 
P.J., Dalley, J.W., Flor, H., Gallinat, J., et al. (2010). The IMAGEN study: reinforcement-
related behaviour in normal brain function and psychopathology. Mol. Psychiatry 15, 
1128–1139. 
Schwartz, R.H., Gruenewald, P.J., Klitzner, M., and Fedio, P. (1989). Short-term memory 
impairment in cannabis-dependent adolescents. Am. J. Dis. Child. 1960 143, 1214–1219. 
Schweinsburg, A.D., Nagel, B.J., Schweinsburg, B.C., Park, A., Theilmann, R.J., and 
Tapert, S.F. (2008). Abstinent adolescent marijuana users show altered fMRI response 
during spatial working memory. Psychiatry Res. 163, 40–51. 
Scott, J.C., Slomiak, S.T., Jones, J.D., Rosen, A.F.G., Moore, T.M., and Gur, R.C. 
(2018). Association of Cannabis With Cognitive Functioning in Adolescents and Young 
Adults: A Systematic Review and Meta-analysis. JAMA Psychiatry 75, 585. 
Shedler, J., and Block, J. (1990). Adolescent drug use and psychological health. A 
longitudinal inquiry. Am. Psychol. 45, 612–630. 
Sherva, R., Wang, Q., Kranzler, H., Zhao, H., Koesterer, R., Herman, A., Farrer, L.A., 
and Gelernter, J. (2016). Genome-wide Association Study of Cannabis Dependence 
Severity, Novel Risk Variants, and Shared Genetic Risks. JAMA Psychiatry 73, 472. 
Silins, E., Horwood, L.J., Patton, G.C., Fergusson, D.M., Olsson, C.A., Hutchinson, 
D.M., Spry, E., Toumbourou, J.W., Degenhardt, L., Swift, W., et al. (2014). Young adult 
sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry 1, 286–
293. 
Sinha, R. (2008). Chronic Stress, Drug Use, and Vulnerability to Addiction. Ann. N. Y. 




Sokol, N.A., Okechukwu, C.A., Chen, J.T., Subramanian, S.V., and Rees, V.W. (2018). 
Maternal Cannabis Use During a Child’s Lifetime Associated With Earlier Initiation. 
Am. J. Prev. Med. 55, 592–602. 
Spear, L.P. (2000a). Neurobehavioral Changes in Adolescence. Curr. Dir. Psychol. Sci. 9, 
111–114. 
Spear, L.P. (2000b). The adolescent brain and age-related behavioral manifestations. 
Neurosci. Biobehav. Rev. 24, 417–463. 
Spear, L.P. (2013). Adolescent Neurodevelopment. J. Adolesc. Health 52, S7–S13. 
Squeglia, L.M., Ball, T.M., Jacobus, J., Brumback, T., McKenna, B.S., Nguyen-Louie, 
T.T., Sorg, S.F., Paulus, M.P., and Tapert, S.F. (2017). Neural Predictors of Initiating 
Alcohol Use During Adolescence. Am. J. Psychiatry 174, 172–185. 
Steinberg, L. (2008). A social neuroscience perspective on adolescent risk-taking. Dev. 
Rev. 28, 78–106. 
Tait, R.J., Mackinnon, A., and Christensen, H. (2011). Cannabis use and cognitive 
function: 8-year trajectory in a young adult cohort. Addict. Abingdon Engl. 106, 2195–
2203. 
Takagi, M., Lubman, D.I., Cotton, S., Fornito, A., Baliz, Y., Tucker, A., and Yücel, M. 
(2011). Executive control among adolescent inhalant and cannabis users. Drug Alcohol 
Rev. 30, 629–637. 
Tapert, S.F., Granholm, E., Leedy, N.G., and Brown, S.A. (2002). Substance use and 
withdrawal: neuropsychological functioning over 8 years in youth. J. Int. Neuropsychol. 
Soc. JINS 8, 873–883. 
Tapert, S.F., Schweinsburg, A.D., Drummond, S.P.A., Paulus, M.P., Brown, S.A., Yang, 
T.T., and Frank, L.R. (2007). Functional MRI of inhibitory processing in abstinent 
adolescent marijuana users. Psychopharmacology (Berl.) 194, 173–183. 
Tarazi, F.I., and Baldessarini, R.J. (2000). Comparative postnatal development of 
dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int. J. Dev. Neurosci. Off. J. Int. 
Soc. Dev. Neurosci. 18, 29–37. 
Teichner, G., Donohue, B., Crum, T.A., Azrin, N.H., and Golden, C.J. (2000). The 
relationship of neuropsychological functioning to measures of substance use in an 
adolescent drug abusing sample. Int. J. Neurosci. 104, 113–124. 
Tervo-Clemmens, B., Simmonds, D., Calabro, F.J., Montez, D.F., Lekht, J.A., Day, N.L., 




Prospective Functional Neuroimaging Study. Biol. Psychiatry Cogn. Neurosci. 
Neuroimaging 3, 713–725. 
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. J. R. Stat. Soc. 
Ser. B Methodol. 267–288. 
Tschann, J.M., Adler, N.E., Irwin, C.E., Millstein, S.G., Turner, R.A., and Kegeles, S.M. 
(1994). Initiation of substance use in early adolescence: the roles of pubertal timing and 
emotional distress. Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. Assoc. 13, 
326–333. 
Volkow, N.D., and Fowler, J.S. (2000). Addiction, a Disease of Compulsion and Drive: 
Involvement of the Orbitofrontal Cortex. Cereb. Cortex 10, 318–325. 
Wechsler, D. (2003). Wechsler intelligence scale for children–Fourth Edition (WISC-IV). 
San Antonio TX Psychol. Corp. 
Whelan, R., and Garavan, H. (2014). When Optimism Hurts: Inflated Predictions in 
Psychiatric Neuroimaging. Biol. Psychiatry 75, 746–748. 
Whitford, T.J., Rennie, C.J., Grieve, S.M., Clark, C.R., Gordon, E., and Williams, L.M. 
(2007). Brain maturation in adolescence: Concurrent changes in neuroanatomy and 
neurophysiology. Hum. Brain Mapp. 28, 228–237. 
Wills, T.A. (1986). Stress and coping in early adolescence: relationships to substance use 
in urban school samples. Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. 
Assoc. 5, 503–529. 
Woicik, P.A., Stewart, S.H., Pihl, R.O., and Conrod, P.J. (2009). The substance use risk 
profile scale: A scale measuring traits linked to reinforcement-specific substance use 
profiles. Addict. Behav. 34, 1042–1055. 
Wong, T.-T. (2015). Performance evaluation of classification algorithms by k-fold and 
leave-one-out cross validation. Pattern Recognit. 48, 2839–2846. 
Yucel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., and 
Lubman, D.I. (2008). Regional brain abnormalities associated with long-term heavy 
cannabis use. Arch. Gen. Psychiatry 65, 694–701. 
Zou, H., and Hastie, T. (2005). Regularization and variable selection via the elastic net. J. 






CHAPTER 2: CROSS-SECTIONAL FACE PROCESSING DIFFERENCES IN 
ADOLESCENTS USING CANNABIS 
 
This Chapter has been previously published in the following format: 
 
Spechler, P. A., Orr, C. A., Chaarani, B., Kan, K.-J., Mackey, S., Morton, A., ... Garavan, 
H & IMAGEN Consortium.. (2015). Cannabis use in early adolescence: Evidence of 
amygdala hypersensitivity to signals of threat. Developmental Cognitive Neuroscience, 




Cannabis use in adolescence may be characterized by differences in the neural 
basis of affective processing. In this study, we used an fMRI affective face processing 
task to compare a large group (n = 70) of 14-year olds with a history of cannabis use to a 
group (n = 70) of never-using controls matched on numerous characteristics including IQ, 
SES, alcohol and cigarette use. The task contained short movies displaying angry and 
neutral faces. Results indicated that cannabis users had greater reactivity in the bilateral 
amygdalae to angry faces than neutral faces, an effect that was not observed in their 
abstinent peers. In contrast, activity levels in the cannabis users in cortical areas including 
the right temporal- parietal junction and bilateral dorsolateral prefrontal cortex did not 
discriminate between the two face conditions, but did differ in controls. Results did not 
change after excluding subjects with any psychiatric symptomology. Given the high 
density of cannabinoid receptors in the amygdala, our findings suggest cannabis use in 
early adolescence is associated with hypersensitivity to signals of threat. Hypersensitivity 









Adolescence is a significant period of psychosocial development, with increases 
in novelty-seeking and risk-taking behaviors (Adriani et al., 1998; Romer et al., 2010; 
Trimpop et al., 1998). Experimentation with drugs of abuse – especially alcohol, tobacco, 
and cannabis, is typically initiated during this phase (Chen and Kandel, 1995). As 
cannabis becomes more available and public opinion trends towards acceptance, 
adolescents may have increased access to the substance.  
Current rates of cannabis use among adolescents are high, with a quarter of all 
10th graders, and over a third of all 12th graders in the US reporting trying cannabis at 
least once (SAMHSA, 2014). Chronic use also appears to be growing; in 2008, 5.5% of 
users aged 12 and up reported near daily use while in 2013 this rate had risen to 8.1% 
(SAMHSA, 2014). These increasing rates of use are consequential in that about 10% of 
those who try cannabis will become weekly users in adulthood (Hall and Pacula, 2003). 
Furthermore, adolescent beliefs about the risks associated with cannabis appear to be 
declining (Johnston et al., 2011).  
Adolescence is also a period of marked neural development including gross 
volume changes, myelination, synaptic pruning, and receptor proliferation (Spear, 2000). 
These changes are especially large in the prefrontal cortex (PFC) (Gogtay et al., 2004; 
Whitford et al., 2007), amygdala, hippocampus, and striatum, and are governed in part by 
the endogenous cannabinoid system (Bossong and Niesink, 2010). Interestingly, the 
primary cannabinoid receptor, CB1, is found in high concentrations in these cognitive 




al., 2001), and appears to be fully expressed by adolescence (Belue et al., 1995; de 
Fonseca et al., 1993; Morozov and Freund, 2003; Romero et al., 1997). Studies have 
shown that exogenous cannabinoids can interfere with the endogenous system (Hoffman 
et al., 2007; Mato et al., 2004). Given the natural maturation occurring in the brain during 
adolescence, and the propensity towards cannabis use, the consumption of exogenous 
cannabinoids during adolescence may disrupt typical neurodevelopment within the 
cognitive and affective neural systems.  
Mounting evidence supports the relationship between early cannabis use and 
mood disorders (Wittchen et al., 2007), even with relatively low levels of use (Cheung et 
al., 2010). Hence, it is crucial to investigate the consequences of cannabis use on 
emotional development. Although numerous studies have associated cannabis use in 
adolescence with an increased likelihood of schizophrenia and/or other affective 
disorders (Arseneault et al., 2004; Degenhardt and Hall, 2006; Fergusson et al., 2006; 
Hall, 2006; Linszen and van Amelsvoort, 2007; Manrique-Garcia et al., 2012) there is 
relatively little research on the impact of cannabis use from a cognitive and affective 
neuroscience perspective.  
The amygdala has a high density of CB1 receptors, notably in the basal and lateral 
nuclei (Katona et al., 2001). In adulthood, increased amygdala activity is associated with 
major depressive disorder (Drevets, 2001; Sheline et al., 2001), and generalized social 
phobia (Evans et al., 2008; Phan et al., 2006). In adolescence, the amygdala was found to 
yield stronger responses to fearful faces than adults (Thomas et al., 2001), and greater 




et al., 2008a; Monk et al., 2008; Roberson-Nay et al., 2006). In consideration of the 
amygdala’s role in the endocannabinoid system and affective processing, adolescent 
vulnerability to mood disorders and propensity for cannabis use, it is important to assess 
functional differences in this region in cannabis-using teenagers.  
Using an animal model, Rubino and colleagues (2008), and Schramm-Sapyta and 
colleagues (2007) examined the relationship between anxiety and THC exposure in 
adolescent and adult rats. Findings indicate that adolescent rats exhibit elevated signs of  
anxiety, depression, and anhedonia when treated with THC compared to placebo. 
Translating these findings to humans may imply cannabis use in adolescence is related to 
differences in the generation and regulation of affect.  
To examine the impact of cannabis use on brain regions subserving emotional 
processing, we conducted an fMRI study on 14-year old cannabis users vs. controls using 
affective face stimuli. Angry and neutral faces provide a robust probe of activity within 
the amygdala and PFC in adults (Morris et al., 1996; Pessoa et al., 2002; Whalen et al., 
1998), as well as children and adolescents (Baird et al., 1999; Thomas et al., 2001). The 
differential activity of the amygdala to angry versus neutral faces is an excellent index of 
emotional processing and may relate to psychopathology. However, in order to prevent 
ceiling effects, we used a set of stimuli that was only mildly negatively valenced on the 
basis that they may provide a sensitive test of enhanced amygdala reactivity (Grosbras 
and Paus, 2006).  
To date, few study have examined the relationship between cannabis and face 




blind, placebo-controlled study of THC intoxication and face processing using fMRI. 
Findings indicate THC attenuates the amygdala response to fearful faces. Similarly, 
Gruber and colleagues (2009) studied 15 chronic cannabis users vs. matched controls 
under fMRI during a masked affective face processing task. Results suggest chronic 
cannabis use is associated with decreased reactivity in the anterior cingulate and 
amygdala. While both Phan and Gruber’s findings suggest anxiolytic effects in 
intoxicated adults, these studies do not address whether the effects would replicate in 
users not intoxicated during scanning, nor does it address whether the effects would 
generalize to adolescents. Nonetheless, these studies provide evidence that cannabis use 
is associated with differences in affective processing.  
In this relatively large fMRI study (N=140), we investigated the impact of 
previous cannabis use (n=70) compared to closely matched controls (n=70) in early 
adolescence using a face processing task during fMRI. To date, there has been no 
previous research directly studying history of cannabis use with face processing, 







We identified a sample of cannabis-experimenting adolescents (n=70) and 
matched controls (n=70) from the IMAGEN dataset, a large multi-site longitudinal study 
of adolescent development (Schumann et al., 2010). The European School Survey Project 




to identify the cannabis-experimenting group. Subjects provided a self-report based on a 
scale from 0 to 6, (1=1–2x; 3= 6–9x; 6=40+; see Table 2.1 for complete distribution, and 
Table 2.2 for substance use age of onset distributions). Subjects who endorsed using 
other illicit substances were excluded, and any subject exhibiting signs of intoxication 
were excluded from scanning.  
Given the relationship between amygdalar reactivity and psychopathology, 
subjects completed the Development and Well-Being Assessment (DAWBA; Goodman 
et al., 2000) to screen for psychopathology symptomology. DAWBA clinical rating 
scores were obtained from trained DAWBA clinicians who generated clinical rating 
scores by reviewing parent, teacher, and adolescent DAWBA responses. Final scores 
consisted of one of three categories: no-diagnosis, unsure, and, sure diagnosis, on any 
DSM-IV symptom class of psychopathology. From our sample, five of the controls and 
nine of the cannabis-experimenting group did not complete the DAWBA. Nonetheless, 
subjects were matched to the best of our ability on the DAWBA as indicated via chi-
square analyses.  
Controls were identified and matched on sex, handedness, age, verbal 
comprehension and perceptual reasoning IQ, pubertal development, socioeconomic 
status, and site. As cannabis use is highly correlated with alcohol and cigarette use (Hall 
and Pacula, 2003), which often makes it difficult to attribute group differences to the 
cannabis use per se, controls were also matched on lifetime alcohol and cigarette use. 




performed on the remaining continuous measures (see Table 2.3 for subject information 
and p-values).  
 
Task  
Participants passively viewed a collection of video clips that contained either a 
person’s face or a control picture (concentric circles). The task was designed and 
originally implemented by Grosbras and Paus (2006) and required participants to 
passively view a series of short (2–5s) black-and-white video clips showing a face that 
started from a neutral expression and progressively turned angry, or, progressively turned 
to a second neutral expression. The control pictures contained expanding and contracting 
concentric circles of various contrasts, roughly matching the contrast and motion 
characteristics of the faces. These control images were designed and originally 
implemented by Beauchamp and colleagues (2003) and were included to account for 
neural activity associated with viewing non-biological motion. All stimuli were presented 
as 18 s blocks, with 4–7 video clips per block during a face block. Each run was 
comprised of 5 blocks of neutral faces and 5 blocks of angry faces.  
 
Imaging parameters  
All MRI data were acquired using 3T MRI scanners made by several 
manufacturers (Siemens, Philips, General Electric, Bruker) in the eight IMAGEN 
assessment sites (London, Nottingham, Dublin, Mannheim, Dresden, Berlin, Hamburg, 




flip angle and matrix; see Schumann et al., 2010) and followed an extensive program of 
cross-site standardization. Although our groups were matched on site, each participant’s 
site was modeled as a nuisance covariate in the statistical analyses. In the present task, 
160 volumes per subject were obtained, each comprising 40 slices. The slices were 
aligned to the connecting line between the anterior and posterior commissure (2.4 mm 
thickness, 1 mm gap, TR=2.20s, TE=30ms).  
 
Imaging analysis  
The pre-processing of the EPI data was done within SPM8 (Statistical Parametric 
Mapping, http://www.fil.ion.ucl.ac.uk/spm/). Time series data were first corrected for 
slice-timing, then corrected for movement (spatial realignment), non-linearly warped into 
MNI space (using a custom EPI template), and Gaussian-smoothed at 5mm-FWHM. 
Activation maps were computed with SPM8, and regressed using a general linear model 
(GLM) with AR noise model (SPM default) against a design-matrix modeling each event 
of the stimulus presentation. Contrast images were obtained for the main effect of angry 
faces and neutral faces, as well as the differential activation for angry vs. neutral faces.  
 
Preliminary analysis  
A preliminary voxel-wise analysis directly comparing the cannabis-experimenting 
group to the control group was conducted using the AFNI toolbox (Cox, 1996). We 
subjected the data to a between-group t-test on the contrast image of angry minus neutral 




cannabis-experimenting group in small clusters spanning potentially interesting cortical 
and subcortical areas (dorsolateral prefrontal cortex (dlPFC), temporal parietal junction, 
fusiform, and right extended amygdala into the striatum). However, at a whole-brain 
uncorrected p < .005, the clusters were small and consequently prompted a functionally 
defined region-of-interest analysis.  
 
Voxel-wise analysis  
The central goal of the voxel-wise analysis was to find unbiased clusters of brain 
activation that discriminated between angry and neutral faces. All cannabis-
experimenting and control subjects were combined and treated as one group in a t-test vs. 
zero using the angry vs. neutral contrast. Scanning site was used as a nuisance covariate 
to account for the variance associated with multisite data collection.  
 
ROI selection  
ROIs were defined based on the results from the above voxel- wise analysis. The 
alpha-level for cluster detection was determined by running Monte Carlo simulations 
using AFNI’s 3dClustSim. The smoothness of the data was estimated using 3dFWHMx 
(details at http://afni.nimh.nih.gov/pub/dist/doc/program help/). Based on a voxel-wise 
uncorrected alpha of p=.005, a minimum cluster extent was determined to be 112 
contiguous voxels, so as to arrive at a corrected ROI-level alpha of p = .01. From these 
criteria, we identified seven regions that were significantly more active for angry faces 




Based on prior knowledge of the importance of the amygdala in affective face 
processing, left and right anatomically defined amygdala ROIs were also included in the 
analysis. Amygdala ROIs were obtained using the Eickhoff–Zilles macro label atlas in 
MNI space distributed within AFNI (Eickhoff et al., 2005). The voxels in the amygdala 
ROIs were then resampled to match the grid dimensions of the functional data.  
 
ROI Analysis  
The seven functionally defined clusters, plus the left and right amygdala ROIs, 
were used to extract the mean BOLD signal from the angry face and neutral face 
contrasts for all subjects. The mean signal for each ROI were then subjected to a 2-by-2 
(group × face type) analyses of variance using SPSS v. 22 (IBM Corp. Armonk, NY). All 
p-values reported were corrected for multiple comparisons using a modified Bonferroni 
procedure (Keppel and Wickens, 2004). For display purposes, the mean signal for face 
type by group was plotted using MATLAB v. R2014a (The MathWorks, Inc., Natick, 
MA). Lastly, we tested for any correlation between the mean signal per face type within 
all the ROIs with the level of cannabis use, and age of onset of cannabis, alcohol, and 




As shown in Table 2.3, the two groups did not differ in sex, handedness, age, verbal or 




diagnoses, lifetime alcohol or cigarette use. Further, the cannabis-experimenting group’s 
mean verbal and perceptual IQ did not significantly differ from the means of the entire 
IMAGEN sample (N = 1849) at p < .05.  
 
Voxel-wise analysis results  
Seven clusters were identified centered on the right and left middle temporal 
gyrus, right and left inferior frontal gyrus, bilateral anterior cingulate, left cerebellum, 
and right lingual gyrus (see Table 2.4).  
 
ROI ANOVA Results  
As expected given how they were identified, all seven functionally defined ROIs, 
plus the amygdalae, exhibited a significant main effect of face type (F9,130=30.03, 
p<.001). None showed a main effect of group but, instead, five of the nine had significant 
interactions between face type and group. These five were the left amygdala (F1,138=8.54, 
p<.001); right amygdala (F1,138=8.54, p=.004); right middle temporal gyrus with extent 
into temporal parietal junction (F1,138=5.28, p=.006); left inferior frontal gyrus with 
extent into dlPFC (F1,138=4.87, p=.008); and right inferior frontal frontal gyrus with 
extent into dlPFC (F1,138=5.71, p=.006) (see Figs. 2.1–3 and Table 2.4).  
Post hoc tests revealed that within the cannabis-experimenting group, there were 
significant differences in the bilateral amygdalae with greater activation for the angry 
faces (right amygdala t69=4.02, p< .001; left amygdala t69=3.15, p=.002) but no effect of 




significant face type differences in all the cortical regions with greater activation for 
neutral faces, but no effect of face type on the BOLD signal in the amygdalae (right 
middle temporal gyrus t69=−7.20, p<.001; left inferior frontal gyrus t69=−5.13, p<.001; 
right inferior frontal gyrus t69=−5.68, p<.001: see Table 2.5 for all post-hoc t-test results).  
 
ROI Correlations with Other Drugs  
To examine dosage–response effects, we investigated Pearson’s correlation on 
frequency of cannabis use with the mean signal per face type within each region. Dosage 
effects within bilateral amygdalae and dlPFC were non-significant at p<.05. Interestingly, 
we detected a significant correlation within the right TPJ cluster with frequency of 
cannabis use. Both the mean signal related to angry faces (r=−.25, p<.05), and neutral 
faces (r=−.26, p<.05), was correlated with frequency of cannabis use, such that, more 
frequent cannabis use is associated with less processing by the right TPJ during 
presentation of both face types.  
We also investigated Pearson’s correlation on age of onset of cannabis, alcohol, 
and cigarette use with the mean signal per face type within each ROI. However, we failed 
to detect any significant correlations at p<.05 between age of onset for any drugs of abuse 
with any of the ROIs.  
 
Psychopathology Symptomology  
The DAWBA clinical rating scores revealed 14 cannabis- experimenters and 10 




symptom class diagnoses. Chi-square analyses revealed the only symptom class that 
significantly differed between the two groups was conduct disorder: X21,122=5.55, p<.05. 
This finding is consistent with previous studies reporting an association between conduct 
disorder and cannabis use initiation during adolescence (Castellanos-Ryan and Conrod, 
2011; Hopfer et al., 2013).  
 
Influence of Psychopathology  
To examine if the conduct disorder finding was related to our results, we first 
excluded the five subjects with a conduct disorder diagnosis and re-ran the ANOVA and 
post hoc t-tests. Both the ANOVA and post hoc t-tests results remained the same as the 
initial analysis with all subjects included. We then tested to see if conduct disorder in the 
cannabis-experimenting group was correlated with the BOLD signal in any of the ROIs, 
but failed to detect any significant correlation at p < .05.  
Lastly, to test if any psychopathology influenced the dataset, we excluded all 14 
cannabis-experimenting and 10 control subjects with a strong probability of a DSM-IV 
category diagnosis from the ANOVA and post hoc t-tests, and reran the analyses. When 
correcting for multiple comparisons, the left and right amygdala and right TPJ maintained 
significance on the ANOVA face type × group interaction. Nonetheless, the same five 
regions that initially survived correction for multiple comparisons for the full sample 
analysis still passed significance at an uncorrected p-value of <.05. Additionally, the post 
hoc t-test results remained the same. Consequently, with minor exceptions regarding 




analyzed on sub-groupings devoid of any mental health symptomology. Hence, these 
findings suggest that mental health symptomology was not contributing to the full sample 
group differences.  
 
Discussion  
In this study, we examined the functional neurobiology of angry and neutral face 
processing in a group of cannabis-experimenting adolescents vs. matched controls using 
fMRI. We found group- by-face type interaction effects in bilateral amygdala and three 
clusters of activation that span the right TPJ and bilateral dlPFC. Decomposing these 
results by face type, we found the cannabis-experimenting group exhibited increased 
activity to angry faces in the amygdala. Conversely, the control group exhibited increased 
activity to neutral faces in the cortical regions. Therefore, cannabis use during early 
adolescence is associated with hypersensitivity to negative affect in the amygdala. While 
we stress that this study does not permit us to conclude cannabis-experimentation caused 
the observed functional neurobiological differences, we are confident these differences 
are associated with the cannabis use status of the participants due to our relatively large 
sample size (N = 140), carefully matched control group (who did not differ on sex, 
pubertal development, IQ, site, psychopathology, or alcohol and cigarette use), and a 
conservative criteria to meet statistical significance.  
With regard to the cortical findings, the right TPJ and bilateral dlPFC showed 
greater activation to neutral faces than angry faces in the control group. The right TPJ has 




2000; Saxe and Kanwisher, 2003; Saxe and Powell, 2006). Furthermore, the right 
superior temporal gyrus encodes biologically relevant motion (Grossman et al., 2000; 
Puce and Perrett, 2003; Saygin, 2007). Therefore this cluster may represent a signal of 
social salience related to the moving face stimuli. In contrast to controls, post hoc t-test 
results show the cannabis-experimenting group fails to process angry faces differently 
from neutral faces within the right TPJ (see Fig. 2.2). As this region was also the only 
region to exhibit significant dosage effects, a higher degree of cannabis experimentation 
may contribute to a departure from healthy social processing. Interestingly, as none of the 
regions exhibited a significant correlation with age of onset for any drugs of abuse, we 
are unable to make claims regarding face processing and cannabis use in relation to age 
of onset with other drugs.  
Considering that the cortical clusters spanned the temporal, parietal, and bilateral 
frontal lobes, we suggest that the neutral faces demanded more cognitive resources. The 
neutral faces had greater ambiguity and variability in their content, such as nose 
twitching, mouth movements, and eye-blinks. Furthermore, all stimuli video clips started 
from neutral and transitioned to angry or neutral faces. The stimuli that transitioned to 
angry faces were more explicit during the shift to threat, whereas the transition to another 
neutral face may have required more cognitive strategies to decode. Hence, the neutral 
faces may have demanded a greater degree of attention and interpretation by these 
cognitive systems.  
With regard to the amygdala findings, it is unclear whether amygdala 




cross-sectional study. If amygdala hypersensitivity preceded use, which might seem most 
plausible given the low levels of reported use, then it’s possible that these individuals 
may have been inclined to self-medicate for the drug’s acute anxiolytic effects (Phan et 
al., 2008). Consistent with this interpretation, recent evidence has identified altered angry 
face processing in the ventromedial PFC (vmPFC) to predict future binge drinking 
(Whelan et al., 2014) and the vmPFC is part of a brain circuit that attenuates amygdala 
activity (Banks et al., 2007; Urry et al., 2006). If, however, the amygdala hypersensitivity 
is a consequence of cannabis use, then it is likely that this is due to exogenous stimulation 
of the endocannabinoid system. If confirmed, these findings would raise concerns 
regarding the risks associated with cannabis consumption and emotional health in 
adolescent users. Animal studies suggest exogenous cannabinoids inhibit GABAergic 
neurotransmission in the amygdala (Katona et al., 2001). Interestingly, this effect is 
magnified when the animal is given THC and placed in a threatening environment (Patel 
et al., 2004). Together these findings suggest that cannabinoids may compromise the 
major neuronal inhibitory mechanism within the amygdala and lower the threshold for 
activation, especially during signals of threat. Consistent with this interpretation, the 
angry faces used in the task were not exceptionally potent signals of threat yet the 
cannabis-experimenting group showed a heightened reactivity to them, an effect that is 
not observed in healthy controls viewing the same stimuli (Grosbras and Paus, 2006).  
The amygdala’s role in affective processing serves an important role in 
evolutionary biology as it directs attention towards aversive stimuli. However, mounting 




disorders. Greater signal change in the amygdala, specifically during affective face 
processing, is exhibited by children with anxiety (Thomas et al., 2001), and adults with 
major depressive disorder (Drevets, 2001; Fu et al., 2008; Sheline et al., 2001) and 
generalized social phobia (Evans et al., 2008; Phan et al., 2006). Thus, cannabis use in 
adolescence may contribute to the etiology of mood disorders in adulthood. Moreover, 
relatively light use by an early age may contribute to an early marker of maladaptive 
affective processing. Nonetheless, major longitudinal studies are needed to illuminate 
these hypotheses as the current study is unable to infer causality.  
The results reported here are inconsistent with those of Phan and colleagues 
(2008) and Gruber and colleagues (2009) who both found attenuated amygdala reactivity 
to threat signals in adults following acute THC administration, and chronic non-
intoxicated users, respectively. In contrast, we report trait-related increased amygdala 
reactivity to threat signals in adolescence. Hence, we report divergent effects in 
adolescents compared to adults. As previous research demonstrates divergent findings 
between adolescents and adults during affective face processing (Guyer et al., 2008a,b), 
we do not hypothesize adolescent data to mirror the adult data. Indeed, our results support 
the notion that adolescence is period of sensitive affective development that can be 
perturbed even with very low levels of cannabis experimentation.  
The current results are consistent with the animal models of cannabinoid exposure 
during adolescence (Rubino et al., 2008; Schramm-Sapyta et al., 2007) and suggest that 
more human research is needed on the long-term effects of cannabis use in adolescence. 




disorders later in life, acute THC consumption effects in the adolescent brain may be 
different or, indeed, the long-lasting effects of repeated exposure may be different beyond 
the acute intoxication phase. As adolescents tend to be more reactive to emotional 
stimuli, especially face processing in the amygdala, the observed differences in 
adolescent cannabisusers may suggest evidence of maladaptive cognitive and affective 
systems related to psychosocial development.  
Lastly, a notable feature of the present results is that our sample of cannabis users 
reported relatively low levels of use, but nonetheless exhibited significant differences in 
processing threat signals. Furthermore, due to the closely matched control group, we 
excluded a range of possible confounding factors, including mental health comorbidities, 
which may have accounted for the observed differences. As excluding subjects with 
mental health comorbidities failed to change the pattern of our results, the findings 
suggests that very low use of cannabis during early adolescence may compromise healthy 
emotional reactivity.  
An alternative explanation regarding the observed differences in affective face 
processing may be attributed to unmeasured pre- existing differences in emotional 
functioning, which might have contributed to the adolescents’ experimentation with 
cannabis. Indeed, we have previously shown that activation in response to these angry 
faces in the left PFC predicted binge drinking two years later, which would suggest 
altered emotional reactivity may precede use (Whelan et al., 2014). However, in the 




levels of any of the affective disorders, therefore, it is unclear which preexisting 
differences, if any, might have been present in the cannabis-experimenting group.  
Future studies will be performed on the follow-up (age 16 and 18) data of this 
project to identify predictive factors contributing to the cannabis use phenotype profile. 
As this was a cross-sectional study from the baseline IMAGEN dataset, we stress that we 
are unable to claim cannabis use caused amygdala hypersensitivity to negative affect. To 
investigate this question, longitudinal data analysis will inform whether hypersensitivity 
to threat signals precedes use or is a consequence of use, and assessments of 
psychopathology will clarify if early cannabis use and differences in face processing 
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* Based on a self-report scale from 0-6. (1=1-2 times; 2=3-5 times; 3=6-9 times; 4=10-19 




1-2 times 49 
3-5 times 7 
6-9 times 7 
10-19 times 2 
20-39 times 3 
40+ times 2 








   
Males/Females (n) 50/20 41/29 .111 
Left / Right Handedness (n) 6/64 5/65 .753 
Age (M,SD) 14.765, 0.40 14.61, 0.655 .607 
Perceptual Reasoning IQ (M,SD) 104.219, 16.876 105.72, 13.879 .555 
Verbal Comprehension IQ (M,SD) 110.74, 16.84 110.43, 13.329 .905 
Puberty Development Scale  (M,SD) 3.60, 0.60 3.8, 0.63 .585 
Socioeconomic Status (M,SD) 18.45, 4.42 18.24, 4.70 .751 
Lifetime Alcohol Use (M,SD) 3.71, 1.63 3.56, 1.32 .530 
Lifetime Cigarette Use (M,SD) 3.106, 2.215 2.54, 2.215 .158 
Lifetime Cannabis Use (M,SD)* 1.70, 1.30 0, 0 .000 
Measure Group p 
 Cannabis (n=70) Controls (n=70)  
    
Age of first cigarette (M, SD) 12.73, 1.07 12.64 , 1.00 .640 
Age of first wine (M, SD) 12.20 , 1.25 12.11, 1.17 .723 
Age of first beer (M, SD) 12.46 , 0.98 12.44 , 1.04 .906 
Age of first wine cooler (M, SD) 12.90 , 1.25 12.97, 0.98 .708 
Age of first spirit (M, SD) 13.25 , 0.87 13.21, 0.84 .858 




Table 2.4: Anatomically and functionally defined ROIs with group by condition 
interaction statistics.  
 
 
Rows in bold survived a modified Bonferroni correction for multiple comparisons. 
  









 x , y, z k F p 
Left amygdala  120 8.54 .000 
Right amygdala  139 5.56 .004 
Right middle temporal gyrus, cluster 
extends into temporal parietal junction 
(TPJ) 
-54, 47, 6 1333 5.28 .006 
Left inferior frontal gyrus, cluster 
extends into dorsolateral prefrontal 
cortex (dlPFC) 
54, -14, 28 417 4.87 .008 
Right inferior frontal gyrus, cluster 
extends  into dorsolateral prefrontal 
cortex(dlPFC) 
-49, -14, 33 356 5.71 .004 
Left middle temporal gyrus, cluster extends 
into temporal-parietal junction (TPJ) 
53, 51, 9 1181 2.19 .115 
Left cerebellum 12, 78, -39 477 2.36 .096 
Right lingual gyrus -13, 79, -8 317 1.53 .219 
Bilateral anterior cingulate, cluster extends 
into ventromedial prefrontal cortex 




Table 2.5: Post-hoc t-test comparison for within-group differences.  
 





Figure 2.1: Mean activation for face type by group plotted for right and left amygdala.  
 
Asterisks indicate post-hoc t-test differences significant at p<.05, corrected. Error bars 
represent the standard error of the mean. 
  
Region of Interest Angry faces vs. Neutral faces 
Cannabis Controls 
  
Left amygdala t(69) = 4.02, p < .001 t(69) = -0.32, p = .750 
Right amygdala t(69) = 3.15, p = .002 t(69) = -0.73, p = .470 
Right middle temporal gyrus, 
 cluster extends into  
temporal parietal junction (TPJ) 
t(69) = -1.21, p = .231 t(69) = -7.20, p < .001 
Left inferior frontal gyrus,  
cluster extends into  
dorsolateral prefrontal cortex (dlPFC) 
t(69) = -0.60, p = .551 t(69) = -5.13, p < .001 
Right inferior frontal gyrus, 
 cluster extends into  
dorsolateral prefrontal cortex (dlPFC) 




Figure 2.2: Mean activation for face type by group plotted for the cluster spanning the 




Blue bars represent angry faces, red bars represent neutral faces. Asterisks indicate post-
hoc t-test differences significant at p<.05, corrected. Error bars represent the standard 




Figure 2.3: Mean activation for face type by group plotted for the cluster spanning the 




Blue bars represent angry faces, red bars represent neutral faces. Asterisks indicate post-
hoc t-test differences significant at p<.05, corrected. Error bars represent the standard 










CHAPTER 3: AMYGDALA REACTIVITY BEFORE AND AFTER CANNABIS 
USE IN ADOLESCENCE 
 
3.1. Before: Amygdala Reactivity Predicts Cannabis Use By Age 19 
 
Introduction 
 Cross-sectional analyses from Chapter 2 (Spechler et al., 2015) identified 
significant group by face-type interactions across several cortical and subcortical regions 
when comparing a group of adolescents reporting cannabis use by age 14 relative to a 
group of matched controls. Of particular interest, heightened bilateral amygdala reactivity 
to angry faces were observed in individuals who reported any lifetime cannabis use at 
baseline. This initial investigation characterizing the functional neurobiology of 
adolescent cannabis use was unable to determine if the amygdala effect was predictive, or 
a consequence, of cannabis use. Fortunately, the longitudinal nature of the IMAGEN 
study can be interrogated to approach this question by analyzing the face processing data 
in a sample of teens who were cannabis naïve at baseline and then report use later in 
adolescence.  
As reported in Chapter 2, there was no correlation between either the left or right 
amygdala activations with cannabis use age of onset. Additionally, no correlation was 
found using the baseline level of cannabis use. It is therefore possible that heightened 
amygdala reactivity was a pre-existing difference in cannabis users, rather than a 
consequence arising from use. Given this lack of association with age of use onset and 
use levels, the hypothesis guiding the subsequent analyses is that heightened amygdala 




  Previous studies indicated that heightened amygdala activations, specifically to 
emotionally evocative faces, may be characteristic of emotional dysregulation in 
adolescence (van den Bulk et al., 2014; Monk et al., 2008; Thomas et al., 2013). And 
while chronic cannabis use (Gruber et al., 2009) and acute administration of THC (Phan 
et al., 2008) have been implicated in the attenuation of amygdala activations to evocative 
faces, there is mounting evidence that cannabis use may negatively impact adolescent 
development (as discussed in Chapter 1). Adolescents with pre-existing heightened 
amygdala reactivity may be vulnerable to initiate and maintain cannabis use as a means to 
down-regulate their amygdala activity and achieve anxiolytic effects. In doing so, these 
adolescents also risk experiencing some consequences of their use.  Further research is 
therefore required to confirm dysregulated amygdala processing as a risk factor for 
cannabis use. If substantiated, these findings may implicate amygdala reactivity as a 
prognostic biomarker in the identification of vulnerable adolescents. These findings 
would also inform safe treatment methods by directly targeting this biomarker via bio-
feedback mechanisms (Zotev et al., 2011), pharmaceuticals (Arce et al., 2008; Paulus et 
al., 2005), or indirectly via cognitive behavioral therapy (McClure et al., 2007).  
For the analyses in the current section, bilateral amygdala reactivity to angry faces 
measured at baseline (age 14) served as the independent variables in a linear regression 
model predicting the level of cannabis use by the age 19 assessment of the IMAGEN 
study. Critically, all participants were selected for being cannabis-naïve at baseline. Other 
variables potentially influencing amygdala reactivity and/or related to future cannabis use 




levels. Therefore, any significant effects related to the amygdala were identified over and 




Participants from the IMAGEN study were selected based on their reported drug 
use levels at all time points from the ESPAD survey (Hibell et al., 1997). Starting with 
the full baseline sample (N=2,224), there were n=2,045 individuals who reported no 
lifetime cannabis use by age 14. From these n=2,045, there were 571 who reported 
cannabis use by age 19. Only those with reliable reporting patterns (age 16 level <= age 
19 level) were selected. No exclusions were made for other drug use levels at any time 
point, although tests for drug specificity were completed (detailed later).  
From those 571, there were 40 who did not supply a face processing scan, and an 
additional 6 excluded for excessive head motion. Therefore, 525 participants were 
included in the subsequent analyses (see Table 3.1.1 for sample characteristics). Across 
these 525, their lifetime cannabis use by age 19 data was plotted. These levels followed a 
U-shape distribution with relatively high levels at the opposite tails, with lower 
intermediate use levels (See Figure 3.1.1 and Table 3.1.2).  
There were no controls in the primary linear regression analyses (described 
below) in order to test if amygdala reactivity would exhibit a dose-response relationship 
in predicting the level of future use in an analysis restricted to users. As a secondary 




as a whole from a sample of participants who were cannabis-naïve at all time points. 
Hence, from the full sample of participants with ESPAD data at baseline (N=2,224), there 
were n=648 identified as being cannabis-naïve at all time points. From those 648, there 
were 46 who did not supply a face processing scan, and an extra 8 who were excluded 
due to excessive head motion. Therefore, 594 participants were included in the cannabis-
naïve sample.  
 
fMRI Data 
 The face processing fMRI data were analyzed using standard preprocessing 
methods as described in Chapter 2. During image realignment, head motion estimates 
were obtained for each of the three translation and rotation directions. From these motion 
estimates, framewise displacement (Power et al., 2012) was calculated. The mean 
framewise displacement across the entire run (mean FD) constituted a single summary 
statistic for head motion and was used as a nuisance covariate in the regression analyses 
(described below). Participants exceeding a mean FD >0.5mm were excluded for quality 
assurance purposes.   
Whole-brain task activation maps were estimated using the GLM, and contrast 
images were obtained for angry faces vs. control images, and neutral faces vs. control 
images. In keeping with the methods of Chapter 2, bilateral amygdala regions of interests 
(ROIs) using the “Eickhoff–Zilles” macro label atlas (Eickhoff et al., 2005) were used to 






A set of nuisance covariates was included to adjust for potentially confounding 
factors influencing both amygdala reactivity and cannabis use levels. These covariates 
included age at baseline scan, pubertal development scale (Carskadon and Acebo, 1993), 
sex, handedness, performance and verbal IQ, mean FD, and site of scanning acquisition. 
Lifetime cigarette and alcohol use from the baseline ESPAD survey were also modeled as 
covariates. Finally, given the relationship between amygdala activation and anxiety, the 
baseline DAWBA band score (Goodman et al., 2000) for generalized anxiety disorder 
(DSM-IV) was included as the final covariate. The band score is an ordinal measure 
estimated by a computer algorithm using the pattern of responses from the DAWBA 
instrument and reflects the probability of receiving a DSM-IV diagnosis. See Table 3.1.3 
for the probability bands for each level of this measure for each group. Bivariate 
correlations between anxiety and the amygdala activation, and, anxiety and the outcome 
measure were also reported to address the self-medication hypothesis. 
 
Regression Models  
 Linear regression analyses were constructed to predict cannabis use by age 19 
from a set of measures collected at age 14 including left and right amygdala reactivity to 
angry faces. The regression models were also estimated in a stepwise fashion in three 
blocks, starting with all the nuisance covariates, followed by the left amygdala, and 
finishing with the right amygdala. This order was implemented to obtain an adjusted R2 




predictor after first modeling the nuisance covariates. Similar regression models were 
estimated using bilateral amygdala activations to neutral faces. Although angry faces was 
the primary contrast of interest given the finding from Chapter 2 indicating angry faces 
elicits the most robust activations. All statistical analyses were conducted using SPSS 
v.24 (Armonk, NY: IBM Corp).   
 
Results 
Primary Regression Analyses (Future Cannabis Users Only) 
 525 participants were included in a multiple linear regression model predicting 
their level of cannabis use by age 19 with a set of independent variables measured at 
baseline. Results indicated that the full model containing all variables at age 14 
significantly predicted cannabis use by age 19 (F19,504 = 3.48, p<.001), explaining roughly 
8% of the variance in future cannabis use. Within this full model adjusted for all nuisance 
covariates, the right amygdala reactivity to angry faces significantly predicted the level of 
cannabis use by age 19 (Right amygdala: β=1.11, p<.05). The positive beta value 
indicates that an increase in right amygdalar activation to angry faces at age 14 predicts 
an increase in the level of future cannabis use. Moreover, sex (β=-.50, p<.05) and 
baseline cigarette use (β=.23, p<.05) also emerged as significant predictors within the full 
model. When estimating a stepwise regression model, it was found that after including all 
other predictors, the inclusion of the right amygdala activation to angry faces explained 




The left amygdala activation to angry faces was not a significant predictor when 
adding it into the stepwise regression either before or after the inclusion of the right 
amygdala, nor was it a significant predictor when considering a simple regression model 
excluding all other predictors. Moreover, when executing identical analytic procedures 
using the bilateral amygdala activations to neutral faces, no significant effects were 
observed. Therefore, when considering angry and neutral face processing in the left and 
right amygdala, only the activation to angry faces in the right amygdala emerged as a 
significant predictor of cannabis use later in adolescence.  
 
Associations With Anxiety Levels  
Interestingly, baseline anxiety did not emerge as a significant predictor within the 
multiple regression model. Baseline anxiety was included as a covariate because anxiety 
has been previously reported to predict both cannabis use (Agosti et al., 2002; Buckner et 
al., 2008), and heigthened amygdala activations (Monk et al., 2008). To address these 
potential relationships in the current dataset, Pearson’s bivariate correlations between 
baseline anxiety, follow-up cannabis use, and the baseline amygdala activations were 
estimated. Results indicated that, again, no relationship was found between baseline 
anxiety and future cannabis use, or, baseline anxiety and any of the amygdala activations 
(left or right; angry or neutral) (all ps > .05). Spearman’s rho correlation was also 
estimated given the ordinal nature of the measure, but null results were reproduced. 




two measures in isolation, or in the presence of the other predictors.  See the following 
Section 3.2 for analyses testing for changes in anxiety levels from baseline to follow up.  
 
Correlated Measures 
Concerns with multicolinearity among the predictor variables can be addressed by 
estimating the variance inflation factor (VIF), which signifies the extent to which a 
regression coefficient’s standard error is inflated given the correlation with the other 
independent variables. Generally, VIFs greater than or equal to 5 indicate serious 
multicolinearity and compromises the interpretation of the results. Considering the 
significant predictors, the VIF for sex (VIF=1.5), baseline cigarettes (VIF=1.3), and the 
right (VIF=1.9) amygdala activation to angry faces, were well below values of concern. 
And while the left amygdala was not a significant predictor, its VIF was also low 
(VIF=1.9).  
Sex was identified as a significant predictor of future cannabis use within the 
multiple regression model. As between-group t-tests indicated that males exhibit higher 
activations to angry faces than females (t=3.5, p<.05), and also use more cannabis (t=2.4, 
p<.05), it could be argued that the amygdala effect is a proxy for sex. This argument is 
countered by the low VIF on sex and the right amygdala coefficients. Those results 
indicated stable coefficient estimates with low colinearity with each other despite their 
modest correlation. Lastly, the low VIF for the left amygdala indicated that it is unlikely 





Secondary Regression Analyses (Inclusion of Cannabis-Naïve Participants)  
 As a final analysis to determine that the reported effects discriminates all future 
users from controls, the linear regressions were repeated with the inclusion of the 
cannabis-naïve sample. Here, the results were consistent with the primary analysis, and 
also indicated a substantial improvement in the overall R2. Results indicated the full 
model containing all variables at age 14 significantly predicted cannabis use by age 19 
(F19,1097 = 4.34, p<.001), explaining roughly 15% of the variance in future cannabis use. 
Consistent with the cannabis-only regression model, the right (but not left) amygdala 
activation to angry faces significantly predicted the level of cannabis use by age 19 
(Right amygdala: β=.74, p<.05). Lastly, when estimating a stepwise regression model, 
the inclusion of the right amygdala activation to angry faces explained an extra .3% of the 
variance (∆R2=.003, p < .05) in future cannabis use. The lower explained variance in this 
secondary model is likely due to the addition of noise. See Figure 3.1.2 for the positive 
linear relationship between the baseline right amygdala reactivity adjusted for all other 
covariates in the model plotted against future cannabis use level. A dose-response 
relationship was observed such that the lowest reactivity is exhibited by the controls, and 
higher reactivity exhibited with increasing cannabis use levels at follow up (see Figure 
3.1.2). And in line with the primary regression results, no significant effects were 






 As the sample of future cannabis users were not excluded on the basis of their 
other drug use levels at age 19 (follow up), a test of drug specificity is warranted. When 
testing the follow up data, it was found that cannabis use level significantly correlated 
with alcohol (r=.20, p<.001) and cigarette use (r=.40, p<.001) levels. Therefore, similar 
linear regression analyses predicting the level of alcohol and cigarette use at follow up 
were necessary to determine if baseline amygdala reactivity is a risk factor that 
generalizes to predict other drug use.  
 To start, a linear regression model predicting follow up alcohol use was estimated 
using the same baseline covariates and right and left amygdala reactivity to angry faces. 
The full model significantly predicted follow up alcohol use (F19,504=2.83, p<.001), with 
verbal IQ (β=.01, p<.05) and baseline alcohol (β=.08, p<.05) identified as significant 
predictors of follow up use. Rerunning the model without baseline alcohol was still 
significant (F19,504=2.44, p<.001). Neither the left or right amygdala emerged as 
significant predictors in these models.  
Results were consistent using a similar model to predict follow up cigarette use 
(F19,504=5.2, p<.001), with baseline age (β=-.65, p<.05) and cigarettes (β=.48, p<.05) 
identified as significantly predicting follow up use. Rerunning without baseline cigarettes 
was still significant (F19,504=2.83, p<.001). Likewise, neither the left nor right amygdala 
reactivity to angry faces emerged as significant predictors in these models. These 
analyses suggest the right amygdala reactivity to angry faces specifically predicted 






 This Section 3.1 builds on the cross-sectional findings of Chapter 2 by indicating 
the right amygdala reactivity to angry faces likely precedes cannabis use in adolescence. 
This effect is supported by the dose-response relationship predicting the level of use five 
years later, and also by the finding that the lowest baseline amygdala activations were 
exhibited by the cannabis-naïve sample. This study is supported by the longitudinal 
design, where all participants were selected on the basis of being naïve to cannabis at the 
baseline scan. And while it would be incautious to assert the amygdala activations caused 
later cannabis use, these findings suggested that amygdala activations to angry faces 
might be considered a specific risk factor for cannabis use in adolescence.  
The finding that the right, but not left, amygdala activation was significantly 
predictive is consistent with the literature. In a meta-analysis of neuroimaging studies on 
the amygdala, data suggests that the right amygdala is specific to rapid detection of 
threatening stimuli as right-sided activations are commonly reported in studies using 
temporally masked presentation (e.g., when a threatening stimulus presentation is brief 
and immediately followed, or “masked”, by an alternate stimulus) (Costafreda et al., 
2007). While the task paradigm used in the IMAGEN study is by no means a masked 
presentation, each stimulus involves a short presentation (2-5 seconds) of faces starting 
from a neutral expression shifting to either a neutral or angry expression (Grosbras, 
2005). It is plausible that a brain system sensitive to detecting threatening stimuli may 




demonstrated rapid right-sided amygdala activations to angry faces using temporally 
precise magnetoencephalography (Dumas et al., 2013; Hung et al., 2010). 
 Interestingly, sex and baseline cigarette use also emerged as significant predictors 
of cannabis use five years later. With regard to sex, this finding is in line with 
epidemiological studies of adolescent drug use indicating that males use both cigarettes 
and cannabis at higher rates than females (Johnston et al., 2018). For baseline cigarette 
use, this finding is also consistent with the literature implicating cigarette use as a robust 
predictor of cannabis use (Agrawal et al., 2012).   
 In considering the significant reactivity of the right amygdala, the positive linear 
relationship uncovered from the regression analysis indicated more amygdala activation 
predicts more cannabis use. Hence, individuals with the most exaggerated amygdala 
activations to signals of threat might be vulnerable to use more frequently. The results of 
these analyses point to a self-medication interpretation. Phan and colleagues (2008) 
previously demonstrated that acute administration of THC attenuates amygdala reactivity 
to angry faces. Therefore, the motivation to consume and maintain cannabis use in these 
individuals is hypothesized to be driven, in part, through negative reinforcement 
properties achieved by the interaction between THC and amygdala function. However, 
the lack of a correlation between baseline anxiety level and amygdala reactivity fails to 
support this framework. Other measures of life stress or psychiatric symptomatology 
might be useful to better explain the reasons for baseline hyperactivity in this sample.   
It will also be important to determine how amygdala reactivity might change 




with this framework, amygdala reactivity is expected to decrease over time with 
protracted use. A similar pattern in anxiety levels is also hypothesized to follow cannabis 
use. See the subsequent Section 3.2 for analyses testing these hypotheses. 
The implication of the current Section 3.1 is that heightened amygdala reactivity 
to angry faces may be considered a biomarker predictive of cannabis use in adolescence. 
Mitigating risk associated with adolescent use might be achieved by targeting this 
biomarker. Research conducted by Paulus and colleagues, and Arce and colleagues, 
provided converging evidence on the attenuation of amygdala reactivity via common 
psychiatric medications. In these studies, researchers demonstrated that acute 
administration of the anxiolytic lorazepam (Paulus et al., 2005) and three weeks use of 
the antidepressant escitalopram (Arce et al., 2008), significantly reduced amygdala 
reactivity to angry faces. In tandem with the Phan report on THC, cannabinoids, 
lorazepam, and escitalopram, may all be effective in normalizing dysregulated affect by 
targeting the same biomarker (despite their differing pharmacological properties). While 
rigorous studies are needed, it is hypothesized that lorazepam or escitalopram might have 
secondary effects of minimizing cannabis use in vulnerable adolescents by attenuating 




















All tabulated measures collected at the baseline assessment (age 14). Future cannabis use 
participants (n=525) were selected for being cannabis-naïve at age 14 and then report 
cannabis use by age 19. Cannabis-naïve participants (n=594) were selected for being 
cannabis–naïve at all time points. PDS: Pubertal development scale (Carskadon and 
















Age in years  (M, SD) 14.39, .39 14.44, .41 .06 
PDS (M,SD) 2.88, .57 2.95, .56 .04 
Sex (M, F) 282, 243 226, 368 .00 
Handedness (L, R) 46, 479 65, 529 .23 
Performance IQ (M,SD) 109.27, 13.33 110.48, 14.02 .14 




Table 3.1.2: Cigarette and Alcohol Use Levels for Each Group  
 





























































































Baseline cigarette and alcohol use from the ESPAD instrument (Hibell et al., 1997) and 





Table 3.1.3: Anxiety Band Score for Each Group 
 






































Anxiety Band Score from the DAWBA instrument (Goodman et al., 2000) and represents 
the probability of receiving a generalized anxiety disorder diagnosis for individuals 






Figure 3.1.1: Cannabis Use By Age 19 in Previously Cannabis-Naïve Participants 
 
 

















Data from the ESPAD survey (Hibell et al., 1997) represents the level of lifetime 
cannabis use by age 19.  All N=525 participants were selected from the IMAGEN study 











1-2x 3-5x 6-9x 10-19x 20-39x 40x+ 















Right amygdala reactivity at baseline adjusted for all other covariates in linear regression 
model containing the controls. Plotted against cannabis use level at follow up (age 19). 
The sample of controls was consistently cannabis-naïve at all time points (n=594). Error 
bars reflect +/- 2 standard deviations at each use level.  
  
Cannabis Use Level at Age 19































3.2. After: Amygdala Reactivity Following Cannabis Use 
Introduction 
 Chapter 2 and the preceding Section 3.1 provided evidence that amygdala 
reactivity to angry faces both correlated with concurrent use and predicted later use. The 
remaining temporal characteristic is to determine if amygdala reactivity changed 
following cannabis use. The longitudinal nature of the IMAGEN study can be leveraged 
to study the extent to which cannabis use may influence amygdalar functional 
development. In this Section 3.2, analyses were conducted on amygdala reactivity at age 
14 and age 19. The individuals from Chapter 2 were studied since they were 
hypothesized to yield the most robust changes in amygdala reactivity as they had the 
most chronic cannabis use in the IMAGEN sample (initiating by age 14). This sample 
was compared to a closely matched sample of individuals who were cannabis-naïve at all 
time points.  
The comparison sample was also used to illuminate typical amygdalar functional 
development. Previous studies on amygdalar functional development provided evidence 
that amygdala reactivity to angry faces increases across development. For instance, in the 
first developmental study on face processing using fMRI, Thomas and colleagues 
reported that angry face processing in the left amygdala increased from childhood to 
adulthood (Thomas et al., 2001). These findings have since been reproduced in a larger 
sample by Todd and colleagues (Todd et al., 2011), although evidence for a 




therefore useful in examining both typically-developing, and cannabis-using, functional 
development using large samples from the IMAGEN study.  
In considering the relationship between cannabis and neurodevelopmental 
processes, research on the endogenous cannabinoid system indicated the primary 
cannabinoid receptor (CB1) proliferates across prefrontal, striatal, and medial temporal 
lobe regions from early development through adolescence (Mato et al., 2003). 
Researchers also consistently identified high CB1 densities in the amygdala, with 
specificity for basal and lateral nuclei (Glass et al., 1997; Katona et al., 2001; Mailleux 
and Vanderhaeghen, 1992). Given the localization of these receptors, the endogenous 
cannabinoid system is putatively involved in regulating emotional and stress responses 
(Marco and Viveros, 2009). Any perturbations of this system by exogenous cannabinoids 
used during adolescence may precipitate changes to the functional neurobiology and 
emotional well being of the individual. Therefore, patterns of both amygdala reactivity 
and anxiety levels from baseline to follow up were examined within the context of 




 The individuals from Chapter 2 who reported cannabis use at the baseline 
assessment (n=70) were revaluated at the age 19 (follow up) assessment. From the 
starting 70, there were 25 who were lost due to attrition. From the remaining 45, there 




age 16). Therefore, n=38 subjects were included in the final sample. A comparison of 
these 38 to the 25 who dropped out indicated the two samples did not differ on various 
demographic measures (See Table 3.2.1 for comparison). Cannabis use patterns at 
baseline and follow up were tabulated for the retained 38 participants. Generally, the 38 
participants exhibited an escalation in their cannabis use levels over time (Table 3.2.2). 
 Next, from the n=594 consistently cannabis-naïve participants identified in 
Section 3.1 on the basis of having acceptable face processing data at baseline, there were 
546 who supplied a face processing scan at follow up. From the 546, there were three 
participants excluded due to excessive head motion. A comparison sample of n=38 
individuals was then selected from this pool of 543 participants who were cannabis-naïve 
at all time points. The comparison sample was selected to be perfectly matched on sex 
and site, and best matched on handedness, IQ, baseline PDS, baseline and follow up 
anxiety levels, baseline and follow up age, baseline and follow up head motion (FD), and 
baseline alcohol use. Unfortunately, it was not possible to best match on baseline 
cigarette or follow up cigarette and alcohol use. The full sample of n=543 participants 
was also used in select analyses to characterize neurotypical patterns of amygdala 
reactivity and anxiety levels over time. See Table 3.2.3 for sample characteristics for the 
cannabis group, matched comparison group, and full sample of controls. 
 
Baseline and Follow Up Amygdala Reactivity 
 Standardization efforts were implemented to ensure the follow up neuroimaging 




was processed using an identical analytic pipeline. Whole-brain contrast images were 
estimated for the angry vs. control images, and neutral vs. control images. In similar 
fashion to Chapter 2 and Section 3.1, the same left and right amygdala ROI was used to 
extract the mean values for angry faces and neutral faces for all subjects.  
The data were then submitted to a 2 x 2 (group [cannabis, controls] by time 
[baseline, follow up]) repeated measures analysis of covariance (ANCOVA) with a test 
for the interaction between the two factors, for the left and right amygdala. To adjust for 
variation in baseline and follow up cigarette and alcohol use, a mean centering approach 
was used. For both measures, the mean of the two time points was computed, and used to 
center the baseline and follow up measure (Winer et al., 1991). These three measures for 
alcohol, and three measures for cigarettes, were included as covariates in the model. 
Follow up analyses on these models were conducted using paired-samples t-tests within 
the cannabis group and control groups, whereby baseline amygdala reactivity was 
compared to follow up.  Finally, to examine changes in anxiety levels, similar repeated 
measures ANCOVA models were estimated using the DAWBA band scores for 
generalized anxiety disorder.   
 
Results 
Comparison of Retained vs. Lost Cannabis Users 
 Chi-square and t-tests were used to determine if the 25 cannabis using participants 
who dropped out of the study prior to the age 19 assessment were different from the 38 




characteristics, except for verbal and performance IQs which were significantly lower in 
the lost sample (p<.05). However, IQ was not correlated with baseline amygdala 
reactivity, and the two groups did not differ on their baseline drug use levels, anxiety 
levels, or amygdala reactivity (Table 3.2.1). Therefore, the retained sample is largely 
representative of the full sample of n=70 studied in Chapter 2.  
 
ANCOVA Findings 
 A repeated measures ANCOVA model indicated there was no significant 
interaction effect for the left (F1,70=0.33, p=.57), or right amygdala (F1,70=1.9, p=.17), and 
no significant main effect of group, time (ps >.05). Given these null results, a similar 
ANCOVA model was estimated using the full sample of cannabis-naïve participants 
(n=543). This model was also adjusted for sex and age as significant between-group 
differences were observed (Table 3.2.3). Again, null results for the interaction for the left 
(F1,576=.17, p=.68), and right amygdala (F1,576=3.02, p=.07), and main effects were 
reproduced (all p>.05). As the interaction trended to significance for the right amygdala, 
the adjusted means for both amygdalae were plotted for the cannabis users and matched 
controls for exploratory purposes (Figures 3.2.1-2). Finally, given the lack of an 
association uncovered by modeling the two groups together, exploratory analyses were 
conducted to analyze amygdala reactivity within each group separately.  
 




Paired-samples t-tests were conducted comparing baseline to follow up reactivity 
to angry faces for the left and right amygdala for each group. To start, the full sample of 
cannabis-naïve participants (n=543) were analyzed to determine a neurotypical pattern of 
functional development. While there was no significant change for the left amygdala 
(t=1.2, p> .05), there was a significant increase in follow up activations observed in the 
right amygdala (t=2.9, p<.005).  When analyzing the matched sample of controls (n=38), 
this effect was reproduced as the right amygdala exhibited a robust increase at follow up 
(t=3.7, p<.005), while the left amygdala approached a significant increase (t=1.8, p<.08). 
In considering the cannabis users (n=38), there was no significant change from baseline 
to follow up for either the left (t=-.30, p>.05) or right amygdala (t=-.53, p>.05).  
For reference, there was no significant change when analyzing neutral face 
processing at either the left or right amygdala, within any group. Therefore, it is 
specifically the right amygdala activations to angry faces that showed an increase in 
reactivity in typically developing adolescents only.  
 
Adjusted Means for Baseline and Follow Up by Group 
The adjusted means for the right and left amygdala along with their standard 
errors were plotted at baseline and follow up for each group for (See Figures 3.2.1 and 
3.2.2). These graphs visually depicted an interaction with group and time despite the null 
results from the ANCOVA models. As reflected by the paired-samples t-tests, the 
matched control group exhibited a clear increase in reactivity from baseline to follow up 




3.2.2). For the cannabis users, an opposite pattern emerged, such that a marginal decrease 
in reactivity from baseline to follow up was reflected in the right and left amygdala 
although statistically non-significant.  
 
Anxiety Levels at Baseline and Follow Up 
 As previous research has supported relationships between amygdala reactivity and 
anxiety levels, the DAWBA band scores for generalized anxiety at baseline and follow up 
were analyzed in a similar fashion. A 2 (Group: cannabis, controls) by 2 (Time: baseline, 
follow up) repeated measures ANOVA model estimated group changes in anxiety levels 
over time. Results indicated there was no significant interaction (F1,72=.08, p=.79), 
however, a highly significant main effect of time (F1,72=24.5, p<.001) was identified, 
with anxiety levels increasing from baseline to follow up (See Table 3.2.2). There was no 
main effect of group. These results were consistent using the full sample of controls 
(n=543). Consistent with the patterns reported in Section 3.1, no significant bivariate 
correlation between anxiety level and left or right amygdala was detected at follow up.  
 
Discussion 
The statistical analyses from this section suggests that amygdala reactivity does 
not significantly change following heavy cannabis use in adolescence. However, the 
control groups exhibited a significant increase in activation from baseline to follow up. 




angry face processing in the amygdala, and is consistent with the smaller developmental 
studies reported by Thomas and colleagues (2001) and Todd and colleagues (2011) .  
The null results for the cannabis group indicated these individuals failed to exhibit 
change over time. One possible interpretation is that cannabis use is associated with 
precocious development. The significantly higher levels of amygdala reactivity at age 14 
reported in Chapter 2 and Section 3.1 might suggest these individuals developed faster 
than their non-using peers. This interpretation is supported by the neurotypical effect that 
indicated higher amygdala activations at age 19. The lack of a significant change at age 
19 in the cannabis users would indicate a ceiling effect of the amygdala if these 
individuals were already at an advanced stage of amygdala reactivity at age 14.  
A group by time interaction effect was visually depicted in Figures 3.2.1-2 but 
should be interpreted cautiously given the null ANCOVA results. Statistical significance 
may have emerged if 25 adolescents from the baseline sample were not lost to attrition. 
And while it is impossible to assume the lost participants would exhibit a similar pattern 
of amygdala reactivity at follow up as the retained sample, the finding that these 25 were 
no different from the retained sample might support this hypothesis (Table 3.2.1).  
 In terms of the anxiety level, the main effect of time demonstrated an increase in 
anxiety levels from age 14 to 19, while the lack of a main effect of group indicated both 
groups increased at the same rate. Throughout this Chapter, it was hypothesized that 
repeated exposure to an anxiolytic like THC would decrease their anxiety levels over 
time. And while the amygdala reactivity did not significantly change in cannabis users, 




cannabis naïve control, might have been interpreted as a decrease in anxiety. Yet, the null 
results from the anxiety analyses failed to support this interpretation, as anxiety level was 
not related to cannabis exposure nor was there a significant interaction with group. 
It is important to note that the anxiety measure used here reflected the probability 
of receiving a generalized anxiety disorder (DSM-IV) diagnosis. Therefore, this measure 
is sensitive to more clinically relevant anxiety. While the cannabis users might not have 
clinical levels of anxiety per se, they might experience more reinforcing properties under 
acute exposure relative to individuals without hyperactive amygdalae. Unfortunately no 
data exists regarding their motivations or intentions for cannabis use. Therefore, these 
analyses were only able to determine if cannabis use predicted a change in anxiety 
disorder diagnoses, and unable to probe nuances related to their motivation or subjective 
experiences during cannabis use.  
Finally, the IMAGEN study is a rich dataset containing other measurements that 
might reflect the nuances influencing cannabis use and therefore better characterize their 
predictive profile. The following Chapters will consider measures from the brain, 
behavioral, and genetic domains to uncover a comprehensive predictive profile of 


















Age (M, SD) 14.6, .42 14.7, .38 .29 
Sex (M, F) 25, 13 19, 6 .39 
Handedness (L, R) 2, 36 4, 21 .16 
PDS (M,SD) 2.9, .47 3.0, .49 .59 
Anxiety (M,SD) 0.58, 1.0 0.32, .84 .08 
Verbal IQ (M, SD) 115.4, 17.2 106.5, 16.0 .04 
Performance IQ (M,SD) 111.3, 15.3 97.7, 15.1 .01 
  
Cannabis (M, SD)  1.4, 1.1 2.0, 1.5 .32 
Cigarettes (M, SD) 2.5, 1.9 3.5, 2.2 .22 
Alcohol (M, SD) 3.9, 1.6 3.6, 1.7 .29 
    
R. Amygdala Reactivity to 
Angry Faces (M, SD) .24, .27 .26, .38 .80 
L. Amygdala Reactivity to 
Angry Faces (M, SD) .25, .29 .32, .24 .26 
 Comparison of the retained cannabis users who provided follow up (age 19) data versus 
the participants who dropped out of the IMAGEN study.  All tabulated measures 
collected at baseline (age 14). P-values from chi-square and t-tests for between-group 
differences. Significant differences detected for IQ only (p<.05). 
 
 












Cross-tabulation of cannabis use levels at baseline (age 14) and follow up (age 19) in the 
cannabis using sample (n=38). Overall, the majority of the sample increased their 











Use Level 1-2x 3-5x 6-9x 10-19x 20-39x 40+ 
1-2x 1 5 1 2 4 17 
3-5x 0 0 0 0 0 4 
6-9x 0 0 0 0 0 2 
10-19x 0 0 0 0 0 0 
20-39x 0 0 0 0 0 1 
40+ 0 0 0 0 0 1 



























A vs. C 
p 
BSL Age (M, SD) 14.6, .42 14.5, .37 14.4 .39 .02 
FU Age (M, SD) 19.4, .96 19.3, .65 18.9, .67 .54 .01 
Sex (M, F) 25, 13 25, 13 210, 336 1.0 .01 
Handedness (L, R) 2, 36 4, 34  61, 485 .40 .26 
PDS (M,SD) 2.9, .47 2.8, .50 2.9, .56 .41 .95 
BSL Anxiety (M,SD) 0.58, 1.0 0.32, .84  0.45, .89 .30 .40 
FU Anxiety (M,SD) 1.34, .97 1.16, .60  1.32, .74 .49 .20 




112.3,13.2 .11 .18 




110.5, 13.8 .42 .74 
  
BSL Cigarettes (M, SD) 2.5, 1.9 1.0, 1.5 0.22, .78 .01 .01 
FU Cigarettes (M, SD) 5.8, .81 1.5, 2.0 1.2, 1.9 .01 .01 
BSL Alcohol (M, SD) 3.9, 1.6 2.9, 1.5 1.4, 1.4, .25 .01 
FU Alcohol (M, SD) 5.8, .55 4.8, 1.5 4.4, 1.7 .01 .01 
 
All measures were collected at baseline except where noted as follow up (Age 19, “FU”). 
Drug use measured on an ordinal scale from 0-6 (See table 3.2.1 for levels) using the 
ESPAD instrument. A.) Sample of cannabis users from Chapter 2 who provided suitable 
imaging data at the follow up assessment. B.) Sample of matched controls who were 
cannabis-naïve at all time points. C.) Full sample of controls who were cannabis-naïve at 







Figure 3.2.1: Right Amygdala Reactivity to Angry Faces by Time (N=76) 
 
 
Plotted adjusted means for angry face processing in the right amygdala for the cannabis 
users (n=38; Green lines) and matched control (n=38; Blue lines) samples at baseline and 
follow up. Error bars represent +/- 1 standard error of the mean. Note, no significant 
differences were identified using repeated measures ANCOVA, nor using a paired-
samples t-test within the cannabis users (ps>.05). Only a paired-samples t-test within the 
controls exhibited a significant increase from baseline to follow up (p<.05).  
  





















Plotted adjusted means for angry face processing in the left amygdala for the cannabis 
users (n=38; Green lines) and matched control (n=38; Blue lines) samples at baseline and 
follow up. Error bars represent +/- 1 standard error of the mean. Note, no significant 
differences were identified using repeated measures ANCOVA, nor using a paired-
samples t-test within either group (ps>.05).  
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CHAPTER 4: USING MACHINE LEARNING TO PREDICT THE INITIATION 
OF CANNABIS USE IN ADOLESCENCE FROM NEUROIMAGING, GENETIC, 
AND PSYCHOSOCIAL DATA 
 
4.1. Predicting the Initiation of Cannabis Use By Age 16 
 
This Chapter has been previously published in the following format: 
 
Spechler, P.A., Allgaier, N., Chaarani, B., Whelan, R., Orr, C., Albaugh, M., D’Alberto, 
N., Higgins, S.T., Hudson, K.E., Mackey, S., Potter, A., ... Althoff, R.R., Garavan, H. & 
the IMAGEN consortium.. (2018). The Initiation of Cannabis Use in Adolescence is 
Predicted by Sex‐Specific Psychosocial and Neurobiological Features. European 




Cannabis use initiated during adolescence might precipitate negative 
consequences in adulthood. Thus, predicting adolescent cannabis use prior to any 
exposure will inform the aetiology of substance abuse by disentangling predictors from 
consequences of use. In this prediction study, data were drawn from the IMAGEN 
sample, a longitudinal study of adolescence. All selected participants (n = 1,581) were 
cannabis‐naïve at age 14. Those reporting any cannabis use (out of six ordinal use levels) 
by age 16 were included in the outcome group (N = 365, males n = 207). Cannabis‐naïve 
participants at age 14 and 16 were included in the comparison group (N = 1,216, 
males n = 538). Psychosocial, brain and genetic features were measured at age 14 prior to 
any exposure. Cross‐validated regularized logistic regressions for each use level by sex 
were used to perform feature selection and obtain prediction error statistics on 
independent observations. Predictors were probed for sex‐ and drug‐specificity using 
post‐hoc logistic regressions. Models reliably predicted use as indicated by satisfactory 




However, males and females exhibited distinct brain predictors that failed to predict use 
in the opposite sex or predict binge drinking in independent samples of same‐sex 
participants. Collapsed across sex, genetic variation on catecholamine and opioid 
receptors marginally predicted use. Using machine learning techniques applied to a large 
multimodal dataset, we identified a risk profile containing psychosocial and sex‐specific 
brain prognostic markers, which were likely to precede and influence cannabis initiation. 
 
Introduction 
Cannabis use in adolescence is associated with a range of adversity in adulthood 
including cannabis dependence (DSM-IV)(Hall and Degenhardt, 2009; Moss et al., 
2014b), polydrug use (Secades-Villa et al., 2015), cognitive deficits (Meier et al., 2012; 
Schuster et al., 2016), compromised physical (Kalant, 2004) and mental health 
(Degenhardt et al., 2013; Kedzior and Laeber, 2014; Malone et al., 2010), and diminished 
life attainment goals (e.g., socioeconomic factors; (Fergusson and Boden, 2008). These 
findings are supported by animal models linking adolescent cannabis exposure with 
detrimental outcomes in adulthood (O’Shea, 2004; Quinn et al., 2008a). However, in 
humans, it is difficult to assert a causal role for cannabis in subsequent outcomes as any 
negative outcomes arising from use could be related to a number of factors confounded 
with the choice to initiate use (Jackson et al., 2016).   
Results from the 2013 National Survey on Drug Use and Health indicated that 
nearly 25% of 10th graders reported ever trying cannabis (NSDUH, 2014). From 2005 to 




females aged 15-17 years (NSDUH, 2014). Moreover, beliefs concerning the risk of use 
are declining (Johnston et al., 2011) despite the increase in drug potency relative to 
previous decades (ElSohly et al., 2016). These trends are a source of concern as in vitro 
models indicate that delta-9-tetrahydrocannabinol (THC), a psychoactive compound in 
cannabis, could be more toxic in adolescent than in adult tissue (Pope et al., 2003; Quinn 
et al., 2008a; Renard et al., 2016; Rubino et al., 2015; Schneider, 2008), and human 
studies suggest early, compared to adult, initiation of cannabis is associated with worse 
outcomes  (Brook et al., 2011; Coffey and Patton, 2016).  
Global studies suggest cannabis use is typically initiated prior to age 18 
(Degenhardt et al., 2008). Thus, adolescence might be a developmental period during 
which initiation can be best predicted. Investigations of the risk factors associated with 
cannabis initiation commonly report features like temperament (Creemers et al., 2010), 
delinquent behaviors (Bree and Pickworth, 2005), alcohol and tobacco use (von Sydow et 
al., 2002), and parental (Day et al., 2006) and peer influences (Ellickson et al., 2004), 
while rarely considering any neurobiological or genetic contributions. Incorporating these 
domains may uncover biobehavioral processes that are specific to the initiation of 
cannabis use. Therefore, we sought to uncover a comprehensive risk profile of adolescent 
cannabis use by predicting the initiation of use via a large multimodal biobheavioral 
dataset.  
Prior studies have stressed the importance of attending to sex differences in 
substance abuse research. Indeed, males and females differ in their biological response to 




al., 1991) and exhibit elevated gene expression levels of both CB1 & CB2 cannabinoid 
receptors (Onaivi et al., 1999) relative to males. Behaviorally, female cannabis users 
endorse more positive subjective ratings associated with abuse liability to smoked 
cannabis (vs. placebo; (Cooper and Haney, 2014). Moreover, converging evidence using 
animal (Fattore et al., 2007) and human studies (Hernandez-Avila et al., 2004; Schepis et 
al., 2011) indicates the transition from cannabis use initiation to regular use is accelerated 
in females. Hence, the identification of a predictive profile may identify sex-specific 
etiological mechanisms while also informing sex-specific interventions to attenuate the 
risk of ever becoming a user.  
While prediction analyses can illuminate the nature of drug initiation, these 
studies are rare as they necessitate large, longitudinal samples, especially when feature-
rich domains are considered (Whelan and Garavan, 2014). Large samples are also needed 
for cross-validation schemes to ensure predictive models are tested on independent 
samples. Hence, we modeled our analytic approach on a related study using the 
IMAGEN dataset in which Whelan and colleagues developed predictive models which 
identified multi-domain features at age 14 that predicted binge drinking at age 16 
(Whelan et al., 2014a). Given this work, we hypothesized cannabis use could be 
predicted in a similar fashion using multi-domain data from the IMAGEN sample. We 
extend the methods of Whelan and colleagues by identifying multi-domain risk profiles 
for each sex while considering a range of subsequent cannabis use levels. In doing so, we 
identify predictive features that are both common and unique between the sexes, and 




psychosocial predictors and uncovering a sparse set of brain and genetic predictors, these 
exploratory analyses are data driven. In an era where large multisite neuroimaging 
projects and big datasets are becoming more prevalent, we leverage machine learning 
techniques to uncover a sparse set of predictors of cannabis use from a large multi-
domain set of variables that generalize to predict use in independent samples.  
 
Methods and Materials 
Full details of the multisite IMAGEN study (Schumann et al., 2010) are available 
in the online Standard Operating Procedures (https://imagen-europe.com/). Imaging 
acquisition parameters and quality assurance procedures were standardized across site to 
ensure comparable data (see Schumann et al., 2010 for standardization of procedures 
across sites). The IMAGEN study conformed to the ethical standards outlined by 
Declaration of Helsinki and was approved by ethics committees at each site including 
King’s College, London; Central Institute of Mental Health, Mannheim; Charite, 
Universitatsmedizin Berlin; University Medical Center Hamburg- Eppendorf; University 
of Nottingham; Trinity College Dublin; Institut National de la Sante et de la Recherche 
Medicale, Orsay. After description of the IMAGEN study to the participants and their 
parents, written informed consent was obtained. Individuals who provided assent were 






Inclusion was determined by a self-report drug use questionnaire (using the 
“ESPAD”, described below). Participants from the baseline sample (age 14) who 
provided ESPAD data and were cannabis-naïve were eligible for inclusion (n=2,018). At 
age 16, n=1,581 participants (78% of the cannabis-naïve sample) provided usable data 
(see Table 4.1.1 for evaluation of participants unavailable for follow-up) and were thus 
included in the analysis. Participants reporting any level of cannabis use by age 16 were 
assigned to the outcome groups (n=365). Participants who remained cannabis-naïve at 
age 14 and 16 were assigned to the comparison group (n=1,216). 
The European School Survey Project on Alcohol and Drugs (ESPAD; Hibell et 
al., 1997) was administered at age 14 and 16 using Psytools (London, UK). Lifetime 
usage was measured on an ordinal scale: 0, 1=1-2x, 2=3-5x, 3=6-9x, 4=10-19x, 5=20-
39x, 6=40x+. See Table 4.1.2 for sample demographics and drug use levels.   
Data  
Participants were extensively characterized at age 14 using psychosocial (of 
parent and child), neuroimaging, and genetic assessments (see supplemental materials). 
Psychosocial data were largely self-reported, and included demographics, summary 
scores for personality dimensions (Cloninger, 1999; Costa Jr. and McCrae, 1995; Woicik 
et al., 2009), frequency of candidate life events (Newcomb et al., 1981), cognitive 
(Robbins et al., 1994) and intelligence (Wechsler, 2003) assessments, and drug use levels 
of the parent and child (additional features described in supplemental materials). Genetic 
data included 108 candidate single nucleotide polymorphisms (SNPs) on genes coding 




(FAAH), eight SNPs previously associated with cannabis dependence (Hartman et al., 
2009; Hopfer et al., 2006; Hurd et al., 2014), and one genetic risk-score based on the 
summation of those eight risk-alleles (Cornelis, 2009). Brain data included three fMRI 
tasks designed to engage cognitive processes associated with substance abuse (reward 
processing, motor response inhibition, and social affective (face) processing; see 
supplemental materials for task specifics) and one structural MRI scan. Whole-brain 
fMRI contrast maps (generated using a standard GLM) and gray matter volume maps 
(GMV; generated using voxel-based morphometry) were each parcellated into 278 
regions of interest (ROIs) (Shen et al., 2013). All data (except the cannabis use outcome) 
were collected at age 14 and used to predict cannabis use by age 16, and all predictors (n 
variables=2,413; see Table 4.1.3 for summary of predictor variables) from each domain 
were considered during predictive model estimation.  
 
Statistical Analyses  
The overall analytic procedure was designed to accomplish three goals: (1) 
perform feature selection to identify the predictors of light to heavy use in males and 
females separately; the selected features then informed post-hoc analyses to (2) probe the 
identified predictors for sex- and drug-specificity, and (3) assess the relative contribution 
of each data domain to the prediction of cannabis use initiation.  
 




Six prediction analyses were conducted for each sex in order to predict each level 
of use via the ESPAD scale (use levels of 1 and above (Males n=207; Females n=158), 
levels 2 and above (Males n=172; Females n=120), and so on up to level 6). Predictive 
models were estimated using elastic-net regularization (Zou and Hastie, 2005) with 
logistic regression to perform feature selection (from n variables=2,413) and reduce 
model overfit. The elastic-net minimizes both the sum of the squared and absolute values 
of the regression coefficients, effectively setting some coefficients to zero, thereby 
performing feature selection during model estimation. Elastic-net parameters (see 
supplemental information) were tuned on independent samples (via nested k-fold cross-
validation), and then final models were tested on an independent internal validation set. 
These analyses were implemented using the “glmnet” function in MATLAB (v. R2014a, 
Natick, MA).  
k(10)-fold cross-validation was used during model estimation to evaluate 
predictive models on independent observations. Partitioning a completely external 
validation set would have reduced an already small group of interest. Therefore, internal 
validation using k-fold cross-validation was used as a proxy for external validation. 
During k-fold cross-validation, the full sample of data is partitioned into subsamples of 
data, where k equals the number of partitions (or “folds”) of the original starting sample. 
k-fold cross-validation then becomes an iterative process whereby a single fold is set 
aside as the test sample (“test fold”), and a “training model” is estimated on the 




to predict the observations in the set aside test fold, thereby ensuring the independence of 
the test fold sample. This procedure returns k final models.  
Each of the six sex-specific prediction analyses were run 100 times to account for 
the subtle differences in results incurred due to the random assignment of participants to 
folds. Results were thresholded to identify only the predictors that were present in at least 
six final models (from k=10) across all 100 runs within a use level analysis. Predictors 
passing this threshold were selected for use in post-hoc analyses. See Figure 4.1.1 for a 
schematic of the analytic method. 
The area under the curve (AUC) of the receiver-operating characteristic (ROC) 
was calculated based on the model’s ability to predict cannabis use in the independent 
samples segregated during cross-validation. Broadly, here the ROC AUC represents the 
probability that a randomly selected individual from the outcome group will be predicted 
as a future user (Fawcett, 2006). Null-hypothesis significance testing on the AUC was 
conducted using a Mann-Whitney U-test (Mason and Graham, 2002) (significance set 
using a Bonferroni corrected p<.008 (p<.05/6 models)) to test the hypothesis that models 
predicted independent samples better than chance.  
Features selected from each use level analysis were then used in post-hoc analyses 
described below. Correlations between each identified feature and cannabis use were also 







Sex-specificity was assessed by including the selected features of male cannabis 
use as the independent variables of a logistic regression model estimated on the female 
sample (and vice versa). Drug-specificity was assessed by including the selected features 
of male cannabis use as the independent variables of a logistic regression model 
estimated on an independent sample of binge drinking males (and likewise for females). 
The binge drinking sample contained new individuals (n=400) who were naïve to binge 
drinking at age 14 (with a maximum of 2 lifetime drinks), but endorsed binge drinking 
episodes (i.e., being drunk from alcoholic beverages) by age 16 (see Table 4.1.4 for binge 
drinking sample demographics).  
 
Domain Contribution Analyses  
The selected features for each sex were also modeled in a hierarchical fashion to 
measure the relative change in model fit after the inclusion of each domain-specific set of 
predictors. Model fit for all post-hoc regressions were determined using a chi-square 
goodness of fit statistic and the delta Akaike information criterion of model selection 
(ΔAIC; Akaike, 1974). 
 
Results 
Feature selection analyses predicting each use level returned a range of ROC 
AUC values (Males: AUC=0.65–0.74, p=1.4x10-8–5.3x10-10; Females: AUC=0.74–0.82, 
p =1.8x10-16–5.5x10-13), indicating high accuracy in predicting independent samples for 




males (AUC=.74, p=5.3x10-10) and ≥10 uses for females (AUC=. 82, p=5.5x10-13).   For 
context, in a study using only psychosocial features to predict the initiation of cannabis 
use, authors reported a final predictive logistic regression model returning a ROC 
AUC=.78 (von Sydow et al., 2002). Additionally, Whelan and colleagues reported a 
cross-validated ROC AUC=.75 in their study of brain, psychosocial, and genetic 
predictors of binge drinking (Whelan et al., 2014a). Hence, the AUCs reported here are in 
line with previous research, while the AUCs from the female models reflect an even 
higher degree of cross-validated prediction than what has been previously reported.  
 
Selected Psychosocial Predictors  
Six psychosocial predictors were found to be common to both sexes, including 
greater lifetime alcohol and cigarette use, parental lifetime cannabis use, novelty-seeking 
personality and the disorderliness personality subscale (Cloninger, 1999), and less-
negative feelings towards deviant behaviors (Newcomb et al., 1981). Post-hoc 
regressions indicated these predictors returned strong model fit for the full sample (males 
and females) for all levels of cannabis use  (χ26,N=1539=184.02, p=4.7x10-37; 
ΔAIC=175.02), and also predicted binge drinking (χ25,N=379=29.58, p=1.8x10-5; 
ΔAIC=19.58) in an independent sample. See Figure 4.1.4 for a summary of all identified 
predictors and their point-biserial correlation with use initiation. 
Male-specific predictors included greater parental novelty-seeking (Cloninger, 
1999) and sensation seeking personality. While these parental personality traits measure 




(r739=.10, p=.005) after accounting for parent novelty seeking personality (r740=.10, 
p=.007). Furthermore, although personality traits are heritable, partial correlations also 
indicated child novelty-seeking personality predicted use (r739=.14, p=2.1 x10-4) after 
accounting for parent novelty-seeking personality, r740=.10, p=.007). 
 Female-specific predictors included greater extravagant personality 
subscale (Cloninger, 1999) in both the parent and daughter. The extravagant subscale 
assesses overspending behaviors and diminished planning, and conveys a tendency to 
approach reward cues. Similar to males, greater extravagance of both the parent and 
daughter made separate contributions to the prediction (post-hoc partial correlation 
between the outcome measure and child extravagance r823=.12, p=3.6 x10-4, after 
accounting for parent extravagance r824=.16, p=6.0 x10-6). Additionally, greater 
impulsive personality subscale (Cloninger, 1999), frequent sexual experiences, and 
higher verbal IQ, predicted female use.  
 
Selected Brain Predictors  
For males, six functional and two structural brain features predicted cannabis use. 
For females, fifteen functional and two structural brain features predicted use with no 
overlap with the predictors for males. Post-hoc point-biserial correlations indicated that 
five regions for males, and sixteen regions for females, significantly predicted any level 
of use across each sample. See Figures 4.1.3-4 for visualization of all brain features and 





Sex- and Drug-specificity  
Post-hoc regressions confirmed that male-specific brain predictors of use returned 
strong model fits when estimated on the male sample (χ28,N=745=24.3, p=.002; 
ΔAIC=8.3), as did the female-specific brain predictors estimated on the female sample 
(χ217,N=836=101.7, p=4.3x10-14 ΔAIC=67.7). The male-specific brain predictors failed to 
predict use in females (χ28,N=836=9.9, p=.272; model with predictors ΔAIC=6.1 relative to 
the base rate model) and failed to predict binge drinking in males (χ28,N=180=8.3, p=.405; 
model with predictors ΔAIC=7.6 relative to the base rate model). Likewise, the female-
specific brain predictors failed to predict use in males (χ217,N=745=18.8, p=.341; model 
with predictors ΔAIC=15.2 relative to the base rate model), and failed to predict binge 
drinking in females (χ217,N=220=16.6, p=.482; model with predictors ΔAIC=17.4 relative 
to the base rate model). See Table 4.1.5 for all sex- and drug-specific post-hoc regression 
summaries.  
Genetic Predictors Sex-specific feature selection analyses did not identify any 
SNPs, therefore, as a post-hoc exploratory analysis, we collapsed across sex and reran the 
analyses with only the genetic predictors (plus nuisance covariates). This analysis 
returned an ROC AUC range = 0.54–0.61; p=.01–1.4x10-6 (See Figure 4.1.5). We note 
that given the relatively small p-values, these models do not pass a Bonferoni correction, 
and as the highest use level analysis (use level 6) yielded a non-significant prediction 
(AUC=.53, p=.23), only results from the uncorrected significant models (use level 1-5) 
were probed further. Moreover, the genetic multidimensional scaling factors plus 




SNPs on genes coding for the β2-adrenergic receptor, one SNP on a gene coding for the 
α1b-adrenergic receptor, two SNPs on genes coding for the DRD1 receptor, and five SNPs 
on genes coding for the µ1-opioid receptor, predicted cannabis use. Post-hoc analyses 
suggested three SNPs were significantly related to cannabis use for the male sample (β2-
adrenergic: rs1042711, rs1801704; and DRD1: rs1174661), whereas none of the SNPs 
were significant for the female sample (see Table 4.1.6 and Figure 4.1.6 for SNP 
statistics, including their correlation with the outcome measure across the entire sample).  
When including these ten SNPs in a post-hoc hierarchical logistic regression 
predicting cannabis use, the model exhibited strong fit to the full sample after first 
modeling the nuisance covariates (Δχ29,N=1581=25.7, p=.002; ΔAIC=7.7). However, these 
SNPs returned poor model fits to the full sample of binge drinkers after first modeling the 
nuisance covariates (Δχ29,N=312=9.03, p=.435; ΔAIC=9 relative to the model with 
nuisance covariates only).  
 
Domain Contribution Effects 
The psychosocial predictors were entered first and significantly improved model 
fit relative to the base rate model for the male sample (χ28,N=742=94.5, p=5.5x10-17; 
ΔAIC=78.53) and the female sample (χ211,N=826=134.1, p=2.5x10-23; ΔAIC=112.13). 
Next, the brain predictors were added and significantly improved model fit for the male 
sample (Δχ28,N=742=17.3, p=.027; ΔAIC=1.3) and the female sample (Δχ217,N=826=101.1, 
p=5.8x10-14; ΔAIC=67.1). Finally, the ten SNPs were added and significantly improved 




sample (Δχ29,N=826=6.5, p=.689; psychosocial and brain model ΔAIC=11.5). These 
findings held irrespective of the order in which each domain was entered. Thus, while 
psychosocial data alone can be used to significantly predict use, models containing both 
psychosocial and sex-specific brain features return superior fits, highlighting the utility of 
capturing individual neurobiological differences in predicting adolescent cannabis use. 
 
Discussion 
Psychosocial Findings  
The six shared psychosocial predictors replicate previous findings establishing 
alcohol and tobacco as predictors of cannabis use (Hall and Pacula, 2003; Siegel et al., 
2014), as are novelty-seeking and disorderliness personality traits (Hale et al., 2003; Sher 
and Trull, 1994), and parental transmission of drug use (Brook et al., 2001; Kandel et al., 
1978; Kosty et al., 2015). As these features also predicted binge drinking, they may be 
considered general risk factors for adolescent drug use. In considering the parental 
influence, parents with behaviorally disinhibited personality traits, coupled with a history 
of cannabis use, were found to increase risk for use in their children, mirroring previously 
published studies (Day et al., 2006; Kerr et al., 2015). Moreover, less-negative feelings 
towards deviant behaviors may signal a predisposition towards conduct disorder, which 
previous literature has linked to cannabis use (Crowley et al., 1998). Risk of use was also 
identified for females exhibiting higher verbal IQ, which has been implicated in cannabis 




sexual experiences are consistent with the novelty-seeking phenotype of individuals most 
likely to initiate substance use. 
 
Brain Findings  
For males, the brain predictors were largely related to cerebellar activation 
differences during response inhibition. Animal models suggest the lateral cerebellum is 
involved in motor preparation and inhibition via projections to cortical motor and 
inhibitory regions through the thalamus (Middleton and Strick, 2001). Additionally, the 
cerebellar regions identified have also been implicated in a network underlying motor 
inhibitory control (Stevens et al., 2007). Thus, hypoactivity in all three cerebellar regions 
may suggest a compromised motor inhibitory control system constitutes a 
neurobiological vulnerability that influences the initiation of cannabis consuming 
behaviors. Moreover, larger GMV in the right medial prefrontal cortex (PFC) might 
indicate a neurodevelopmental delayed maturation in regions supporting executive 
functioning. This finding is supported by studies reporting an adolescent male-specific 
increase in PFC volume with alcohol use disorder (Medina et al., 2008) and conduct use 
disorder (Brito et al., 2009).   
In females, a structural-functional finding in the right pre-supplemental motor 
area (pre-SMA) predicted cannabis use. As myelination proliferates during adolescence, 
especially in motor areas requiring expedited signal propagation (Paus, 1999), higher 
GMV and activity during failed inhibitions observed in the right pre-SMA suggests a 




for the female sample as cortical maturation (thinning) occurs earlier in females 
compared to their male peers (Giedd, 2004).  
Additionally, lower activity compared to non-users in the right inferior frontal 
gyrus (IFG) during failed inhibitions was predictive of cannabis use in females. As the 
right IFG is a key region implicated in the stop task (Garavan et al., 1999), lower activity 
is notable as hypoactivity here is also associated with cigarette use (Spechler et al., 2016). 
As our test for drug-specificity was restricted to binge drinking, some brain predictors 
might generalize to other drugs of abuse not tested here.  In the orbitofrontal cortex 
(OFC), females also displayed lower bilateral activations during successful inhibitions, 
and lower right-sided GMV. The volumetric finding is concordant with Cheetham and 
colleagues who reported lower OFC GMV at age 12 predicts use at age 16, with only the 
right OFC remaining significant after accounting for poly-drug use (Cheetham et al., 
2012b), thus underscoring the right OFC specificity to cannabis initiation. Furthermore, 
as other studies have correlated OFC hypoactivity with adolescent substance use (Whelan 
et al., 2012), the anterior prefrontal cortex might be especially valuable for inquiry 
relating female-specific neurobiological pathways with substance abuse.  
For females, more predictors related to face processing were identified. 
Specifically, lower processing of neutral faces in the right superior frontal and lingual 
gyri. Previous studies suggest neutral faces can be misperceived as threatening, especially 
in individuals with social anxiety disorder (Cooney et al., 2006; Yoon and Zinbarg, 
2008). Given the higher prevalence of social anxiety in females (Schneier, 1992) and the 




al., 2006, 2007) these results suggest a female-specific pathway towards cannabis use. 
Additionally, higher female-specific activation to angry faces in the ventromedial 
prefrontal cortex is notable given this region’s involvement in emotion regulation (Urry 
et al., 2006).  
 
Genetic Findings  
The number of predictive µ1-opioid receptor SNPs highlights the importance of 
the opioid system in substance abuse. Opioid and cannabinoid systems co-localize in the 
striatum (Rodriguez et al., 2001) and exhibit reciprocal signaling (Robledo et al., 2008).  
However, the biobehavioral effects orchestrated by these systems remain unclear in 
humans. Animal models suggests the µ1-opioid receptor is specifically involved in 
reinforcement as µ1-opioid receptor knockout mice failed to exhibit THC-induced 
conditioned place preference compared to δ1-knockout and wild-type mice (Ghozland et 
al., 2002). Hence, our findings that cannabis users had a greater number of risk alleles for 
both DRD1 SNPs and three µ1-receptor SNPs suggest alterations in their neurobiological 
processing of rewards. As these findings were uncovered from exploratory models that 
were not as robust to predict use as the multi-domain models, larger GWAS studies or 
candidate SNP analyses are needed to reinforce these results.  
 
Conclusions  
In this large longitudinal study, we offer evidence that psychosocial and sex-




teenage cannabis consuming behaviors. Hence, these analyses identified individual 
differences at age 14 that predict later cannabis use, and thus have potential for guiding 
proactive interventions. Despite having thousands of multi-domain variables per 
individual, prediction with high generalizability was achieved with a sparse set of sex-
specific brain and psychosocial features, and six shared psychosocial features. And while 
the psychosocial data alone was found to predict both cannabis and binge drinking, the 
addition of the brain features improved cannabis prediction and augmented the sex-
specificity of the findings.  
The superior prediction of the female sample suggests they exhibit a more distinct 
predictive profile at age 14, despite having lower levels of subsequent use. These findings 
are clinically meaningful given the female-specific vulnerability towards accelerated 
dependency. Moreover, the fMRI findings highlight the sex-specific psychological 
processes potentially driving the initiation of cannabis use in adolescence. Thus, our 
findings underscore the importance of attending to sex-differences in addiction research, 
and fulfills the recent NIH policy for investigators to examine sex-differences in 
biobheavioral research (Clayton and Collins, 2014).  
Limitations of this study include the absence of measures of peer influences. The 
addition of these variables, as well as interactions between features, might yield a higher 
AUC, as the reported AUCs indicate a departure from perfect prediction. Future analyses 
to identify how psychosocial, brain, and genetic feature interact to influence the 
likelihood of cannabis use are needed. Additionally, the convenient community sampling 




Finally, despite predicting high levels of use (e.g., ≥40 uses by age 16), it is 
unknown if these individuals will meet DSM-V diagnostic criteria for cannabis use 
disorder later in life. However, by design of the analysis, all participants were early 
initiators of cannabis, with the heavy users always present in the prediction models. 
Therefore, these predictors may signify risk for higher use. Still, the heavy users only 
encompassed a small proportion of the sample, therefore even larger studies are needed. 
And while our predictive models generalized to independent observations via internal 
cross-validation, a completely set aside external validation set was not possible due to the 
limited sample sizes. As such, the gold standard remains a completely independent 
external validation set. Studies assessing the degree by which cross-validated prediction 
metrics may differ by cross-validation scheme are also needed (although Whelan et al., 
2014 reports similar AUCs for internal and external validation). Taken together, our 
findings supply new hypotheses to be tested using additional time points from the 
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Participants who completed the baseline ESPAD assessment and reported no lifetime cannabis 
use but then were unavailable for follow up assessment two years later were assigned to the 
dropout sample. Compared to the retained sample, the dropout sample had significantly higher 











Age (M,SD) 14.6, 0.41 14.5, 0.42 .002 
Sex (Male, Female)  229, 208 745, 836 .051 
Handedness (L,R) 37, 400 169, 1412 .174 
PDS (M,SD) 3.6, 0.7 3.5, 0.8 .573 
Perceptual IQ (M,SD) 104.5, 13.24 108.11, 13.8 .000 
Verbal IQ (M,SD) 106.8, 14.8 111.2, 13.5 .000 




Table 4.1.2: Participant Demographics 
 
 
PDS: Puberty Development Scale (Carskadon & Acebo, 1993); SES: Socioeconomic 
status. Cannabis use levels from the ESPAD and measured on an ordinal scale (1=1–2x, 
2=3–5x, 3=6-9x, 4=10-19x, 5=20-39x, 6=40+) All data (with the exception of cannabis 
use) were obtained at age 14. All demographics measures were also included as 

























(M,SD) 14.50, 0.47 14.52, 0.39 .54 14.51, 0.53 14.54, 0.42 .33 
Handedness 
(L,R) 25, 182 66, 472 .94 18, 140 60, 618 .32 
PDS 
(M,SD) 2.65, 0.49 2.54, 0.55 .01 3.22, 0.39 3.17, 0.44 .13 
Perceptual IQ 
(M,SD) 108.11, 13.55 108.18, 14.56 .95 109.40, 13.49 107.77, 13.23 .17 
Verbal IQ 
(M,SD) 114.19, 13.267 112.07, 13.14 .05 112.93, 12.29 109.22, 13.80 .002 
SES 
(M,SD) 18.52, 3.97 17.88, 3.82 .05 18.26, 3.94 17.88, 3.68 .26 
     
Cannabis Use 
Levels 1 2 3 4 5 6  1 2 3 4 5 6  




























A related analysis including psychopathology measures was conducted but did not improve 
predictive performance. Site was also modeled in the analysis and yielded Paris (data not shown) 
as a significant predictor due to the higher prevalence of cannabis use at age 16 for both sexes.  
 
 













All participants at baseline reported no lifetime binge drinking episodes and a maximum of 2 
lifetime alcoholic drinks. Participants who then went on to report any level of binge drinking by 
age 16 were included in the binge drinking at age 16 sample, compared to participants who 
endorsed a maximum of 2 lifetime drinks. 




• Demographics  
• Cognitive assessments  
• Personality assessment 
• Life-events questionnaires 
• Baseline cigarette & alcohol use 
• Parent personality and drug use 
• 80 measures 
Genetic • A-priori SNPs 
• Cannabinoid Receptor 
• Catecholamine Receptors 
• Opioid Receptors 
• 108 SNPs 
Structural 
Neuroimaging 
• Total GMV 
• Gray-Matter Volume ROIs 
• 1 total GMV 




• Reward Processing Task  
• (2 Contrasts) 
• Stop Signal Task  
• (2 Contrasts) 
• Face Processing Task  
•  (3 Contrasts) 
• 1946 ROIs  
 
• 278 per contrast 








Age (M,SD) 14.5, 0.41 14.5, 0.39 .71 
Sex (Male, Female)  103, 105 77, 115 .06 
Handedness (L,R) 21, 171 20, 188 .67 
PDS (M,SD) 2.8, 0.6 2.9, 0.6 .61 
Perceptual IQ (M,SD) 106.2, 13.5 105.8, 14.3 .78 
Verbal IQ (M,SD) 109.5, 13.1 108.5, 14.5 .51 





Table 4.1.5: Post-hoc Regression Model Summaries. 
 
Features identified from each cannabis predictive modeling scenario were used to probe sex- and 
drug-specific effects. Male & Female shared psychosocial predictors of cannabis use also 
predicted binge drinking by age 16. Male brain predictors and female brain predictors failed to 
model cannabis use in the opposite sex, or, binge drinking in the same sex. *ΔAIC always in 
reference to the better fitting model. ΔAIC= AICmodel_i – AICmin and reflects the relative increase 


















29.6, p<.01  
 








 9.9, p >.05  6.1 (model with predictors –base rate 
model) 
 Males:  
Binge Drinking 








 18.8, p >.05  15.2 (model with predictors –base 
rate model) 
 Females:  
Binge Drinking 










Table 4.1.6: Statistics and Frequencies for Cannabis Predictive SNPs. 
 
Measures of Hardy-Weinberg Equilibrium (HW), Minor Allele Frequency (MAF). Association 
with cannabis use by age 16 calculated using Spearman’s rank correlation between SNP and the 
outcome measure collapsed across sex.  Hminor: Homozygote minor (high-risk genotype), HT: 





























Cannabis Use r p Cannabis Use 
by age 16 
Comparison 
Group 
rs1042711 ADRB2 .86 .122 T:C .97 .06 .02 12:54:34 16:55:30 Protection 
rs1801704 ADRB2 .86 .122 T:C .97 .06 .02 12:54:34 16:55:30 Protection 
rs6888306 ADRA1b .92 .099 C:T .89 .03 .25 3:33:64 4:32:64 Protection 
rs686 DRD1 .85 .135 A:G .85 -.03 .23 12:51:37 12:44:44 Risk 
rs11746641 DRD1 .84 .060 T:G .64 -.05 .05 4:25:71 2:22:76 Risk 
rs2281617 OPRM1 .88 .098 G:T .86 .01 .72 2:23:76 1:23:76 Risk 
rs563649 OPRM1 .91 .158 G:A .89 .03 .27 0:14:86 1:13:86 Protection 
rs10485057 OPRM1 .89 .094 A:G .87 .02 .41 1:13:86 1:14:85 Protection 
rs1074287 OPRM1 .90 .256 A:G .99 -.04 .15 9:34:57 8:29:63 Risk 





Table 4.1.7: Frequency of Selected Male Features 
 
 




 Analysis Levels 





Lifetime Cigarette Use 100 100 100 100 100 100 
Parental Cannabis Use 100 100 100 98 100 100 
Feelings of Deviance 100 100 100 100 0 5 
Lifetime Alcohol Use 100 100 90 0 0 0 
Sensation Seeking Personality (Parent) 100 100 33 0 0 0 
Disorderly Personality 100 96 97 100 100 100 
Novelty Seeking Personality 40 100 100 100 69 0 
Novelty Seeking Personality (Parent) 28 88 100 20 0 0 
Structural MRI L. Mid-Cingulate Cortex 24 0 0 0 0 100 





Stop Success: R.Midbrain-Thalamus 100 12 0 0 0 0 
Stop Success: L. Inferior Temporal Gyrus 84 9 2 15 100 100 
Stop Success: L. Post-Lateral Hemisphere 0 0 100 100 100 100 
Stop Success: L. Anterior Cerebellum 0 0 0 0 0 100 
Stop Success: L. Paravermis 0 1 97 0 100 98 




Table 4.1.8: Frequency of Selected Female Features 
 




 Analysis Levels 






Lifetime Cigarette Use 100 100 100 100 100 100 
Lifetime Alcohol Use 100 100 100 100 100 50 
Novelty Seeking Personality 100 100 100 100 42 0 
Parental Cannabis Use 100 100 100 100 0 0 
Extravagant Personality (Parent) 100 100 87 97 0 0 
Feelings of Deviance 100 89 23 100 0 0 
Disorderly Personality 100 46 100 100 100 81 
Verbal IQ 100 17 0 0 0 0 
Impulsive Personality 100 0 0 0 0 0 
Frequency of Sexual Life Events 97 44 100 100 0 0 
Extravagant Personality 33 89 86 100 1 0 
Structural 
MRI 
R.Pre-Supplementary Motor Area 100 35 95 0 0 0 








Stop Success: L. Orbital Frontal Cortex 100 0 0 0 0 0 
Stop Success: R. Orbital Frontal Cortex 100 0 0 0 0 0 
Stop Success: R.Middle Temporal Gyrus 100 0 0 0 0 0 
Stop Success: R.Middle Temporal Gyrus 100 0 0 0 0 0 
Stop Failure: L.Midbrain 100 0 0 0 0 0 
Stop Failure: R.Post-Central Gyrus 100 0 0 0 0 0 
Stop Failure: R.Inferior Frontal Gyrus 100 4 0 0 0 0 
Stop Failure: R.Pre-Supplementary Motor Area 87 62 100 100 100 4 
Stop Failure: L.Lateral Paravermis 0 0 0 100 9 34 
Stop Failure: L.Pre-Post Central Gyrus 100 100 53 0 0 0 
Angry Faces: R.Anterior Cerebellum 100 0 0 1 0 5 
Angry Faces: L.Ventromedial Prefrontal Cortex 100 0 0 0 0 0 
Neutral Faces: R. Superior Frontal Gyrus 100 0 0 0 0 0 
















Framewise displacement was calculated from the six-directional head motion parameters 
estimated during image realignment. 2-sample t-tests on the participants endorsing any cannabis 
at age 16 vs. their non-using peers failed to detect significant differences in head motion (mean 
FD) for any of the tasks for either sex, with the exception of the faces task for females. The 
modest motion effect detected for the faces task in females is driven by outliers in the comparison 
sample. Exclusion of these participants does not affect predictive model performance. 
Furthermore, the faces task predictors were lower activity (with one exception) in the cannabis 






Mean Framewise Displacement: 




Faces t720= -0.73, p > .05 
MID t684= -0.85, p > .05 





Faces t806= -2.09, p =.04 
MID t772= -0.22, p > .05 










First, data are divided into k(10) outer-folds. k-1 outer-folds are then divided into k(10) 
nested subfolds. Elastic-net regularized logistic regression applied to k-1 subfolds, during 
which the α, λ parameters are tuned by finding the optimal pair returning the highest 
AUC when it’s model is tested on the kth subfold. The iterative process is completed for 
the k(10) subfolds, generating 10 final nested models. The 10 nested models are ranked 
by their AUC returned when tested on each respective test-fold. The highest-ranking 
model is then tested on the outer fold, and used to generate the reported test AUC. This 
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Mean ROC AUC indicates the performance of the predictive models on independent 






















Minimum Cannabis Use Level at Age 16
ROC AUC 






Figure 4.1.3: Sex Specific Brain Predictors of Adolescent Cannabis Use 
 
Panels A&B: Brain regions where age 16 cannabis users displayed higher average group-
level activation or gray matter volume relative to their non-using peers.  
Panel A: Male Specific Predictive ROIs. Stop Success refers to successful inhibition 
trials minus implicit baseline during the stop signal task; ROI (red) in left inferior 
temporal gyrus. GMV ROI (yellow) in right medial prefrontal cortex.   
Panel B: Female Specific Predictive ROIs. Stop Failure refers to failed inhibition trials 
minus implicit baseline during the stop signal task; ROIs (pink) in left lateral paravermis, 
left midbrain, left pre- & post-central gyrus, right post-central gyrus. Angry Faces refers 
to passive viewing of angry faces minus control images; ROI (orange) in left 
ventromedial prefrontal cortex. Reward Anticipation refers to the processing of monetary 
reward cues; ROI (dark green) in left middle frontal gyrus. Stop Failure & GMV 
overlapping ROI (purple) in right pre-supplementary motor area.   
 
Males Females 
Cannabis > Controls 
Cannabis < Controls 
Stop Success = 
GMV =  
Stop Failure = 
Angry Faces = 
Reward Anticipation =  
Stop Failure & GMV =
Stop Success = 
GMV = 
Neutral Faces & Stop Success=  
Angry Faces = 
Stop Success = 
GMV =  







Panels C&D: Brain regions where age 16 cannabis users displayed lower average group-
level activation or gray matter volume relative to their non-using peers.  
Panel C: Male Specific ROIs. Stop Success ROIs (dark blue) in left cerebellum include 
the anterior cerebellum, paravermis, and posterior-lateral portion of the left hemisphere. 
GMV ROI (bright green) in left middle cingulate. Neutral Faces (passive viewing of 
neutral faces minus control images) & GMV overlapping ROI (teal) in right midbrain 
with extent into thalamus.  
Panel D: Female Specific ROIs. Angry Faces ROI (light blue) in right cerebellar tonsil. 
Stop Success ROIs (dark blue) in bilateral orbitofrontal cortex and two contiguous 
regions in the right middle temporal gyrus. GMV ROI (bright green) in right middle 
frontal gyrus. Neutral Faces ROIs (maroon) in right superior frontal gyrus and lingual 





Figure 4.1.4: Correlations Between Identified Predictors and Outcome Measure by Sex. 
 
 
Pearson’s point-biserial correlation (r) between predictor and outcome. Error bars 
represent 95% confidence intervals generated from 5000 bootstrap samples. 
Circles=Drug use (ESPAD). Triangles=personality (from TCI & SURPS). Squares=Life 


























ROC AUC indicates the performance of the predictive models on independent samples. 
















































Pearson’s point-biserial correlation (r) between SNP and outcome. Error bars represent 
95% confidence intervals generated from 5000 bootstrap samples. 
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4.2: Predicting The Initiation Of Cannabis Use By Age 19: Exploratory Analyses 
 
Introduction 
As discussed in Chapter 1, early age of onset for cannabis use predicts worse 
functional outcomes later in life (Lisdahl et al., 2013). Therefore, predicting initiation by 
age 16 was likely the most impactful cannabis prediction analysis that can be conducted 
using the IMAGEN dataset. Those analyses provided evidence that cannabis use by age 
16 is reliably predicted using multi-domain data collected at age 14 prior to exposure. 
Results from those analyses identified sex- and drug-specific psychosocial and 
neurobiological predictors that might inform etiological mechanisms and provide targets 
for interventions related to cannabis use by age 16.  
As the IMAGEN study also contained assessments at age 19, a natural extension 
of this line of inquiry is to also predict cannabis initiation by age 19. If the age 16 
predictors identified from Chapter 4.1 (future cannabis users vs. all non-users) were 
reproduced, then that would underscore their predictive validity. A reproduction might 
also be used to characterize those features as trait-like predictors, meaning, those features 
are predictive of cannabis use regardless of the age of initiation. Alternatively, if the 
predictors were not reproduced, that might highlight their specificity to early initiation.  
These analyses were conducted for exploratory purposes to test if any level of 
cannabis use by age 19 can be predicted using multi-domain data collected at age 14, 
regardless of the future use level. Hence, the technique in Chapter 4.1 that involved 
predicting each increasing use level was not used here. That technique dramatically 




importance to identify the predictors of early initiation. Moreover, the majority of the 
predictors from Chapter 4.1 were identified from the most lenient cannabis use threshold 
(ESPAD 1>=1; Tables 4.1.7-8). Therefore, these exploratory analyses reported here were 
most likely to identify the greatest number of predictors to compare to the predictors from 
Chapter 4.1. Lastly, setting a low threshold to include all future cannabis users also 




Participants from the IMAGEN study were selected based on their reported drug 
use levels at all time points from the ESPAD survey (Hibell et al., 1997). From the full 
baseline sample (N=2,224), there were n=648 (Females n=398) identified as being 
cannabis-naïve at all time points and were therefore used in the comparison groups. Next, 
there were n=313 (Females n=145) who were cannabis-naïve at age 14 and 16 and then 
reported any cannabis use by age 19. In keeping with the theme of sex-specificity, the 
samples were separated by sex. See Table 4.2.1 for demographic information for each 
group including their cannabis use levels by age 19.  
 
Data Analysis 
 Similar data analytic procedures from the preceding section were used here. In 




used to predict cannabis initiation by age 19 separately for each sex. All predictors were 
drawn from the age 14 assessment only.  
As these analyses were exploratory in nature, the increasing use level technique 
was not used here. Therefore, the analysis was designed to predict any amount of 
cannabis use (ESPAD >=1) by age 19 vs. controls. The predictors selected from these 
analyses were identified using the same threshold as Chapter 4.1 (i.e., present in at least 
six final models (from k=10) across all 100 runs). Finally, sex-specificity was assessed in 
a similar fashion by including the selected predictors in a post-hoc logistic regression 




 Prediction model accuracies indicated a significant prediction of age 19 cannabis 




When probing the results from the female-specific analysis, only two predictors 
passed feature selection threshold and they were higher baseline alcohol use and novelty 
seeking personality (Cloninger, 1999). The results from the male-specific analysis were 






 In keeping with the methods of Chapter 4.1, the two psychosocial predictors 
(alcohol and novelty seeking personality) from the female specific analysis were used to 
estimate a post-hoc logistic regression model on the male sample.  Findings indicated that 
these two psychosocial predictors returned strong model fits when tested on the full male 
sample (χ22,N=418=13.5, p=.001; ΔAIC=9.4). As there were only two predictors, the 
regression coefficients were probed in an exploratory fashion. Findings indicated only 
novelty seeking personality emerged as a significant predictor of cannabis use by age 19 
for males (Adj.OR 1.03 [95% CI: 1.01-1.05], p<.05).  
 
Discussion 
 These results indicated that age 19 cannabis use can be predicted for females but 
not males using machine learning applied to a large set of multi-domain data collected at 
age 14. The predictive profile identified from the female-specific analysis contained two 
psychosocial predictors: higher baseline alcohol use and novelty seeking personality. 
Tests for sex-specificity indicated that novelty seeking personality generalized to predict 
cannabis use by age 19 in males.  
 Here, males were not predicted using machine learning, but were predicted using 
the single novelty seeking personality predictor. This may have been due to the loss of 
statistical power incurred when the sample was split during cross-validation prior to 




modest odds ratio and confidence interval might reflect this subtle effect was observed 
due to the increase in statistical power.  
 Baseline alcohol predicted cannabis use by age 19 for females, but not males. 
This finding is consistent for females relative to the results in Chapter 4.1 and suggests 
higher baseline alcohol use is a trait-like characteristic that predicts cannabis use 
throughout adolescence and into adulthood.  
In these analyses, novelty seeking personality predicted females using machine 
learning, and predicted males in a post-hoc fashion. Novelty seeking personality was also 
identified as a predictor common across the sexes in Chapter 4.1. This converging 
evidence indicated that novelty seeking personality is also trait-like, and confers risk for 
cannabis use regardless of sex or age of initiation.  
Translating these findings into treatment is challenging, however, personality-
targeted intervention programs may be useful (Conrod, 2016). These interventions are 
grounded in cognitive-behavioral therapies, and are tailored to the individual following 
measurement on the substance use risk profile scale (SURPS) personality instrument 
(Woicik et al., 2009). Although SURPS data was collected in IMAGEN and used in all 
the machine learning analyses here, only the Temperament and Character-Inventory 
(TCI) (Cloninger, 1999) measurement of novelty seeking personality was identified as 
predictive. The SURPS measurement that is broadly in line with novelty seeking 
personality is the sensation seeking personality trait, which measures sensitivity to 




 Personality-targeted intervention programs have been effective in adolescent 
samples. Mahu and colleagues tested this intervention technique at high schools with 
students who were designated high risk for cannabis use (Mahu et al., 2015).  Following a 
brief personality-targeted intervention in 9th grade (ages 13-14), adolescents were 
followed up every six months for two years. Authors reported that children from schools 
receiving the intervention exhibited a reduction in cannabis use frequency 12 and 18 
months later compared to control schools. Of note, authors also reported that individuals 
receiving a targeted intervention for an elevated sensation seeking personality 
demonstrated a delay in the onset of cannabis use (Mahu et al., 2015). Therefore, 
targeting novelty seeking personality traits in a similar fashion as the Mahu report might 
be effective in altering the risk phenotype for both males and females. A delay in the 
onset of use might generalize to the samples characterized using the TCI novelty seeking 
personality trait following a similar personality-targeted intervention.  
 These analyses used only the predictors measured at age 14. The IMAGEN study 
also assessed participants at age 16. Future analyses could incorporate the age 16 data, 
and could, for example, also incorporate changes in relevant measures from age 14 to 16. 
For example, the life events questionnaire at age 16 (Newcomb et al., 1981) is expected 
to reflect the stressful life experiences that are more proximal in time to cannabis use at 
age 19. Moreover, the difference in those measures would reflect severity of change and 
is hypothesized to better predict cannabis use. Likewise, baseline cigarette use was a 
strong predictor in Chapter 4.1, but not reproduced here. It would be interesting to test if 




commonly reports a correlation between those two drugs (Agrawal et al., 2012). Finally, 
the brain data were absent from these results. Future analyses could also incorporate the 
age 14 brain data with the age 16 psychosocial data to perform mediation analyses 
linking the brain to behavior two and five years later. For example, a path from one the 
baseline predictors of cannabis use uncovered in Chapter 4.1, might predict performance 
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Table 4.2.1: Participant Demographic Information by Sex 
 
PDS=Puberty Development Scale (Carskadon and Acebo, 1993). SES=Socioeconomic Status. 
Cannabis Use Levels from the ESPAD and measured on an ordinal scale (1=1-2x, 2=3-5x, 3=6-
9x, 4=10-19x, 5=20-39x, 6=40x+). All measures (with the exception of cannabis use) were 
obtained at age 14. All demographics measures were also included as predictors in feature 








Males (N=418) Females (N=543) 
Cannabis Use 
















(M,SD) 14.5, 0.36 14.5, 0.42 .30 14.5, 0.4 14.6, 0.4 .11 
Handedness 
(L,R) 15, 153 29, 221 .38 10, 135 39, 359 .30 
PDS 
(M,SD) 2.6, 0.5 2.5, 0.56 .33 3.1, 0.5 3.2, 0.4 .16 
Perceptual IQ 
(M,SD) 106.6, 13.3 111.0, 15.1 .01 108.5, 13.2 109.3, 13.0 .52 
Verbal IQ 
(M,SD) 112.3, 12.9 113.4, 13.1 .40 110.5, 12.7 110.4, 13.9 .97 
SES 
(M,SD) 18.0, 4.0 18.2, 3.7 .54 18.7, 3.4 18.0, 3.6 .03 
     
Cannabis Use 
Levels 1 2 3 4 5 6  1 2 3 4 5 6  




CHAPTER 5: DIFFERENTIAL PREDICTION OF FUTURE CANNABIS 





 It is important to consider drug specificity in analyses identifying risk factors and 
predictors of a single substance as it is uncommon for individuals to only use one drug of 
abuse. For instance, data from a nationally representative sample of adolescents indicated 
that cannabis is commonly used in tandem with alcohol and tobacco and only 1% of 
individuals who use cannabis do so exclusively (Patrick et al., 2018). When considering 
cannabis and alcohol use together, Terry-McElrath and colleagues report that 13% of 
teens use the two drugs concurrently (defined as separate use occasions within the past 30 
days), whereas 21% of teens use the two drugs simultaneously for overlapping 
intoxication (Terry-McElrath et al., 2014).  
 Alcohol is the most commonly used drug during adolescence (Johnston et al., 
2018), however many teens with binge drinking episodes might not necessarily have 
experiences using cannabis. Instead, for the adolescents who use cannabis, it may be 
considered common for these teens to engage in excessive alcohol consumption. 
Therefore, when predicting future cannabis use in adolescence it is important to consider 
the extent to which teens also go on to binge drink. Evidence of concurrent drug use 
could undermine the strength of the study conclusions, as it is unclear if the prediction 
accuracy or predictors themselves are indicative of cannabis use per se or a likelihood to 




Guided by this framework, the study in Chapter 4 contains an important caveat 
that the future cannabis users also reported some binge drinking by age 16. The 
examination of drug specificity in that Chapter involved testing the sex-specific 
predictors on an independent sample of future binge drinkers only. Therefore, a stricter 
test of drug specificity targeting a typical pattern of cannabis use is required.   
To this end, a differential prediction analysis between the future cannabis use 
sample (which also contained some binge drinking) and future binge drinking without 
future cannabis use will be performed. These analyses are therefore much more rigorous 
than Chapter 4. In considering these very similar behavioral phenotypes, it is 
hypothesized that the prediction accuracy in these analyses will not be as large as those 
reported in Chapter 4.  
Few investigations have used neuroimaging to explicitly predict or compare teens 
with concurrent cannabis use and binge drinking (“cannabis+binge drinking”) to teens 
with binge drinking only. While the study by Whelan and colleagues used very similar 
methods to classify and predict binge drinking, the authors compared binge drinking 
teens to a sample with very light alcohol use (maximum two lifetime alcohol uses, no 
binge drinking), and did not comment on the amount of co-occurring cannabis use in 
their samples (Whelan et al., 2014b). Three cross-sectional structural neuroimaging 
studies compared teens with cannabis+binge drinking experiences to teens with only 
binge drinking experiences. Medina and colleagues found that binge drinkers exhibited 
smaller left hippocampal volumes, and larger right-to-left hippocampal asymmetry 




colleagues used diffusion tensor imaging and found the binge drinking only group had 
lower fractional anisotropy (a measure of white mater integrity) relative to teens with 
cannabis+binge drinking, in four major white matter tracts across the brain (Jacobus et 
al., 2009). Finally, Schweinsburg and colleagues used a working memory fMRI task and 
reported the cannabis+binge drinking group exhibited lower activations than the binge 
drinking only group in bilateral prefrontal and right temporal and occipital regions 
(Schweinsburg et al., 2005).  
Together, these findings underscore the use of neuroimaging in delineating group 
differences between cannabis+binge drinking and binge drinking only adolescents. In 
both structural studies, authors posited that cannabis might have provided some 
neuroprotective properties relative to alcohol. In the fMRI study, authors suggested that 
the cannabis+binge drinking group might have compromised their attentional processing 
abilities. And while all authors were unable to assert causality, they were less inclined to 
interpret their findings as being predictive of use. Therefore, the analyses here are 
tailored to address a gap in the literature by identifying a generalizable predictive profile 
characterizing a typical pattern of cannabis use in adolescence.  
Critically, the analysis in this Chapter will, by design, compare two groups who 
are matched on their levels of future binge drinking. The distinctive characteristic of one 
group will therefore be their future cannabis use. Any predictors that separate these two 
groups are hypothesized to be specific to the combination of future cannabis use and 
binge drinking. Moreover, as the results from Chapter 4 demonstrated that the shared 




drinking, it is hypothesized that the psychosocial predictors will no longer discriminate 
the two groups, and instead, the discriminating predictors will be from the neuroimaging 
and/or genetic domains.  
  
Methods 
Participants & Data 
 All data were drawn from the IMAGEN study. Binge drinking levels reported by 
age 16 were tabulated for both the male and female samples of future cannabis use 
studied in Chapter 4 (now referred to as “cannabis+binge drinking”), as well as the binge 
drinking levels for the future binge drinking only group (See Figure 5.1). Participants 
from the starting samples of cannabis+binge drinking and future binge drinking groups 
were then randomly sampled without replacement to identify a reduced sample of two 
groups perfectly matched on future binge dinking levels. For example, in the male 
starting sample, there were 32 participants in the cannabis+binge drinking group, and 50 
in the binge drinking only group, who reported a binge drinking level of 1-2x by age 16 
(see Table 5.1 or Figure 5.1). Therefore, 32 participants from the binge drinking only 
group use level 1-2x were randomly selected for inclusion to match the size of the future 
cannabis+binge drinking group. Similar logic was executed for each use level for each 
sex. This procedure resulted in n=148 females (74 per group), and n=178 males (89 per 
group) who were matched on the level of future binge drinking. See Tables 5.2 and 5.3 
for baseline demographic information and drug levels by age 16 for the samples used in 




The same set of multi-domain predictors (2,412 total predictors) collected at 
baseline (age 14) was used in the differential prediction analyses, except for baseline 
alcohol use. The exclusion of baseline alcohol use was necessary so that data from the 
participants in the binge drinking only group were minimally confounded with 
consequences of early alcohol use. Thus, the future binge drinkers were restricted to have 
used alcohol a maximum of 1-2x in the life by age 14.  
 
Analysis 
Similar logistic regressions with elastic-net regularization (Zou and Hastie, 2005) 
as explained in Chapter 4 were applied separately for each sex. The main difference is 
that given the reduced sample sizes, a smaller k-fold cross-validation scheme was 
implemented (k=5). All other procedures applied, including the nested k(5)-fold cross-
validation scheme to tune the alpha and lambda parameters for the elastic-net. Likewise 
from Chapter 4, these procedures were looped 100 times to account for the randomness 
of participants being assigned to the k-folds.  
As preliminary analyses using regularized logistic regressions returned very 
sparse results for the male sample, the prediction analyses were conducted again using a 
random forest model (Breiman, 2001). This model was chosen based on the hypothesis 
that non-linear relationships between the predictors might better differentiate between 
two very similar behavioral phenotypes. When estimating the random forest models, a 
similar 5-fold cross validation scheme was implemented, including a nested 5-fold cross 




the number of decision trees (100 to 500 trees), and the number of samples required for a 
“leaf” node (defined as the minimum number of samples to be contained within a 
partition of the decision tree). Generally, more decision trees the better, however, an 
excessive number of decision trees risks fitting many trees using poor predictors. The 
minimum samples per leaf may be considered a method to resist overfitting. By requiring 
a larger number of samples in a leaf, the decision tree is restricted from becoming overly 
complex and fitting to the noise and nuances of small samples. As above, the entire 
analytic scheme was run 100 times to account for the random assignment of participants 
to folds.  
After running the logistic regression and random forest analyses separately for 
each sex, the predictors were evaluated for sex-specificity using post-hoc analyses. 
Predictors identified from the logistic regression analyses for one sex were used in a post-
hoc regression model to predict the opposite sex. For the results of the random forests, in 
keeping with tree-based estimators, the predictors for one sex were used to estimate a 
single decision tree to predict the opposite sex. Prediction model accuracy was evaluated 
for all scenarios using the area under the receiver-operating characteristic curve (ROC 
AUC). Null-hypothesis significance testing on the ROC AUC was conducted using a 
Mann–Whitney U-test (Mason and Graham, 2002).  
 
Results 




The exact levels of future binge drinking in the cannabis+binge drinking group 
and the future binge drinking only group was plotted for each sex (see Figure 5.1). The 
distribution of binge drinking within the cannabis+binge groups was nearly uniform 
across the use levels for males and females, whereas the future binge drinking only 
groups were more skewed to lighter binge drinking. These data suggest that while it is 
likely for future cannabis users to also binge drink, the patterns of use are not consistent 
across the two drugs. Therefore, identifying subsamples of individuals matched on binge 
drinking (described below) removes the confound of predicting co-occurring use, and 
substantiates future cannabis use as the defining outcome measure.  
Prior to the pseudo-random selection process to match groups on future binge 
drinking levels, it was found that 89% of females, and 91% of males in the future 
cannabis using groups from Chapter 4 also indicated some level of future binge dinking. 
Therefore, 11% and 9% of participants for each sex who had not initiated any binge 
drinking were initially excluded from the sample. Of the remaining samples, participants 
were randomly sampled without replacement from the larger group within each binge 
drinking level (described above). This procedure yielded n=178 males (89 per group; see 
Table 5.2) and n=148 females (74 per group; see Table 5.3) who were then passed 
forward to the differential prediction analysis (See Figure 5.2 for graphs of matched 
samples use levels). For each sex, chi-square and t-test analyses on various baseline 
demographic measures indicated the two groups did not differ on age, handedness, 




male cannabis+binge drinking group, see Table 5.3). Nonetheless, all demographics were 
also included as candidate predictors in the analysis.  
 
Predictive Models Performance 
 When evaluating the logistic regression differential prediction analyses on 
independent samples, results indicated significant predictions in the female sample: mean 
ROC AUC=.6567 (p<5.92x10-6), and the male sample: mean ROC AUC=.6140 
(p<4.6x10-4). When evaluating the random forest prediction analyses on independent 
samples, results were nearly identical for females: mean ROC AUC=.6593 (p<4.23x10-6) 
and consistent for males: mean ROC AUC=.6286 (p<9.25x10-5), relative to the AUCs 
from the logistic regression analyses. Hence, the prediction accuracy was consistent 
across the two machine learning algorithms.  
 
Permutation Tests 
The AUCs reported above may be considered modest relative to those reported in 
Chapter 4. To further investigate the prediction accuracies for these analyses, a non-
parametric test on the significance of the ROC AUCs was performed. Here, the 
prediction analyses were run an additional 100 times while randomly shuffling the group 
labels. These analyses empirically derive a distribution of ROC AUCs over the null 
hypothesis. The ROC AUCs from the true label analysis are then compared to this null 
distribution. Given the very similar AUCs across the two machine learning algorithms, 




These permutation analyses returned a mean ROC AUC=.50 for both males and 
females, indicating the models failed to predict the two randomly labeled groups better 
than chance. For both males and females, the true label AUC results for both the logistic 
and random forest models were greater than 95 of the 100 ROC AUC derived from the 
random label permutation analysis (p<.05). Taken together, these results provide strong 
supporting evidence that for each sex, the two groups were distinct and the performance 
of the prediction analyses were significantly above chance levels.    
 
Features Selected  
 As the differential prediction models were fitted within a 5-fold cross validation 
framework (thus supplying 5 final models), and looped 100 times, a threshold was 
necessary to perform feature selection. Therefore, in keeping with the threshold from 
Chapter 4, a feature must have been present in at least half of the final models (here, a 
minimum 3 of 5) across all 100 runs. With this threshold in place, the logistic regression 
analyses identified four features for females, and one feature for males. After 
interrogating the random forest analyses, five features for females, and three features for 
males were identified.  
 Starting with the four female features from the logistic regression analyses, higher 
baseline cigarette use and less negative feelings towards deviant behaviors in the future 
cannabis+binge drinkers were the two psychosocial predictors identified. From the brain 
domain, higher activations in the left superior cerebellum during reward anticipations was 




rs521674, a SNP on a gene coding for the alpha-2A adrenergic receptor, with a higher 
number of risk alleles present in the future binge drinking only group. See Table 5.4 for 
summary of SNP rs521674 allele frequencies by group.  
Moving to the five female features identified from the random forest analyses, 
only higher baseline cigarette use was reproduced from the logistic results. The other four 
predictors were brain predictors from the stop signal task. During stop success, lower 
activations in the right inferior temporal and paracentral lobule, and left middle frontal 
gyrus, were identified in the cannabis+binge drinking group. Finally, during stop failures, 
lower activation in the left inferior frontal gyrus was identified in the cannabis+binge 
drinking group. See Figure 5.3 for all female brain predictor results. 
 Considering the male results, only higher baseline cigarette use in the future 
cannabis+binge drinking group was identified from the logistic regression analyses. For 
the random forest analyses, higher baseline cigarette use was also observed, and less 
negative feelings towards deviant behaviors in the cannabis+binge drinking group was 
identified. Finally, higher gray matter volume in the right inferior temporal lobe was 
identified in the cannabis+binge drinking group (Figure 5.4). Interestingly, this was the 
same ROI that exhibited lower activations during stop success trials for future female 
cannabis+binge users.  
 
Sex-Specificity 
 Like Chapter 4, the differential prediction analyses returned a unique set of brain 




that a post-hoc logistic regression model using the female-specific brain predictors was 
estimated on the entire female sample, and then tested on the entire male sample. This 
was done only for females because the male analysis identified only one shared predictor 
(baseline cigarette use) using a logistic regression model.  
To begin, estimating a post-hoc logistic regression model using only the 
cerebellar ROI during reward processing returned a ROC AUC=.65 (p<8.2x10-4) when 
tested on the entire female sample, and a ROC AUC=.48 (p>.05) when tested on the 
entire male sample. Thus, cerebellar activations to rewards may be considered a female-
specific differential predictor of future cannabis+binge drinking. For reference, 
estimating a post-hoc logistic regression model using all the female-specific predictors 
(feelings of deviance, SNP rs521674, and the cerebellar ROI) returned a ROC AUC=.80 
(p<1.5x10-10) when tested on the entire female sample. When tested on males, that model 
returned a ROC AUC=.61 (p<.05). This modest prediction is likely driven by the feelings 
toward deviant behaviors predictor, which was identified for males using the random 
forest model, and approached selection threshold for the male logistic model (64 of 100 
runs). See Table 5.5 for the number of runs each predictor was selected by the alternate 
analytic model. 
Turning to the predictors uncovered from the random forest analyses, sex-
specificity was assessed in a similar way using a decision tree. Here, a post-hoc decision 
tree using the four female-specific brain predictors from the stop signal task was 
estimated on the females. This decision tree returned a ROC AUC=.83 (p<2.1x10-12) 




tested on the full male sample, ROC AUC=.53 (p>.05). Taken together with the result of 
the cerebellar ROI from the logistic regression analysis, all brain predictors for females, 
regardless of the model from which they were identified, exhibit clear sex-specificity in 
differentially predicting future cannabis use vs. binge drinking.  
For the male results, only the random forest identified a brain predictor. A single 
post-hoc decision tree was estimated on the male sample using the GMV ROI. This 
decision tree returned a ROC AUC=.74 (p<1.6x10-8) when tested on the full male 
sample, and failed to predict better than chance when tested on the full female sample, 
ROC AUC=.49 (p>.05). Hence, the random forest identified brain predictor exhibited 
sex-specificity for males. For reference, estimating a single post-hoc decision tree using 
the two male-specific predictors (feelings towards deviant behaviors and the GMV ROI) 
returned a ROC AUC=.76 for males (p<1.5x10-9). This decision tree predicted marginally 
better than chance when tested on the full female sample, ROC AUC=.57 (p<.05), and 
was likely driven by the feelings towards deviant behaviors predictor.  
 
Comparison of Predictors Identified from Random Forests vs. Logistic Regression 
With the exception of baseline cigarette use, the predictors identified from the 
random forest were different than the predictors identified from the logistic regression. A 
likely interpretation of these discrepant findings is that the random forest is capable of 
modeling predictors exhibiting both linear and non-linear relationships. To assess this 
possibility, the predictors identified form the random forest analyses were used to 




hypothesized that the AUCs for the logistic regression models would be lower than the 
decision trees, thus supporting the argument that the tree-based estimators achieve their 
results by capturing non-linearities among the features. 
The four female-specific brain predictors identified from the random forest 
analysis were first used in a post-hoc logistic regression model on the full female sample. 
This model returned a ROC AUC=.71 (p<5.2x10-6). Using these predictors in a post-hoc 
decision tree returned a ROC AUC=.83 (p<2.1x10-12). Similarly for males, the one male-
specific brain predictor identified from the random forest model was used to estimate a 
post-hoc logistic regression model on the full male sample. This model returned a ROC 
AUC=.70 (p<2.4x10-6). Using this predictor to estimate a post-hoc decision tree returned 
a ROC AUC= .76 (p<1.5x10-9).  
In all cases, using predictors identified from the random forest analyses returned 
inferior prediction in a logistic regression model relative to the decision tree model. 
Interestingly, the post-hoc logistic regression models were still highly significant when 
predicting each sample, although to a lesser extent than the decision tress. These results 
indicate that tree-based estimators are more flexible in modeling relationships. And while 
the predictors uncovered from the random forests exhibit some degree of non-linearity (as 
the post-hoc decision tree returned superior performance), they also exhibit linear 
relationships as the logistic regression also return highly significant prediction. Post-hoc 
analyses using predictors identified from the logistic regression analyses to estimate 
decision trees were not conducted. This is because decision trees are robust in capturing 





Influence of Baseline Cigarette Use 
Given the finding that baseline cigarette use was the most robust predictor, the 
logistic regression and random forest analyses were executed again with this variable 
excluded. Any fluctuation in the ROC AUC would indicate the extent to which the 
prediction accuracy is dependent on baseline cigarette use. Additionally, the dominant 
relationship between baseline cigarette use and the outcome measure might interfere with 
the likelihood of other predictors being selected within the context of the regularization 
procedure. As regularization favors sparse models, the predictors that were less correlated 
with the outcome measure were unlikely to coexist in a model containing baseline 
cigarettes. This problem is less of an issue with random forests, but similar logic applies 
if baseline cigarettes was part of the randomly selected set of predictors. Therefore, 
rerunning the analyses without cigarettes might permit discovery of novel predictors.  
For females, the logistic regression analyses returned a mean ROC AUC=.6196 
(p<.01), whereas the random forest analyses returned a mean ROC AUC=.6077 (p<.05). 
Relative to the original analyses with baseline cigarette use included, the logistic 
regression model was slightly more resilient (∆AUC= -.0371) than the random forest 
(∆AUC= -.0516). These results indicate that baseline cigarette use is important, but not 
critical, to differentially predict future cannabis+binge drinking in females. Probing the 
logistic regression analyses further, all three predictors identified from the original 
analyses (feelings of deviance, SNP rs521674, and the cerebellar ROI during reward 




domains. Probing the random forest analyses, only two of the four stop task ROIs were 
reproduced (right inferior temporal and left middle frontal gyrus during stop success) 
from the original analyses. One additional ROI during stop success (right cerebellum) 
and neutral face processing (left visual cortex) were identified from the random forest. In 
both scenarios, the models attempted to compensate for the loss of the best predictor 
through other predictors, as indexed by the many new predictors selected by the logistic 
regression analysis, and the lack of a consistency in the predictors identified by the 
random forests. 
For the male sample, a different finding emerged. The logistic regression analyses 
returned a mean ROC ACU=.49, and the random forest returned a mean ROC AUC=.54 
(p>.05). Therefore, the exclusion of baseline cigarettes eliminated the ability of either 
model to significantly predict between the two groups. For exploratory purposes, the 
predictors selected from these non-significant models were probed to determine if there 
was any consistency with the original analyses despite their non-significant prediction. 
Interestingly, both the right temporal GMV ROI and feelings towards deviant behaviors 
predictors were identified as the top predictors across both of the non-significant 
analyses, along with frequency of sexual life events. These results indicated that GMV 
ROI and feelings towards deviant behaviors predictors explained a very small portion of 
the variance, and must be modeled with baseline cigarette use to predict between the 
groups. Frequency of sexual life events was identified presumably as a proxy for baseline 






The analyses reported here better model the predictive profile of teenagers who 
use cannabis in adolescence. As it is rare for an adolescent to use cannabis exclusively, 
these prediction analyses target a typical pattern of adolescent cannabis use by 
differentially predicting cannabis and binge drinking versus binge drinking only. This 
chapter was also distinguished by its exploratory use of two competing machine learning 
algorithms. As elastic-net regularized logistic regression was used successfully in 
Chapter 4 to develop predictive profiles containing brain and behavioral data, the use of 
regularized regression in this chapter returned very sparse profiles. While these sparse 
results here may seem in conflict with Chapter 4, those results were an amalgamation of 
six analyses predicting each increasing use level. Implementing a similar technique for 
the differential predictions outlined here would not be feasible due to the very low sample 
sizes within each use level.  
Starting with the cross-validated prediction accuracies, the random forest analyses 
returned surprisingly similar ROC AUCs relative to the logistic regression analyses, 
indicating one model is not necessarily superior to the other. This is beneficial in that 
both results may be considered a form of internal replication, and reaffirms the significant 
differential prediction between the two groups. And while both analyses returned a very 
sparse set of shared and unique predictors within each sex, the difference between the 
predictors identified is likely due to the flexibility of the random forest model.  
Higher baseline cigarette use predicted future cannabis+binge drinking across all 




cannabis use vs. controls for both sexes. These consistent results across samples, models, 
and sexes provided strong evidence that cannabis use in adolescence is likely to follow 
from early cigarette use. The similarities in route of administration for the two drugs may 
influence transition from one to the other as experiences smoking a cigarette may 
facilitate smoking cannabis.  
Epidemiological data indicated a downward trend in cigarette use in teens 
(Johnston et al., 2018), and researchers are just starting to study how these trends might 
impact cannabis use. Miech and colleagues assert that despite the observed decrease in 
cannabis risk perception, a hypothesized increase in cannabis use has not been observed 
due to the decrease in cigarette use levels (Miech et al., 2017). This interpretation 
suggests lowering cigarette use would be protective against cannabis use. Therefore, 
policies and programs designed to discourage cigarette use in youths are already showing 
efficacy in helping to delay cannabis use. However, considering the change in landscape 
regarding e-cigarette use, it will be important to monitor how e-cigarettes might influence 
cannabis use in adolescence.  
The other identified psychosocial predictor was less negative feelings towards 
deviant behaviors taken from the life events questionnaire (Newcomb et al., 1981). This 
measure asks the teen to assign a valence score to the idea of engaging in deviant 
behaviors (e.g., stealing something valuable). Given the nature of this measure, the 
finding reported here is likely signaling a propensity for poor conduct. This interpretation 




disorder predicted cannabis initiation in adolescence for both sexes, with a stronger 
association reported for females (Pedersen et al., 2001). 
Interestingly, the feelings towards deviant behaviors predictor were identified for 
both sexes but using different models (Females: logistic regression; Males: random 
forests). For males, this predictor was selected less often during the logistic regression 
model (64 of 100 runs) but nearly passed threshold for females with the random forest 
model (95 of 100; Table 5.5). Post-hoc analyses supported these trends, and indicated the 
inclusion of this predictor in a decision tree modestly improved prediction for males 
(∆AUC=.02), whereas the inclusion of this predictor (and rs521674) in a logistic 
regression model dramatically improved prediction for females (∆AUC=.15).  
Given the superiority of the post-hoc logistic model predicting cannabis use in 
females relative to the decision tree predicting cannabis use in males, the relationships 
between the feelings toward deviant behavior predictor and the other variables may be 
characterized as linear for females, and non-linear for males. This result underscores the 
use of the random forest model, as one might have assumed feelings toward deviant 
behaviors to be female-specific if only a linear model was used. As Chapter 4 only used a 
logistic regression model for both the prediction analyses and post-hoc tests, it is possible 
that some of the sex-specific predictors for one sex might generalize to the opposite sex if 
non-linear model was used. This finding highlights the need for prediction analyses to 
consider both types of relationships when modeling human behavior.  
As baseline cigarette use and less negative feelings toward deviant behaviors were 




they would also emerge as differential predictors here. Indeed, this effect counters the 
initial hypothesis that the differential predictors will be from the brain and genetic 
domain. Given this effect, it is likely the case that there is a linear relationship with these 
two psychosocial predictors and the three samples (controls, binge drinking only, and 
cannabis+binge drinking). In other words, the controls have the lowest levels on these 
two measures, followed by the future binge drinking only, with the cannabis+binge 
drinking groups exhibiting the highest levels. This pattern would explain why these two 
measures are consistently identified as a predictor of cannabis use relative to the two 
comparison samples.  
In support of the initial hypothesis, a unique finding for females was SNP 
rs521674 identified from the logistic model. For this SNP, more risk alleles were present 
in the future binge drinking only group (Table 5.5). This finding is in line with a study by 
Clarke and colleagues who reported a correlation between this SNP and a family history 
of alcoholism in a sample of individuals with alcohol use disorder (Clarke et al., 2012). 
And while the exact predictive mechanism is difficult to ascertain, it is likely that these 
future binge drinking only adolescents initiated alcohol abuse for different reasons, one 
of which being this genetic variation.  
From the female brain results, the logistic analyses identified that the future 
cannabis+binge drinking group exhibited higher activations in the superior cerebellum 
during reward outcome (Figure 5.3). This predictor was also selected by the random 
forest model, albeit at a slightly lower threshold (91 out of 100 runs; Table 5.5). This 




Cservenka, Jones, & Nagel (2015). In that study, lower activations during reward 
outcome in the left superior cerebellum correlated with binge drinking levels later in 
adolescence. Moreover, the peak voxel location reported in that study is contained in the 
ROI identified here. Therefore, this study adds converging evidence on blunted reward 
processing in the cerebellum as predictive of adolescent binge drinking. And while the 
cerebellum is classically implicated during motor functioning, recent work has identified 
cortical-cerebellar circuits involved during cognitive and affective processing (Strick et 
al., 2009), and have incorporated the cerebellum into brain-based models of addiction 
(Moulton et al., 2014).   
In the random forest analyses, all the brain predictors identified for females were 
from the stop signal task. When referencing the brain predictors from Chapter 4, 10 out 
of the 17 female brain predictors were from the stop task so this task may be especially 
useful in developing brain-based predictive profiles. The effects observed here were all 
lower activations in the future cannabis+binge group. This pattern is broadly consistent 
with Schweinsburg and colleagues who reported lower activations in prefrontal regions 
for cannabis+binge drinking adolescents (Schweinsburg et al., 2005).  
The lower activations reported here might indicate that these individuals failed to 
recruit sufficient processing resources to execute inhibitory control behaviors. Lower 
activations in the left middle frontal gyrus and left inferior frontal gyrus were implicated 
during stop success and stop failures (respectively). This finding may suggest that in 
these individuals, the left hemisphere failed to supplement the predominantly right-sided 




right paracentral lobule and inferior temporal region have both been implicated in the 
motor (Zhang et al., 2015) and visual processing (Boehler et al., 2010) features of the 
stop signal task. Taken together, these results suggest that a compromised network of 
regions supporting inhibitory control constitutes a female-specific risk profile. 
For males, the sole brain predictor was higher gray matter volume in the right 
inferior temporal gyrus (Figure 5.4). As healthy neurodevelopment is characterized by 
gray matter volume reduction over time (Giedd et al., 1999; Spear, 2000b), this effect 
might suggest a neurodevelopmental delay at this region. The finding of lower stop 
success activation in this same region for females might indicate that this delayed 
neurodevelopmental process only manifests as a functional difference later in life. As 
neurodevelopment begins sooner for females (Lenroot et al., 2007), this interpretation 
may explain why males exhibit structural differences, whereas females exhibit functional 
differences at this region during the age 14 scan. Future analyses could be conducted to 
determine if this functional difference is observed in the male sample using the age 19 
assessment of the IMAGEN study.  
The post-hoc analyses suggested that the brain predictors from the random forest 
analyses were the most robust predictors. For instance, for females, the highest ROC 
AUC was found using the predictors from the random forest in a post-hoc decision tree 
(ROC AUC=.83). Using the four female brain predictors identified from the random 
forest to estimate a post-hoc logistic regression model returned superior prediction (ROC 
AUC=.71) than using the single brain predictor identified from the logistic regression 




linear analyses (random forest) to inform a post-hoc linear model (logistic regression) 
was superior to a consistently linear model course of inquiry. These results indicate that 
looking across the post-hoc results, the four stop task brain predictors are superior 
predictors than the reward task predictor. And as the random forest analyses only 
uncovered brain predictors passing threshold for males, it can be concluded that random 
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Starting Samples to Later Match on Binge Drinking Levels 

























0 23 0 14 0 
1-2x 32 50 26 61 
3-5x 33 30 25 27 
6-9x 27 14 25 8 
10-19x 29 9 32 9 
20-39x 31 3 20 3 
40+ 33 1 17 3 
 
These data reflect the amount of binge drinking within the starting samples. All Future 
Binge Drinking Only participants were cannabis naïve. Referencing these levels, two 
subgroups for each sex were randomly selected for differential prediction analyses. First, 
the 23 male and 14 female participants from the Future Cannabis+Binge Drinking sample 
with a binge drinking level of zero were excluded. Then, within each use level, the larger 
group was randomly subsampled to match the size of the smaller group (see Tables 5.2 

























Age (M,SD) 14.4, .45 14.5, .38 .41 
Handedness (L, R) 13. 76 12, 77 .83 
PDS (M,SD) 2.6, .49 2.5, .55 .12 
Verbal IQ (M,SD) 114.3, 14.7 110.2, 13.8 .06 
Performance IQ 
(M,SD) 108.5, 15.4 110.2, 13.8 .04 
SES (M,SD) 18.7, 4 17.9, 3.7 .16 
 
Drug Use Level 1 2 3 4 5 6 1 2 3 4 5 6  
Binge Drinking by 
Age 16 32 30 14 9 3 1 32 30 14 9 3 1 1.0 
Cannabis Use by 
Age 16 39 10 8 6 9 17 0 0 0 0 0 0 .00 
 
The two groups were pseudo-randomly selected from the starting sample (Table 5.1) to 
be matched on binge drinking levels. P value reflects significant between-group 
differences determined via chi-square (for handedness) and t-tests. All demographic 
information measured at baseline, and were also included as candidate predictors in the 
differential prediction analyses. PDS: Pubertal Development Scale (Carskadon and 
Acebo, 1993). SES: Socioeconomic Status. Drug levels from the ESPAD and measured 
























Age (M,SD) 14.5, .48 14.5, .47 .70 
Handedness (L, R) 9, 65 5, 69 .26 
PDS (M,SD) 3.2, .37 3.1, .42 .20 
Verbal IQ (M,SD) 112.5, 11.8 108.5, 15.1 .08 
Performance IQ 
(M,SD) 110.1, 12.6 105.8, 13.8 .06 
SES (M,SD) 19, 3.9 18, 3.7 .10 
 
Drug Use Level 1 2 3 4 5 6 1 2 3 4 5 6  
Binge Drinking by 
Age 16 26 25 8 9 3 3 26 25 8 9 3 3 1.0 
Cannabis Use by 
Age 16 22 18 6 11 5 12 0 0 0 0 0 0 .00 
 
The two groups were pseudo-randomly selected from the starting sample (Table 5.1) to 
be matched on binge drinking levels. P value reflects significant between-group 
differences determined via chi-square (for handedness) and t-tests. All demographic 
information measured at baseline, and were also included as candidate predictors in the 
differential prediction analyses. PDS: Pubertal Development Scale (Carskadon and 
Acebo, 1993). SES: Socioeconomic Status. Drug levels from the ESPAD and measured 



































Hminor:HT:Hmajor Hminor:HT:Hmajor  
rs521674 T:A 41: 27: 6 57: 0: 17 .001 
 
Count of the number of risk alleles for the two groups. Hminor: Homozygote minor (high 
risk alleles, A/A). HT:heterozygote major (A/T). Hmajor: Homozygote major (low risk 
alleles, T/T). A higher number of risk alleles were present in the future binge drinking 
only group. P-value derived from a chi-square analysis. SNP rs521674 located on 




Table 5.5: Summary of Predictors Selected 
 











Psychosocial Lifetime Cigarettes RF & LR - 









Stop Success R. Inferior Temporal Lobe RF LR (0) 
R. Paracentral Lobule RF LR (43) 
L. Middle Frontal Gyrus RF LR (1) 
Stop Failures L. Inferior Frontal Gyrus RF LR (0) 





Psychosocial Lifetime Cigarettes RF & LR - 
Feelings of Deviant Behaviors RF LR (64) 
Brain 
Gray Matter Volume 
 






The primary model denotes the model for which the predictor passed the initial threshold 
for identification: 3 of 5 final models across all 100 runs. The secondary model denotes 
the model for which the predictor did not pass the initial threshold, and the selection 
frequency denotes the number of runs for which the predictor was selected by the 















































A: Binge drinking levels by age 16 for starting sample of males. B: Binge drinking levels 















Future Binge Drinking Levels in Starting Sample 
 for Females (N=270) 
Cananbis+Binge Drinking (n=159) 














Future Binge Drinking Levels in Starting Sample 
for Males  (N=315) 
Cannabis+Binge Drinking (n=208) 
















































A: Binge drinking levels by age 16 for analytic sample of males. B: Binge drinking levels 














Binge Drinking Levels in Matched 
Samples of Females (N=148) 
Future Cannabis+Binge (n=74) 















Binge Drinking Levels in Matched 
Samples of Males (N=178) 
Future Cannabis+Binge (n=89) 






Figure 5.3: Female Brain Predictors Identified for Each Model 
 
For the logistic regression results, higher activations to reward outcomes in the left 
superior cerebellum was identified as a differential predictor. For the random forest 
results, lower activations in the left middle frontal gyrus, right inferior temporal gyrus, 
and the right paracentral lobule during stop success, and lower activations in the left 
inferior frontal gyrus during stop failure, were identified as differential predictors.  
 
 
Figure 5.4: Male Brain Predictor Identified From the Random Forest.  
 
Only the random forest analysis identified a single predictor from the brain domain for 
males. Higher gray matter volume in the right inferior temporal lobe was identified as a 





Cannabis+Binge > Binge Only 
 
Stop Success 
Cannabis+Binge < Binge Only 
Stop Failure 
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CHAPTER 6: DISCUSSION & CONCLUSIONS 
 
6.1: General Discussion 
Overall Objectives 
 This dissertation identified a set of brain and behavioral features that 
characterized cannabis use in adolescence. Findings were reported within the context of 
prediction as age 14 data was used to predict cannabis initiation or level of cannabis use 
two or five years later. And even though Chapter 2 contained a cross-sectional analysis, 
Chapter 3 provided evidence that the observed amygdala hyperactivity is likely a pre-
existing difference.  
Chapters 4 and 5 searched beyond the amygdala and identified a comprehensive 
risk profile that contained predictors from the psychosocial and brain domains collected 
prior to cannabis exposure. Therefore, this dissertation improves on the largely cross-
sectional body of work by uncovering sex- and drug-specific predictors that were 
disentangled from any consequences of cannabis use. And although prediction was the 
dominant theme throughout this dissertation, exploratory analyses also tested for changes 
in amygdala reactivity and anxiety levels following an escalation of cannabis use from 
age 14 to 19. 
 Results from these analyses are discussed here in terms of their utility in 
stratifying risk and informing interventions. For risk stratification, these results help 
gauge severity of risk for cannabis use by how closely an adolescent fits the identified 
risk profiles. For instance, a female who drinks, smokes cigarettes, and exhibits a novelty 




neurobiological predictors further aid in risk stratification if neuroimaging batteries ever 
become commonly administered as a screening tool in behavioral health. Furthermore, 
the identified predictors are discussed in terms of their ability to inform treatment 
strategies. Those treatments are hypothesized to attenuate the likelihood of cannabis use 
by altering the risk phenotypes for males and females.  
 
Data Analysis Philosophy 
Throughout this dissertation two lines of inquiry were pursued, hypothesis- and 
data-driven (machine learning) analyses. Starting with the hypothesis-driven analyses, a 
theoretical framework related to amygdala reactivity was used to characterize and predict 
adolescent cannabis use. For the data-driven analyses, additional measures from the 
IMAGEN study were explored without being limited by a specific theoretical framework 
and uncovered a set sex-specific psychosocial and neurobiological predictors.  
Hypothesis-driven studies have the advantage of being more transparent and may 
lead to more interpretable findings guided by a theoretical framework. Alternatively, 
data-driven studies provide a unique opportunity to make discoveries that were not 
specifically theorized a-priori. This characteristic of data-driven studies was reflected by 
the set of multimodal brain measures that predicted cannabis use by age 16. However, 
only the hypothesis-driven line of inquiry yielded a brain measure that predicted cannabis 
use by age 19. Therefore, both approaches can be used to make valuable insights into the 




Moreover, these two lines of inquiry are not in opposition. This notion is 
demonstrated by the post-hoc analyses in Chapters 4 & 5 that were informed by the data-
driven analyses. Given the high-dimensionality of the brain data (1,946 ROIs; Table 
4.1.3), it was impossible to theorize or test hypotheses related to each measure or 
combination thereof. Instead, machine learning was required to identify the most robust 
and generalizable brain features. Those results were then passed forward to test 
hypotheses related to sex and drug-specificity. This approach embraced the high-
dimensionality of the brain data while employing a set of best practices (Whelan and 
Garavan, 2014) that rigorously examined relationships between adolescent cannabis use 
and the underlying neurobiology. Hence, this line of inquiry facilitated the discovery of 
many novel neurobiological predictors of adolescent cannabis use. 
 
6.2: Main Findings & Implications 
Chapters 2 & 3 Findings 
 Chapters 2 & 3 together demonstrated that amygdala hyperactivity to angry faces 
was likely a pre-existing difference that partially predicted the level of cannabis use five 
years later. This dose-response prediction of cannabis use, and the lack of a significant 
difference in amygdala reactivity at age 19, indicated that the amygdala is a predictive 
biomarker, rather than a marker of a cannabis-related effect.  
As the amygdala has been implicated in threat monitoring processes (Fox et al., 
2015; Mobbs et al., 2010), these results might suggest an exaggerated threat monitoring 




this by testing for associations between amygdala reactivity and anxiety levels. However, 
this association was not confirmed and indicated that the DAWBA band score for 
generalized anxiety is not a suitable measure to probe this construct for this sample.  
For the anxiety level data, a significant main effect of time indicated that anxiety 
levels increased from baseline into late adolescence. No main effect of group, or a group-
by-time interaction was uncovered, which indicated cannabis use did not influence 
symptoms of generalized anxiety. Instead, the main effect of time suggested it was 
typical to report higher anxiety levels later at age 19. This pattern of results is consistent 
with Van Oort and colleagues who previously reported that generalized anxiety disorder 
symptom levels peaked in late adolescence (Van Oort et al., 2009). This phenomenon 
might be due to the exploratory nature of early adolescence where lower anxiety levels 
may be evolutionary beneficial to motivate autonomy (Spear, 2000b). These youths may 
then experience more stress and uncertainty later in adolescence as they first become 
independent outside of the household (i.e., for college, military, new careers, etc.).  
Chapter 3.2 tested for changes in amygdala reactivity from age 14 to 19 with 
chronic cannabis use. No significant differences were detected, although plotting the data 
visually displayed a decrease in amygdala reactivity with chronic cannabis use (Figures 
3.2.1-2). Despite the null statistical results, these analyses motivated a comparison of the 
relatively large sample of typically developing (cannabis-naïve) adolescents. Those 
analyses indicated healthy amygdala development was characterized by an increase in 
activation from age 14 to 19. The observed pattern of amygdala reactivity might also be 




interpretation of the anxiety data, lower threat monitoring responses in adolescence might 
facilitate exploration with novel environments and elevations in novelty seeking 
personality, whereas a higher threat monitoring system in adulthood is beneficial to 
maintain survival and independence (Spear, 2000b).   
  
Chapters 2 & 3 Implications 
The meaning of the amygdala findings were difficult to dissect. Considering the 
role of the amygdala in threat monitoring (Fox et al., 2015), it is plausible that these data 
reflected an attentional-bias to negative affect or an inability to suppress automatic threat 
detection in favor of goal-directed behavior. However, it is difficult to make these 
conclusions because the passive viewing face processing task did not have any task 
performance measures.  
Previous fMRI studies on adolescent psychopathology characterized both 
generalized and social anxiety, as well as depression, in terms of amygdala hyperactivity 
to evocative faces (Beesdo et al., 2009; Lau et al., 2009; Monk et al., 2008; Yang et al., 
2010). To better decompose this apparent lack of disorder specificity, van den Bulk and 
colleagues correlated amygdala activations to faces with dimensional scores of anxiety 
and depression in diagnosed children (DSM-IV) compared to controls (van den Bulk et 
al., 2014). Results indicated that the right (but not left) amygdala activation to happy, 
neutral, and angry faces significantly correlated with anxiety, but not depression scores. 
Anxiety dimension scores explained 28% of the variance in right amygdala activations to 




al., 2014). Although the cannabis users reported here were not selected for having an 
anxiety disorder diagnosis, and their DAWBA band score levels did not differ from the 
cannabis-naïve sample (Table 3.1.3), their pattern of amygdala reactivity were in line 
with the papers above. And while that should not lead to the conclusion that the cannabis 
users were an anxious sample, their similarities are worth considering. Nonetheless, the 
lack of a correlation between anxiety scores and amygdala reactivity reported here was 
consistent with the null effects reported by van den Bulk and colleagues for their control 
sample (van den Bulk et al., 2014). Although, the van den Bulk report used a dimensional 
measurement tool for anxiety (Revised Child Anxiety and Depression Scale) (Chorpita et 
al., 2000) which was likely better suited to identify a linear relationship with amygdala 
reactivity than the ordinal nature of the DAWBA band score. 
Despite the lack of a suitable measure for anxiety, the baseline amygdala 
reactivity may have signaled the child was under some level of distress more generally. 
As these youths continued their cannabis use throughout the intervening five years, the 
follow up amygdala reactivity indicated a visual decrease in activation relative to baseline 
(Figure 3.2.1-2). Those findings were interpreted as broadly supporting a negative 
reinforcement model of addiction, as proposed by Koob (Wise and Koob, 2014). While 
this model asserts positive reinforcement is necessary for the initial repetition of drug 
taking, it is the removal of distress that maintains and escalates drug use. Here, the 
distress experienced by the individual, as reflected by heightened amygdala reactivity at 
baseline, might be alleviated with cannabis use. This framework also accommodates the 




only required low levels of cannabis, whereas high distress necessitated frequent use. 
This line of reasoning also supports the downward shift in amygdala reactivity as 
repeated cannabis use may have lowered distress levels and amygdala reactivity.  
Translating the findings of Chapters 2 & 3 into practice is difficult. As discussed 
in Chapter 3, common antianxiety and antidepressant medications have been effective in 
attenuating amygdala reactivity to angry faces. Therefore, pharmaceutical intervention 
might be considered only for teens with especially high risk. On the other hand, it is 
challenging to justify a treatment approach relative to the risks of cannabis use. If 
schizophrenia is taken as the most functionally impairing or clinically relevant outcome 
associated with adolescent use, it is worth noting that the lifetime prevalence rates of 
schizophrenia is nearly 1% of the population (Simeone et al., 2015). And although a 
recent meta-analyses indicated adolescent use of cannabis is associated with a four-fold 
increase in the odds of receiving a schizophrenia or psychotic disorder diagnosis 
(Marconi et al., 2016), those results should be interpreted in light of the very low base 
rate. Moreover, the stepwise regression models indicated the right amygdala effect only 
explained an extra 1% of the variance in cannabis use levels at age 19. Therefore, it is 
unlikely that a clinically meaningful effect (i.e., lowering cannabis use) might be 
achieved by pharmacologically targeting this biomarker.  
  
Chapters 4 & 5 Findings 
 Chapters 4 & 5 outlined a series of sex-specific machine learning analyses that 




validated ROC AUCs indicated the models predicted future cannabis use well above 
chance levels, with some caveats to be addressed.  
 Analyses failed to predict better than chance only for males when baseline 
cigarettes were excluded for the differential prediction (Chapter 5), and predicting 
cannabis initiation by age 19 (Chapter 4.2). These findings suggest the female prediction 
analyses were more resilient to differences. This also highlights a theme throughout this 
dissertation that females exhibit a more distinct predictive profile for cannabis use 
relative to their male peers. Indeed, prediction accuracies for females were higher across 
all prediction analyses regardless of the comparison sample (controls or binge drinkers), 
machine learning algorithm (logistic regression or random forest), and age of initiation 
(16 or 19).  This finding was encouraging as it signaled that females are more accurately 
predicted and may therefore be targeted more reliably for interventions than males. 
Despite the finding that substance use disorders are generally higher in males (Kuhn, 
2015), the superior prediction for females is consequential as the literature indicates that 
females are more vulnerable to drug initiation (Anker and Carroll, 2010) and advance to 
substance use disorders faster than males (Hernandez-Avila et al., 2004).  
From Chapter 4.1, the predictive profiles contained six psychosocial predictors 
that were shared across the sexes. Three of those predictors were related to other drugs, 
namely higher baseline cigarette and alcohol use, and parental cannabis use. Of the 
remaining three shared predictors, less negative feelings towards deviant behaviors, and 




Personality measures of the parent and child were frequently identified in 
predicting cannabis use. Despite the differences in the exact personality measure 
uncovered, all generally characterized a novelty seeking personality (see Figure 4.1.3 for 
exact personality measures). Moreover, novelty seeking personality was the most robust 
predictor of cannabis use by age 19 for females, and generalized to males in a post-hoc 
fashion (Chapter 4.2). Therefore, this measure may be considered a trait-like feature that 
predicts cannabis use regardless of the age of initiation or sex.     
The identification of novelty seeking personality is consistent with the adolescent 
and substance use literature. Researchers previously implicated this personality trait in 
predicting cannabis use (Bidwell et al., 2015; Dugas et al., 2018), cigarette use (Hu et al., 
2008) and alcohol abuse (Boson et al., 2019). Animal studies concluded that animals 
displaying more novelty seeking behaviors self-administered drugs like alcohol and 
psychomotor stimulants at a higher rate than animals that did not display similar 
behaviors (Belin and Deroche-Gamonet, 2012; Nadal et al., 2002; Suto et al., 2001). 
Furthermore, animal (Adriani et al., 1998), and human studies (Spear, 2000b) reported 
the novelty seeking personality phenotype peaks during adolescence. Together, these 
findings suggest adolescents with higher novelty seeking personality traits than their 
peers are at an even greater likelihood of drug initiation. This risk phenotype is therefore 
an important target for intervention and will be discussed later. 
 Less negative feelings towards deviant behaviors was identified as a shared 
predictor for males and females in Chapter 4.1, and also a shared differential predictor in 




they would feel about engaging in deviant behaviors, so it was unclear if they reported 
based on personal experience or a hypothetical cognitive appraisal. And although 
IMAGEN did not collect measures on peer relationships, the literature suggests 
adolescents are more likely to engage in delinquent behaviors with their peers (Haynie 
and Osgood, 2005). Moreover, Van Ryzin & Dishion reported that cannabis use in young 
adults is predicted by deviant peer group membership (Van Ryzin and Dishion, 2014). 
Therefore, this effect might be characterizing the adolescents’ social network, although 
the lack of other corroborating data does not support this interpretation.   
 Machine learning analyses also discovered many novel brain predictors of 
cannabis use in adolescence. Starting with 1,946 brain measures, there were 22 brain 
predictors identified for females (17 in Chapter 4, and five in Chapter 5), and nine brain 
predictors identified for males (eight in Chapter 4, and one in Chapter 5). Despite this 
profound data reduction, the results were complex given the differences in modality and 
localization uncovered for each region of interest (ROI). 
 The brain predictors for males were related to the stop signal task and gray matter 
volume, whereas all task modalities were identified for females. The presence of the stop 
signal task ROIs highlights the utility of this task in capturing individual differences 
related to cannabis use. Appendix 2 contains a review paper that highlights how 
hypoactivations observed during this task relate to addictive behaviors (Spechler et al., 
2016). The findings reported here are in line with that pattern as the majority of the stop 
task predictors for both sexes were hypoactivations relative to comparison samples 




The anatomical locations of these hypoactivations are mostly in regions 
previously implicated in response inhibition tasks. For instance, regions supporting motor 
functioning like the cerebellum and thalamus (Ide and Li, 2011), and prefrontal regions 
supporting executive control functioning like the inferior frontal gyrus (Garavan et al., 
1999) and orbital frontal cortex (OFC) (Whelan et al., 2012), were identified. A higher 
impulsive personality was also identified as a female-specific psychosocial predictor 
(Figure 4.1.3). Higher impulsivity and hypoactivations in the OFC have been reported to 
predict drug use in adolescence (Whelan et al., 2012). All together, these results 
suggested that deficits in the neurobiological systems supporting cognitive control 
mechanisms confer an increase in risk for cannabis use in adolescence.   
Work by Tapert and colleagues previously reported that cannabis users 
demonstrated higher activations across prefrontal regions relative to controls following 
one month monitored abstinence (Tapert et al., 2007b). As no behavioral differences 
were observed, that study indicated more prefrontal processing resources are required for 
cannabis users to execute inhibitory control behaviors at the same level as non-users. 
Therefore, the predominant hypoactivations reported here may have facilitated drug 
taking behaviors (Nigg et al., 2006). And while the Tapert report was cross-sectional, 
those data contrast with the findings here and might imply prefrontal hyperactivations 
arise following cannabis use.  
Relative to the other tasks, the reward task was infrequently identified and was 
also female-specific. Relative to controls, higher reward anticipation in the left middle 




left superior cerebellum was identified in Chapter 5. The evident hyperactivations during 
anticipation might signal a propensity to over-evaluate the incentive salience of rewards, 
which generally aligns with the “wanting” component of the “wanting vs. liking” model 
of addiction (Berridge and Robinson, 2016).  
Finally, a set of face processing predictors was identified for males and females. 
Lower neutral face reactivity appeared to be shared across the sexes, although in different 
regions for males and females (Figure 4.1.3). Higher activation for angry faces was 
identified for females only in the right ventromedial prefrontal cortex and possibly 
signaled an emotion regulation strategy (Urry et al., 2006).  
The face processing amygdala effects reported in Chapters 2 & 3 were not 
reproduced in any of the data-driven analyses in Chapters 4 & 5. Reasons for this 
discrepancy are likely due to differences in measurement and modeling. For 
measurement, the ROI containing the amygdala in Chapters 2 & 3 were different from 
that used in Chapters 4 & 5. The parcellation atlas used in Chapters 4 & 5 was 
constructed using functional connectivity from resting state fMRI (Shen et al., 2013). 
This atlas did not contain an ROI as specific to the amygdala as the anatomically defined 
ROI used in Chapters 2 & 3. Upon visual inspection, the ROI covering the amygdala 
used in Chapters 4 & 5 contained voxels from the anterior temporal lobe and 
hippocampus. For modeling differences, Chapter 3 identified the right amygdala within 
the context of a relatively large sample (n=525) collapsed across sex. This large sample 
may have contributed to the statistical power necessary to detect a predictor that 




executed separately for each sex for theoretical reasons, and also because sex was 
consistently the most robust predictor when running preliminary analyses collapsed 
across sex. Together, the reduction of statistical power and lack of amygdala ROI 
specificity reduced the likelihood of the amygdala being reproduced in Chapters 4 & 5.  
These fMRI results from Chapters 4 & 5 add to the very sparse literature using 
fMRI to predict cannabis use in adolescence. There appeared to be only one study using 
fMRI to predict cannabis use in adolescence. In that study, Tervo-Clemmens reported on 
a visuospatial working memory task (Tervo-Clemmens et al., 2018). The results reported 
here are not comparable to the Tervo-Clemmens data given the inconsistent task 
modalities. Nonetheless, the results reported here add three more fMRI task modalities 
related to different psychological constructs to the literature on cannabis prediction.   
Lastly, the GMV results were modestly male-specific, although differences were 
observed for females. Furthermore, the directions and locations were inconsistent within 
each sex. For females, greater GMV in the right pre-SMA, and less GMV in the right 
middle frontal gyrus (MFG) were identified (see Chapter 4.1). For males, greater GMV in 
the right inferior temporal lobe was the sole brain predictor uncovered in Chapter 5, 
whereas greater GMV in the right medial prefrontal cortex and less GMV in the left mid-
cingulate cortex was uncovered in Chapter 4.1.  
Medial temporal lobe differences were entirely absent from these structural results 
despite previous literature pointing to an inverse relationship between cannabis use and 
hippocampal and amygdalar brain volumes (Ashtari et al., 2011; Cousijn et al., 2012; 




reflective of consequences of use given the animal studies that reported neurotoxicity of 
cannabinoids on those structures (Lawston et al., 2000; Quinn et al., 2008b).  
Two prospective structural studies by Cheetham and colleagues, and Jacobus and 
colleagues, reported less brain volumes relative to controls across many prefrontal 
regions like the OFC (Cheetham et al., 2012b) and precentral gyri (Jacobus et al., 2016). 
Of note, Jacobus also reported less thickness in the right MFG predicted cannabis use, 
which was reproduced here for females only. Therefore, these results add to the literature 
by affirming less GMV in prefrontal regions predicts use, while the medial temporal lobe 
regions are more likely to reflect differences following use.  
 
Chapters 4 & 5 Implications 
Chapters 4 & 5 demonstrate that a machine learning approach yielded strong 
predictions and made novel discoveries that related the neurobiology to future cannabis 
use in adolescence. These chapters advance the field of psychiatry more generally by 
identifying sex- and drug-specific predictive biomarkers for cannabis use. Psychosocial 
predictors were also identified and can be used to tailor intervention strategies. As large 
neuroimaging studies like IMAGEN become more common, these approaches help 
maximize the information gained from large datasets.  
Starting with the prediction accuracies, the generally high ROC AUCs highlighted 
the generalizability of the models. It is important to stress again that these prediction 
models were all estimated within a cross-validation scheme and therefore addressed some 




However, the gold standard remains to replicate findings in a completely external dataset. 
Therefore, these prediction models could be tested on the forthcoming data releases of the 
ABCD study, which is a population-level longitudinal study of development from 
childhood to adulthood (www.abcdstudy.org).  
 Returning to the idea of risk-stratification, the post-hoc regressions from Chapters 
4 & 5 demonstrate that the addition of predictors from a different feature domain 
improves prediction accuracy. This finding is generally in line with prior “big data” 
prediction studies that reported improvements with the addition of new modalities 
(Jacobus et al., 2016; Whelan et al., 2014b). Therefore, adolescents can first be stratified 
by how well they align with the psychosocial predictors. Following identification of these 
profiles, the adolescent might be referred for a functional neuroimaging assessment. 
Those who exhibit the structural and/or functional neurobiological differences could be 
stratified again given their alignment with the neurobiological risk profiles. Although, at 
this point in time, this scenario is likely not justifiable in light of the amount of time and 
resources involved with functional neuroimaging assessments. Replication studies are 
needed to ensure the brain predictors reported here generalize to other datasets. Also, 
intervention studies informed by the neurobiological predictors are needed.  
In terms of informing treatment interventions, it is challenging to recommend how 
the brain findings inform interventions. This challenge is underscored by the quantity of 
brain predictors uncovered from different modalities. To start, the functional tasks 
broadly informed the psychological constructs that influenced cannabis use in 




Chapters 2 & 3. As inferred from Chapters 4 & 5, heightened reward evaluations might 
be a female-specific construct, whereas poor response inhibition is a shared construct 
across the sexes. Rather than directly targeting each brain predictor per se, targeting these 
constructs might be a useful first step as a global approach.  
Targeting a reduction in cigarette use is hypothesized to be most effective in 
reducing cannabis use. In light of the clear predictive relationship between cigarette and 
cannabis use reproduced here, special attention must be given to cigarette reduction 
efforts as they are hypothesized to lower cannabis initiation rates. This idea is supported 
by an epidemiological study that demonstrated a recent reduction in cigarette use likely 
protected against an increase in cannabis use in youths (Miech et al., 2017). Nicotine is 
also strongly implicated in alcohol use behaviors as both animal (Lê et al., 2003) and 
human studies (Barrett et al., 2006) demonstrated that nicotine facilitated alcohol 
consumption. In considering this pattern, a recent population level study indicated that 
smoking cessation predicted a reduction in alcohol use (Brown et al., 2016). Given this 
cross-drug reduction, and the pattern reported by Miech and colleagues, it is very likely 
that cannabis use will decline by removing the influence of cigarettes. 
Targeting personality features to inform substance use interventions is an ongoing 
line of research by Conrod and colleagues (Conrod, 2016). As discussed in Chapter 4.2, 
personality-targeted intervention programs have successfully lowered cannabis use in 
adolescence (Mahu et al., 2015). The Mahu and colleagues intervention demonstrated 
specific effects on cannabis use levels by targeting a sensation seeking personality 




personality elevations reported here. Altering the novelty seeking personality phenotype, 
as demonstrated by Mahu, will likely be effective in lowering cannabis use.   
A final set of psychosocial predictors to be considered is the influence of the 
parent. The most robust predictor of use identified in Chapter 4 was parental cannabis use 
(Figure 4.1.3). There are currently ten states in the US that legalized recreational cannabis 
use, with commercial distribution approved in all but Vermont and the District of 
Columbia (as of April 2019). Therefore, parents/guardians living in those states who use 
legally (and other parents/guardians with illicit use) should be informed about the 
influence their use might have on their child initiating cannabis (O’Loughlin et al., 2018; 
Sokol et al., 2018), and the risks of  adolescent use per se (Gobbi et al., 2019; Volkow et 
al., 2016). On the other hand, the measure used here was for lifetime cannabis use, 
therefore it is unknown if parental cannabis use was at all concurrent with the life of the 
child. Nonetheless, it will be important to monitor how cannabis use patterns may change 
in adolescents in states permitting recreational cannabis use for adults. Finally, as 
parental personality measures also predicted use in the child (Figure 4.1.3), these findings 
demonstrated that the parent should also be considered during risk-stratification and 
possibly incorporated into interventions for their child when necessary. 
 
Genetic Results 
The genetic data used here were generally less predictive of cannabis use in 
adolescence than data from other domains. Chapter 4 described how it was necessary to 




SNPs. And although Chapter 5 identified a single SNP implicated in the differential 
prediction for females, it was determined that the frequency of the high-risk allele was 
higher in the binge drinking only sample. This finding therefore may better characterize 
the binge drinking only sample rather than the cannabis+binge drinking sample.  
These findings add to the sparse literature relating genetic data to cannabis use. 
And while most GWAS studies reported on clinical levels of cannabis use in adults 
(Agrawal et al., 2011; Sherva et al., 2016), this study was unique in predicting cannabis 
initiation in adolescence. The candidate gene approach used here helped conceptualize 
neurobiological vulnerabilities to cannabis initiation as only SNPs related to 
neurotransmitter receptors and cannabinoid pharmacology were included.  
Genetic variation on genes coding for norepinephrine, dopamine, and opioid 
(ADRA1b, ADRB2, DRD1, OPRM1) neurotransmitter receptors partially predicted 
cannabis use in adolescence. The mechanisms by which these variations confered risk 
need to be studied further. Nonetheless, these findings are in line with previous studies. 
Animal models have implicated the role of norepinephrine and opioid pharmacology in 
cannabis use. Work by Oropeza and colleagues, and Page and colleagues, demonstrated 
that relative to vehicle, a cannabinoid agonist precipitated norepinephrine release in the 
prefrontal cortex of rats (Oropeza et al., 2005; Page et al., 2008). Thus, individuals with 
norepinephrine receptor variants might be more sensitive to the effects of cannabis due to 
prefrontal activation differences. Ghozland and colleagues demonstrated specificity of the 
mu-opioid receptor in THC-induced conditioned place preference (Ghozland et al., 2002) 




dopamine, a human study by Ferri and colleagues reported more DRD1 risk alleles were 
found in cigarette+cannabis smokers relative to cigarette only smokers (Ferri et al., 
2009). Therefore, the findings reported here are situated in the ongoing literature relating 
these neurotransmitter systems to cannabis use. 
The findings across all results suggest genetic variation on the SNPs used here 
were modestly related to cannabis initiation. Instead, the psychosocial and brain 
predictors were better suited to predict initiation and use levels. These findings motivate 
the hypothesis that the SNPs are more relevant to the maintenance or escalation of 
cannabis use following initiation. For instance, genetic variation on genes related to the 
pharmacodynamic (CB1 receptors) and pharmacokinetic (FAAH) properties of cannabis 
might only exert their influence on use behaviors following cannabis exposure. Future 
directions testing these hypotheses are outlined below.   
 
6.3: Limitations & Future Directions 
 This dissertation contained several important limitations to be discussed. To 
begin, the IMAGEN study employed a convenient community sampling method 
(Schumann et al., 2010). While the study contained a very large sample for a 
neuroimaging project, the dataset is unable to make population level inferences. The 
predominantly white European sampling also raises questions related to the 
generalizability of these findings to other populations and settings. Cultural differences 
were also apparent within the IMAGEN study. The Paris site covariate typically emerged 




 The IMAGEN study is also limited by the ESPAD drug use questionnaire. This 
instrument contained poor drug use level quantification as exhibited by the ordinal level 
(e.g., level 5=20-39x). It was also collected with poor temporal precision (age 14, 16, 19). 
Additionally, there is no information about the route of administration (inhalation, 
ingestion), drug preparation (plant matter, oils, etc.), or potency (THC composition). 
These features may have different abuse liabilities and functional outcomes. Additionally, 
the IMAGEN study did not collect any measures on social networks, peer drug use or 
other peer influences. As these measures have previously predicted use (Ali et al., 2011), 
their inclusion might have altered the prediction analyses reported here.   
As a final limitation related to the data used here, Chapter 4.2 attempted to predict 
the initiation of cannabis use by age 19 from data collected at age 14. Future studies 
could incorporate measures collected at the age 16 assessment. The inclusion of data that 
were more proximal in time to the outcome measure might improve prediction. 
Moreover, the age 16 data could be used in reference to the age 14 data to determine if 
any changes between the time points might improve the prediction of age 19 use. 
 
Future Studies 
 The majority of the findings were discussed in their ability to inform treatment 
interventions designed to alter a risk phenotype. Therefore, studies are needed to 
demonstrate how effective those interventions might be on yielding reductions in 
cannabis use. In doing so, those studies would also provide supporting evidence that the 




As noted in discussion above related to the SNP results, genetic variation might 
be related to cannabis maintenance or escalation, rather than initiation. Therefore, future 
studies could test for linear associations (rather than the binary initiation association) 
between the SNPs and future cannabis use level. Random forest analyses might also be 
useful in identifying interactions between SNPs without having to explicitly model an 
excessive number of interaction terms in a linear regression model.  Alternatively, the 
nine predictive SNPs from Chapters 4 & 5 could be selected to build interaction terms 
with any combination of predictors. Along these lines, the nine SNPs could also be 
selected for mediation analyses investigating how genetic variation relates to the 
neurobiology. For example, modeling the SNPs as a mediator between cannabis use and 
the brain data is hypothesized to inform the biological mechanisms of cannabis-
precipitated brain changes.  
The hypothesis-driven studies in Chapter 2 & 3 targeted the amygdala, in part, 
due to the high density of CB1 receptors. Future studies could focus on other regions with 
high CB1 densities like the hippocampus and cerebellum (Kawamura, 2006). Chapter 3 
was also unique as it tested for consequences arising from cannabis use. As only the 
amygdala was considered, future analyses could explore functional differences at the 
whole-brain level. Moreover, all the brain data were analyzed within a mass univariate 
framework. That is, each brain predictor reflected the mean activation level (or total 
GMV) contained at that ROI. All ROIs were then modeled together as a collection of 
independent variables. Moving forward, functional connectivity or graph theoretical 




structure of the neurobiology and might better characterize the relationship between the 
brain and cannabis use beyond a mass univariate approach.  
Connectivity measures have been previously used in addiction research to 
characterize neurobiological differences related to drug cue-reactivity (Janes et al., 2012) 
and craving (Janes et al., 2014). Previous studies have also successfully incorporated 
functional connectivity metrics with machine learning algorithms to classify cigarette 
smokers (Pariyadath et al., 2014), and predict treatment outcomes in individuals with 
substance use disorders (Steele et al., 2018). Therefore, applying these techniques would 
further illuminate the neurobiological mechanisms associated with cannabis use in 
adolescence.  
 Finally, the IMAGEN study is just starting to release the age 23 assessments of 
roughly 800 individuals. Future analyses examining how neurobiological trajectories 
from early adolescence to early adulthood either predicts cannabis use or changes as a 
consequence of use could be explored. Additionally, more clinically relevant prediction 
analyses could be conducted on the individuals who might have met diagnostic criteria 
for cannabis use disorder (DSM-5). A differential prediction analysis comparing 
individuals with cannabis use vs. cannabis use disorder would better characterize 
pathological use and stratify risk. A final clinical outcome to be predicted in these 
samples is schizophrenia as this disorder is typically not diagnosed until late adolescence 
into early adulthood (Gogtay et al., 2011). Those analyses would contribute to the debate 
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Historically, neuroscientific research into addiction has emphasized affective and 
reinforcement mechanisms as the essential elements underlying the pursuit of drugs, their 
abuse, and difficulties associated with abstinence. However, research over the last decade 
or so has shown that cognitive control systems, associated largely but not exclusively 
with the frontal lobes, are also important contributors to drug use behaviors. Here, we 
focus on inhibitory control and its contribution to both current use and abstinence. A 
body of evidence points to impaired inhibitory abilities across a range of drugs of abuse. 
Typically, studies suggest that substance-abusing individuals are characterized by relative 
hypoactivity in brain systems underlying inhibitory control. In contrast, abstinent users 
tend to show either normal or supernormal levels of activity in the same systems attesting 
to the importance of inhibitory control in suppressing the drug use urges that plague 
attempts at abstinence. In this chapter, the brain and behavioral basis of response 
inhibition will be reviewed, with a focus on neuroimaging studies of response inhibition 
in current and abstinent drug abusers.  
INTRODUCTION 




is central to the diagnosis of a substance use disorder, it is characteristic of the all-
too common relapses of abstinent users attempting to stay clean, and it is apparent 
when initial intentions to have just one drink escalate into a binge drinking session. 
Although hedonic processes such as liking and craving may form the core motivation to 
consume drugs, certain cognitive processes, such as attention and memory, likely 
contribute to these drives whereas others, such as response inhibition, likely contribute to 
the individual’s efforts to resist these drives. For instance, Bechara’s cognitive theory of 
addiction posits that the augmented bottom-up signal of appetitive salience for drugs, in 
part, attenuates top-down inhibitory control (Bechara, 2005).  
Cognitive control processes, also commonly referred to as executive functions, 
are attentionally demanding, and consciously available, volitional processes that initiate a 
certain action or interrupt ongoing actions (Atkinson and Shiffrin, 1968; Schneider and 
Shiffrin, 1977; Shiffrin and Schneider, 1977). Cognitive control takes on many forms, 
including, but not limited to, attentional control and inhibitory control. Attentional 
control involves the interaction between perceiving environmental cues and the allocation 
of perceptual processing resources (Norman and Shallice, 1985) whereas inhibitory 
control broadly refers to counteracting behaviors preceding, accompanying, or resulting 
from cues. With regard to addiction, initiation of drug cravings may involve mechanisms 
by which stimuli associated with previous drug use are detected and processed (Grant et 
al., 1996; Hester et al., 2006), while the inhibition of behavior may involve mechanisms 
related to monitoring and regulation (Forman et al., 2004; Kaufman et al., 2003). This 




and its contribution to substance abuse. Specifically, response inhibition will be 
considered as a means to characterize substance use, abstinence, and recovery in 
substance-dependent individuals.  
RESPONSE INHIBITION TASKS  
Inhibitory control is broadly conceptualized as the ability to suppress or 
countermand a thought, action, or feeling. Many investigators study inhibitory control 
using carefully designed tasks like the stop-signal task, or the go/no-go task, that measure 
an individual’s ability to suppress a prepotent motor response. During the stop-signal 
task, subjects perform a primary task such as identifying with button-press responses if a 
visually presented arrow (the target stimulus) points to the left or the right. On a minority 
of trials, often one quarter of trials, a unique auditory or visual stimulus (the stop-signal) 
follows the target and instructs the subject to countermand their response. Task difficulty 
is manipulated by varying the delay between the target and stop stimulus, such that the 
longer the delay the more difficult it is to inhibit the response. By calculating how fast 
subjects respond on trials without a stop-signal and the average stop-signal delay on trials 
in which they successful inhibit 50% of the time, one can estimate the speed of the 
response inhibition process known as the stop signal reaction time (SSRT) (Logan and 
Cowan, 1984). During go/no-go tasks, subjects are presented with a continuous stream of 
stimuli, the majority of which require a button-press response (go trial), and a minority 
requiring no response (no-go trial) with the inhibitory demand being induced through the 
prepotency to respond even on no-go trials. While both tasks are arguably very 




neural circuitry subserving response inhibition is also involved in other types of cognitive 
and emotional inhibition, thereby indicating that they may serve as reasonable probes for 
more complex inhibitory demands, including those related to resisting drugs. As the 
neural circuitry of response inhibition is relatively well understood and yields reliable and 
sensitive behavioral measures of inhibitory ability, it has generated a significant number 
of studies focused on the role of response inhibition in addiction (Luijten et al., 2014; 
Smith et al., 2014).  
THE NEUROBIOLOGY OF CONTROL 
Neuroimaging research has identified the dorsolateral prefrontal cortex (dlPFC) as 
a brain region critical for cognitive control. Evidence suggests the dlPFC is implicated 
during dual-task coordination (D’Esposito et al., 1995; Mansouri et al., 2009), task 
switching (Badre and Wagner, 2006; Dove et al., 2000; Sohn et al., 2000), memory 
updating (Edin et al., 2009; Salmon et al., 1996), and response sequencing, monitoring, 
and manipulation (Kim et al., 2013; Owen et al., 1996). This is consistent with the human 
lesion literature implicating the frontal lobes in organizing, regulating, and producing 
coherent behavior (Luria and Pribram, 1973; Stuss and Frank Benson, 1987). Frontal 
lobe-damaged patients appear to lose important aspects of autonomous cognitive control 
as evidenced by the loss of behavioral control to environmental contingencies (e.g., 
capture errors and utilization behaviors; Lhermitte, 1986). Although the focus of this 
review will be on prefrontal systems mediating control, these systems operate in 
conjunction with extensive parietal, premotor, cingulate, subcortical, and cerebellar 




the assignment of specific frontal loci to specific functions is far from resolved due, 
perhaps, to one of the defining characteristics of the frontal lobes being their ability to 
flexibly adapt to task demands. Dosenbach and colleagues suggest that different brain 
networks are involved in distinct aspects of control with the frontoparietal cortex 
implicated in initiating and adapting behavior, while sustained stable task performance is 
associated with the anterior cingulate cortex (ACC), anterior insula, frontal operculum, 
and anterior prefrontal cortex (Dosenbach et al., 2007).  
With a specific focus on inhibitory control, a body of research (lesion, transcranial 
magnetic stimulation (TMS), and fMRI methodologies) implicates the right inferior 
frontal cortex (rIFC) in motor response inhibition (Aron et al., 2003; Chambers et al., 
2006; Garavan et al., 1999, 2006). More broadly, the rIFC is one node of a motor 
inhibition network which also includes the pre-supplementary motor area (pre-SMA), and 
subthalamic nucleus (STN) (Aron et al., 2014). It is unclear about the exact causal 
pathways of these regions (Duann et al., 2009; Neubert et al., 2010; Swann et al., 2012), 
but research proposes that the STN receives input from both the rIFC and pre-SMA, and 
the STN inhibits motor activity at the basal ganglia (Aron and Poldrack, 2006; Schmidt et 
al., 2013). Figure A2.1 shows a number of the main cortical areas activated during 
response inhibition from the largest neuroimaging study of the STOP task (Whelan et al., 
2012). Human lesion studies provide converging evidence that lesions in the right pre-
SMA (Floden and Stuss, 2006; Nachev et al., 2007) and the right inferior frontal gyrus 
(IFG) subregion pars opercularis impair response inhibition (Aron et al., 2003, 2004, 




opercularis selectively impaired the ability to stop an already initiated action, whereas the 
deactivation of the same region did not affect physiological arousal or the ability to 
execute responses, confirming the important role of the IFG in the regulation of response 
inhibition (Chambers et al., 2006). In addition, Cai and colleagues showed that 
stimulation of the right pre-SMA slowed the implementation of stopping (measured via 
SSRT) but had no influence on modulation of response tendencies and suggested that this 
region impairs stopping behavior through a specific disruption of response inhibition (Cai 
et al., 2012). These studies are supported by the temporal and spatial precision afforded 
by electrocorticography studies, which have found the rIFC responds prior to successful 
inhibition (Swann et al., 2009, 2012). Recent studies suggest that this may reflect a 
broader role for this region in detecting attentionally salient events (Hampshire et al., 
2010), although it may be the case that in order to evoke right IFG activity, the salience 
of these events must be relevant to response control (Dodds et al., 2011).  
Although typically not activated in imaging studies of motor response inhibition, 
there is considerable evidence of a role for the orbitofrontal cortex (OFC) in impulse 
control. For example, OFC damage in a rodent model increases SSRT (Eagle et al., 
2008), while patients with lesion damage to the OFC show increased self-report and 
cognitive measures of impulsivity and altered time perception relative to healthy controls 
and non-OFC lesioned patients (Berlin et al., 2004). That said, many behaviors that 
appear impulsive might not be driven by a deficit in impulsivity per se. For example, 
Torregrossa and colleagues argue that the most robust deficit in OFC damaged animals is 




and failure to alter responding when rewards for a learned behavior are devalued, may in 
fact reflect impairment in the ability to update the value of an outcome, especially under 
changing circumstances (Torregrossa et al., 2008).  
There is evidence that regions implicated in motor inhibition and, in particular, 
right frontal cortex, are involved in aspects of inhibitory control beyond response 
inhibition. This includes the suppression of drug cravings elicited by a cocaine video: 
brain activation in the rIFC was increased when inhibiting a craving response and was 
negatively coupled with activation levels in the right nucleus accumbens (Volkow et al., 
2010). In a think/no-think paradigm, in which paired associates are actively suppressed, 
activation in rIFC was associated with suppressing the sensory components of memories 
(Depue et al., 2007). de Fockert and colleagues showed that increasing working memory 
load increased activity levels in bilateral inferior and middle frontal gyri while 
simultaneously increasing the distraction caused by (and sensory processing of) irrelevant 
faces (de Fockert et al., 2001). Hester and colleagues modified this paradigm to show that 
irrelevant drug stimuli produced heightened activity in visual cortex in cocaine users 
relative to drug–na ̈ıve controls (Hester and Garavan, 2009). Critically, those users with 
the greatest levels of activity in right prefrontal cortex showed the smallest behavioral 
interference caused by the distracting drug stimuli. In a similar manner, a study of the 
ability to ignore ecstasy-related stimuli produced greater occipital activation but reduced 
right prefrontal activation in ecstasy users relative to controls (Roberts and Garavan, 
2013). Tabibnia and colleagues identified the rIFC in a number of inhibitory deficits of 




gray matter in the rIFC in dependent subjects relative to controls, and gray matter in this 
region was correlated with drug craving, response inhibition performance, and a test of 
affect regulation. Finally, Behan and colleagues have recently shown that the rIFC is 
more active when subjects suppress reward anticipation (Behan et al., 2015). Here, a 
novel task required subjects to prepare for either a target to which they must respond as 
fast as possible to receive a reward, or, a stop-signal indicating they should make no 
response. A psychophysiological interaction analysis suggested the possibility of having 
to inhibit, rather than respond quickly, produced activity increases in the rIFC, which 
were correlated with activity decreases in the ventral striatum. Further, the rIFC activity 
was adjacent to a distinct rIFC region associated with motor inhibition. Combined, this 
brief review suggests that the rIFC may have a broad role in inhibitory processes that 
extend beyond motor inhibition. That said, there remains a lack of a comprehensive 
theory relating the similarities and differences between the various types of inhibitory 
control to their neurobiological and psychological overlap. Further research probing the 
multiple types of inhibitory control in the same sample may be a valuable advance.  
RESPONSE INHIBITION AND DRUGS OF ABUSE  
Substance using populations are characterized by deficits in response inhibition. 
A recent meta-analysis (Smith et al., 2014) of 97 studies found evidence for impaired 
response inhibition among those dependent on alcohol, cocaine, methamphetamine, 






Although findings in the literature are mixed, a recent meta-analysis found a small 
but significant effect relating cigarette smoking to response inhibition deficits (Smith et 
al., 2014). Results from neuroimaging investigations have generally found alterations in 
the neural circuitry associated with response inhibition in smokers compared to 
nonsmoking controls (de Ruiter et al., 2012; Luijten et al., 2013; Nestor et al., 2011; but 
see Galva ́n et al., 2011). For example, Nestor et al. (2011) found that smokers showed 
reduced activation compared to nonsmokers in a widely distributed network including the 
ACC, left IFG, bilateral inferior parietal lobules, and bilateral insula. This is similar to the 
findings of de Ruiter et al. (2012) who found reduced activation of the rostral ACC 
during inhibition in smokers.  
One interesting line of research has examined the relationship between neural 
activity during successful response inhibition and craving for cigarettes. Berkman et al. 
(2011) demonstrated that subjects with greater task-related neural activity in nodes of the 
response inhibition network (bilateral inferior frontal gyrus, SMA, putamen, and left 
caudate) smoked less in response to subsequent, naturally occurring occasions of 
cigarette craving. These results suggest that functioning in the circuitry underlying motor 
inhibition translated to greater behavioral control in response to craving. Further, these 
investigators found an inverse relationship between amygdala activation during response 
inhibition and behavior, such that subjects with greater amygdala activation had a 
stronger positive relationship between craving and smoking behavior. These findings link 
altered patterns of neural activation with behavioral constructs known to be critical in 




response inhibition without differences in task performance, this study underscores the 
potential utility of neuroimaging as a sensitive measure of neurobiological alterations 
related to impulsive behavior. Finally, there is considerable value in studies that link lab-
based measures of neurobiological function with assessments of inhibitory control in the 
real world. Real-world behaviors as assessed, for example, by mobile technologies, open 
up valuable opportunities to relate the neurobiology of inhibitory control to avoid drug 
use in the natural environment, which in many cases is laden with cues to use.  
 
Alcohol 
Alcohol abusers have increased commission error rates compared to nondrinkers 
or social drinkers on go/no-go tasks (Kamarajan et al., 2005; Murphy and Garavan, 
2011), and longer SSRTs on the stop-signal task compared to controls  (e.g., Goudriaan et 
al., 2011; Lawrence et al., 2009; Rubio et al., 2007). However, mixed results have been 
reported with a number of studies showing no difference in response inhibition related to 
alcohol consumption (Li et al., 2009; Papachristou et al., 2013; Schmaal et al., 2013). It 
has been suggested (Smith and Mattick, 2013) that this may relate to sex differences, 
based on evidence that heavy drinking may be preferentially associated with impaired 
response inhibition in females (Nederkoorn et al., 2009; Smith and Mattick, 2013; 
Townshend and Duka, 2005). That said, few studies have been sufficiently powered to 
specifically examine sex differences in response inhibition related to alcohol 
consumption. Nonetheless, Smith and colleagues reported an overall impairment in 




may exist between impaired response inhibition and drinking patterns (Smith et al., 
2014). However, there have been no systematic studies addressing this possibility.  
Studies using functional neuroimaging to examine response inhibition in problem 
drinkers are limited. Li and colleagues found no performance differences on SSRT but 
lower activation in left dlPFC in alcohol-dependent patients (Li et al., 2009). However, 
these subjects were all successfully abstinent in alcohol treatment at the time of scanning, 
making it difficult to determine if activation patterns were related to alcohol withdrawal 
or early recovery from alcohol dependence. Recent findings have shown that alcohol-use 
disorders are associated with lower activation in the IFG, insula, inferior parietal lobule, 
and ACC compared to controls (Claus et al., 2013). When comparing heavy to light 
alcohol consumption in college drinkers, the heavy drinkers showed impaired 
performance and altered patterns of neural activity during response inhibition in areas 
including the ACC, portions of the frontal lobe, hippocampus, and thalamus (Ahmadi et 
al., 2013). Structural neuroimaging experiments have suggested that chronic alcohol 
abuse is associated with global volume reduction, cortical and subcortical gray matter 
reductions, and enlargement of the ventricles. The volume loss in frontal, cerebellar, and 
subcortical regions are believed to play a critical role in individual differences related to 
task performance (Chanraud et al., 2007; Scheurich, 2005; Sullivan, 2003). Therefore, as 
the neural architecture supporting response inhibition deteriorates, behavioral inhibition 






Studies in both adolescent and adult cannabis users have found little evidence for 
disrupted cognitive performance (Grant et al., 2012; Jager et al., 2010; Schweinsburg et 
al., 2010; Tapert et al., 2007); however, see Moreno et al. (2012). Interestingly, several 
studies have demonstrated that while there are inconsistent effects of cannabis use on 
inhibitory performance, there are neural differences that can be detected via fMRI (Behan 
et al., 2014; Hester et al., 2009; Roberts and Garavan, 2010; Schweinsburg et al., 2008; 
Tapert et al., 2007). For example, Roberts and Garavan investigated neural activity using 
fMRI during response inhibition in adolescent cannabis users and nondrug using controls. 
While users had equal performance to control subjects, the users had increased activation 
in frontal and parietal regions during successful inhibitions. This pattern of activation was 
interpreted to indicate increased neural resources required of the users to achieve 
performance levels comparable to controls (Roberts and Garavan, 2010). Similar results 
were found in a study of college students (cannabis users compared to nondrug users) 
where there was equal task performance but increased activation in the right inferior 
parietal lobule, the right putamen, and the supplementary motor area in the users (Hester 
et al., 2009).  
It is notable that the pattern of effects in cannabis users (comparable performance 
but greater activation relative to controls) differs from the hypoactivity associated with 
other drugs of abuse. Some evidence suggests that heavier use, earlier onset, and greater 
cumulative cannabis consumption is associated with smaller increases in activation in 
frontal and parietal regions compared to lighter users or those who begin using later 




of brain development and cannabis exposure on brain function and may additionally 
suggest a compensatory mechanism in heavy cannabis users (Jacobus et al., 2009). 
Another possibility is that the increased activation of cannabis users may compensate for 
altered functional connectivity between regions. Recently, Orr and colleagues showed 
increased intrahemispheric and decreased interhemispheric resting-state connectivity in 
adolescent heavy cannabis users (Orr et al., 2013). The same sample of adolescent users, 
when performing a go/no-go task showed impaired performance but no regional 
activation differences relative to controls. Instead, the users showed increased 
connectivity during the task between bilateral parietal lobes and left cerebellum, and 
these same regions showed increased resting-state connectivity (Behan et al., 2014). 
Although these results may suggest that atypical patterns of activation in cannabis users 
may be related to differences in inter- and intrahemispheric connectivity, the full set of 
results fails to offer a straightforward message. As cannabis is the most commonly used 
illicit drug and the onset of use is common during the sensitive adolescent 
neurodevelopmental period, it is important that the effects of cannabis on neurocognitive 
function vis-à-vis inhibitory control be the subject of further inquiry.  
 
Cocaine 
There is strong evidence that cocaine users have poorer response inhibition than 
nonusers. This is observed in studies using the stop-signal task (Colzato et al., 2007; 
Fillmore and Craig, 2002; Li et al., 2006; Morie et al., 2014; but see Vonmoos et al., 




Hester et al., 2007; Kaufman et al., 2003; Lane et al., 2007). A review by Spronk and 
colleagues calculated pooled effect sizes for both SSRT on the stop-signal task and errors 
of commission on go/no-go tasks and found a moderate pooled effect size (0.50) of 
cocaine user status on the stop-signal task and a moderate to large (0.64) pooled effect 
size for errors of commission on the go/no-go task (Spronk et al., 2013). fMRI studies 
have generally shown reduced neural activity in the PFC including rostral ACC and SMA 
(Hester and Garavan, 2004; Kaufman et al., 2003; Li et al., 2007).  
Using independent component analysis on a stop-signal task, Elton and colleagues 
discriminated cocaine users from nonusers based on activity patterns decomposed into 11 
components. Two of these components were specifically related to stop-signal success, 
and cocaine users exhibited decreased activation in these networks compared to controls. 
One network comprised the bilateral IFG, angular gyri, middle temporal, and posterior 
parietal gyri, and the other network comprised the dlPFC, ventrolateral PFC, dorsomedial 
PFC, anterior insula, and middle temporal gyrus (Elton et al., 2014).  
 
MDMA/Ecstasy  
A meta-analysis found that overall there is a small effect size on inhibitory errors 
in heavy MDMA users compared to controls (Smith et al., 2014). Among individual 
studies, there are several that reported no behavioral performance differences (von 
Geusau et al. 2004; Quednow et al., 2006; Roberts et al., 2013; Roberts and Garavan, 
2010). However, two of these studies used neuroimaging and found altered neural 




ecstasy/polydrug users showed altered EEG patterns suggestive of attentional or 
inhibitory deficits (Roberts et al., 2013). Similarly, Roberts and Garavan (2010) found 
intact performance but increased activation in the response inhibition network (right 
DLPFC, inferior frontal gyrus, and parietal lobule) in recreational ecstasy users. Other 
studies of current MDMA users have reported moderately impaired behavioral 
performance in response inhibition (Hoshi et al., 2007). Taken together, the available 
literature suggests a small impairment in response inhibition associated with MDMA use 
and altered neural processing in users with intact behavioral performance.  
RESPONSE INHIBITION AND ABSTINENCE  
Relapse is, in many regards, a defining characteristic of drug dependence. 
Successful abstinence might be viewed within a framework whereby prefrontal cognitive 
systems seek to control biased attention and pathological behaviors. Hence, successful 
abstinence may rest on the outcome of the antagonism between drug-wanting systems 
driven, for example, by ventral striatally mediated salience attribution systems (Robinson 
and Berridge, 2003), and drug-denying systems governed by the prefrontal cortex 
(Goldstein and Volkow, 2002; Figure A2.2).  
There is, however, relatively little empirical data on the neurobiology of 
successful abstinence despite its potential value for informing therapeutic interventions. 
The extant literature has typically investigated short-term abstinence and has revealed 
many persistent deficits, which, for example, for cocaine users, are more pronounced in 
heavy users in lateral and medial prefrontal regions associated with cognitive control 




medial hypoactivity but have also been reported to show bilateral hippocampal 
hyperactivity (Eldreth et al., 2004). There is, however, evidence to suggest that prolonged 
abstinence will correct the general pattern of prefrontal hypoactivity in users (see below) 
with, for example, cocaine abstinence reducing high-risk responses on a gambling task 
(Bartzokis et al., 2000). Structural MRI studies have found reduced gray matter volume 
in prefrontal, orbitofrontal, and cingulate regions in cocaine abstinent individuals (Fein et 
al., 2002; Matochik et al., 2003), which, some argue, can last even with prolonged 
abstinence (Tanabe et al., 2009). Interestingly, Connolly and colleagues found in a cross-
sectional analysis that cocaine abstinent individuals reached control-like levels of gray 
matter volumes in the cingulate, insula, and dlPFC by 35 weeks of abstinence (Connolly 
et al., 2013).  
During abstinence, impulse control might be important for suppressing drug- 
seeking behaviors and drug cravings. Although subjective reports of craving often prove 
to be poor predictors of subsequent abstinence, cognitive and neuroimaging measures can 
sometimes do better (Grüsser et al., 2004; Kosten et al., 2005). For example, higher 
scores on a self-report measure of impulsivity (the Barratt Impulsiveness Scale) have 
been shown to predict poorer treatment outcome (Moeller et al., 2001; Patkar et al., 
2004). With regard to brain predictors, unfortunately, the neuroimaging literature on 
predicting relapse is small and has employed a variety of tasks that were not necessarily 
designed to induce a craving response or to assess the user’s ability to exercise inhibitory 
control over that response. Nonetheless, the existing results do identify prefrontal 




using a two-button prediction task, Paulus and colleagues showed activation levels in 
prefrontal, temporal, and posterior cingulate regions early in abstinence to predict 
subsequent relapse for methamphetamine users (Paulus et al., 2005). Grüsser et al. (2004) 
found that activity in response to alcohol-related stimuli in the putamen, ACC, and 
medial prefrontal cortex predicted relapse. In cocaine treatment-seeking individuals, 
fMRI error-related processing (stop-error vs. stop-success) revealed blunted activity in 
the dorsal ACC predicted relapse in both sexes, while females exhibited reduced thalamic 
activity, and males exhibited reduced insular activity (Luo et al., 2013). Although it does 
not follow from these findings that behavioral measures of impulse control should also 
predict abstinence, the predictive value of prefrontal cortex suggests that regulatory 
processes may be involved.  
Given the important role that cognitive processes may play in avoiding relapse in 
drug users and gamblers (Cox et al., 2002; Goudriaan et al., 2008; Passetti et al., 2008; 
Waters et al., 2003), it may be the case that the best predictors of treatment outcome are 
those that reflect cognitive control over drug urges rather than the drug urges themselves. 
This is supported by a study by Brewer et al. (2008) who identified cognitive control 
prefrontal regions, in addition to other subcortical and posterior cingulate regions, as 
being the best predictors of treatment outcome in a treatment-receiving sample of cocaine 
users. Further evidence for the assertion that impulse control might contribute to 
successful abstinence arises from cross-sectional research of abstinent former users using 
a go/no-go task. These studies show an apparent reversal in activation patterns, such that 




users. For example, Connolly et al. (2012) showed that both short-term abstinent cocaine 
users (1–5 weeks) and long-term abstinent users (4–24 months) present with fMRI 
hyperactivity in cognitive control regions relative to drug–na ̈ıve controls. That is, the 
brain regions involved in impulse control (e.g., right middle and rIFC), which are 
consistently shown to be hypoactive in current users, show elevated activity in former 
users compared to drug–na ̈ıve controls. Subsequent studies have shown former users to 
be either comparable in performance, fMRI activation levels, and motor-inhibition- 
related ERP components to controls (Bell et al., 2014; Morie et al., 2014) or to show 
elevated activation associated with successful inhibitions (Hester et al., 2013). The latter 
study also revealed blunted activation in response to errors and punishments in the former 
users suggesting some deficits may persist longer into abstinence.  
Evidence for enhanced cognitive control contributing to successful abstinence is 
also observed in former cigarette smokers (abstinent for 2 years). Using a go/no-go task, 
current smokers showed reduced activity relative to controls in the dlPFC and the ACC 
while the former smokers revealed greater inhibitionand error-related activation in the 
ACC relative to the current smokers (Nestor et al., 2011). A recent study in cigarette 
smokers highlighted behavioral effects of practicing self-control (i.e., small acts of 
impulse control such as avoiding sweets were practiced over 2 weeks before quitting) 
which significantly improved abstinence rates; 27% in the self-control group, relative to 
12% in a control condition, were still abstinent 1 month after quitting (Muraven, 2010).  
TMS and tDCS have shown some efficacy in enhancing cognitive control. 




frontal gyrus (Jacobson et al., 2011). Applying this technique to substance-abusing 
individuals may prove fruitful. One study in alcohol detoxification found a single session 
of TMS over the rIFC facilitated cognitive control performance a week later (Herremans 
et al., 2013). Similarly, pharmacological interventions targeting cognitive enhancement in 
cigarette smokers have provided some support for the facilitation of abstinence. Focusing 
on studies directly assessing response inhibition performance, galantamine, a 
cholinesterase inhibitor, has reduced subjective craving for cigarettes, while improving 
performance on a go/no-go task (Sofuoglu et al., 2012). Another study suggests that the 
use of an NMDA partial agonist, D-cylcoserine, attenuates subjective ratings of cigarette 
“stimulation” and “relaxation,” while improving performance on a go/no-go task (Nesic 
et al., 2011). Lastly, in a combined fMRI-pharmacological study of guanfacine, a 
noradrenergic agonist, smokers exhibited reduced cigarette consumption. While no effect 
was found on task performance, the fMRI results indicate guanfacine attenuated dlPFC 
responses. The authors interpret this finding as a possible guanfacine-related facilitation 
of cognitive efficiency.  
In summary, the extant literature suggests compromised inhibitory control in 
active users and normalized or enhanced control in abstinent users. If inhibitory control is 
shown to be an important contributor to abstinence then this raises exciting possibilities 
for pharmacological or behavioral interventions. In time, neuroimaging measures may 
enable us to predict who is most likely to abstain (e.g., related to the integrity of the 
circuitry underlying inhibitory control) and, by tracking recovery in this circuitry, give 




CONCLUSION AND FUTURE DIRECTIONS  
The preceding review suggests that deficits in inhibitory control characterize 
substance dependence. There are, however, drug-specific effects that require further 
elaboration (e.g., the mixed findings in cannabis users). The integration of functional 
activation, functional connectivity, and brain structural data is important, but so too is a 
much richer phenotypic characterization of the users including their drug use histories 
(age of onset, polydrug use), mental health comorbidities, family and environmental 
influences, and so on. In reviewing the literature, there persists a lack of a comprehensive 
understanding on how the various types of inhibitory control relate to one another, 
psychologically and neurobiologically. More assessments of drug use and other types of 
inhibitory control (e.g., delaying gratification) or inhibitory control in reward-related 
contexts may yield new insights. It is a conundrum that although different aspects of 
inhibitory control appear to be uncorrelated with one another (e.g., self-report personality 
measures, impulsive choice, and impulsive responding; Reynolds et al., 2006), drug users 
score highly impulsive on all. Combining this with the evidence that inhibitory control is 
related to reward processes such as drug-induced euphoria and drug self-administration 
(Cervantes et al., 2013; Weafer and de Wit, 2013), suggests that more conceptual work is 
required to integrate these constructs. Finally, as noted above, relating lab-based 
measures of inhibitory control to drug urges and craving in the natural environment is an 
important extension of the existing research.  
With regard to abstinence, there are two questions of primary importance, and for 




inhibitory control predicts abstinence? This is important clinically (i.e., identifying who is 
most likely to relapse can help in allocating interventions and additional services) and 
also theoretically (i.e., the predictors of relapse give good guidance on the mechanisms 
that may contribute in a causal manner to abstinence; Garavan et al., 2013). Second, what 
is the time-course of recovery of inhibitory control and other processes pertinent to 
addiction? One speculation is that certain processes (e.g., the incentive salience attributed 
to drugs and drug cues mediated by structures such as the ventral striatum) may persist 
long after the cessation of use and may underlie relapse risk. It may be the case that 
inhibitory control recovers to normal (or greater than normal) levels relatively early in 
abstinence, and while inhibitory control exercised over drug cravings and behaviors is 
essential to abstinence, relapse is highly likely when this regulatory function becomes 
disrupted as happens, for example, under stressful situations. Large sample, longitudinal 
studies of abstainers that assess multiple functions at multiple time-points are required to 
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Figure A2.1: Response inhibition on the STOP task produces robust activation in parietal 
and frontal cortex, including bilateral inferior frontal gyrus.  
 
     
 
Figure A2.2: Stop Task Related Activity Hypotheses 
  
We hypothesize that abstinence relies upon recovery of prefrontal systems involved in 
inhibitory control (regions such as the right IFG and OFC shown on the left). 
Vulnerability to relapse may be reflected in reinforcement or salience systems (involving 
regions such as the ventral striatum shown on the right). We hypothesize that relapse may 





APPENDIX 3: STRUCTURAL BRAIN CORRELATES OF ADOLESCENTS 
WITH BEHAVIORAL AND EMOTIONAL DYSREGULATION 
 
This Chapter has been previously published in the following format: 
 
Spechler, P.A., Chaarani, B., Orr, C., Mackey, S., Higgins, S.T., … Garavan, H., Althoff, 
R.R. & the IMAGEN consortium.. (2019). Neuroimaging evidence for right orbitofrontal 
cortex differences in adolescents with emotional and behavioral dysregulation. Journal of 





Objective: To characterize the structural and functional neurobiology of a large group of 
adolescents exhibiting a behaviorally and emotionally dysregulated phenotype.   
Methods: Age 14 adolescents from the IMAGEN study were investigated. Latent class 
analysis (LCA) on the Strengths and Difficulties Questionnaire (SDQ) was used to 
identify a class of individuals with elevated behavioral and emotional difficulties 
(“dysregulated”; n=233) who were compared to a matched sample from a low symptom 
class (controls, n=233). Whole-brain gray matter volume (GMV) images were compared 
using a general linear model with 10,000 random label permutations. Regional GMV 
findings were then probed for functional differences from three fMRI tasks. Significant 
brain features then informed mediation path models linking the likelihood of psychiatric 
disorders (DSM-IV) with dysregulation.  
Results: Whole-brain differences were found in the right orbitofrontal cortex (R.OFC; 
p<.05; k=48), with dysregulated individuals exhibiting lower GMV. The dysregulated 
group also exhibited higher activity in this region during successful inhibitory control 
(F1,429=7.53, p<.05). Path analyses indicated significant direct effects between the 




returned modest partial effects, suggesting the path linking the likelihood of an anxiety or 
conduct disorder diagnoses to dysregulation is partially explained by this anatomical 
feature. 
Conclusion: A large sample of dysregulated adolescents exhibited lower GMV in the 
R.OFC relative to controls. Dysregulated individuals also exhibited higher regional 
activations when exercising inhibitory control at performance levels comparable to 
controls. These findings suggest a neurobiological marker of dysregulation, and highlight 




 Adolescents exhibiting severe difficulties regulating behavior and emotion are 
commonly referred for psychiatric evaluation but are difficult to classify into discrete 
diagnostic categories, with “comorbidity” being the rule rather than the exception in child 
psychiatry. Previous labels for these dysregulated children included severe mood 
dysregulation (SMD) or irritability (Leibenluft, 2011) with the acknowledgement that 
these individuals will likely meet diagnostic criteria for other disorders. Recently, 
“disruptive mood dysregulation disorder” (DMDD) (American Psychiatric Association, 
2013) was added to the DSM-5 to better classify dysregulated children. Research 
indicates the prevalence of dysregulation is between 0.8 and 3.3%, with particularly high 
co-occurrence with externalizing and internalizing disorders (Copeland et al., 
2013),(Dougherty et al., 2014). As individuals with a singular diagnosis may be thought 
of as behaviorally or emotionally dysregulated, it is specifically the individuals with a set 




further. Considering the addition of this disorder into the DSM, and research showing the 
functional outcomes of dysregulated youths are strikingly poor, (Copeland et al., 2014) it 
is imperative to identify the neurobiological correlates of dysregulation. Characterizing 
the pathophysiological substrates will help inform dysregulation nosology, provide 
diagnostic biomarkers, and help inform targeted treatment methods. 
 The NIMH recently advocated the Research Domain Criteria (RDoc), which 
hypothesizes psychiatric problems coexist on a spectrum of severity with symptoms that 
cut across discrete diagnostic categories. Therefore, in this report using a large dataset of 
adolescents (the IMAGEN study), (Schumann et al., 2010) we adopted a latent class 
analysis (LCA) approach to the Strengths and Difficulties Questionnaire 
(SDQ)(Goodman, 1997) to identify groups of individuals endorsing similar patterns of 
behavioral and emotional problems. The result of an SDQ-LCA provides class groupings, 
as well as dimensional characteristics of emotional and behavioral problems hypothesized 
to contain varying patterns of symptomatology that resist discrete categorization. One 
class is specifically hypothesized to comprise a profile analogous to DMDD. In other 
words, in the absence of DMDD diagnoses, we hypothesized a class of individuals 
exhibiting a profile in line with a dysregulation phenotype. Although measurement of a 
dysregulation profile is a major challenge in the field, (Althoff et al., 2010a; Deutz et al., 
2016, 2018) the intent of our investigation is to characterize the neural correlates of 
dysregulation as defined by one measurement method (among a suite of others). (Althoff 




 Structural neuroimaging, and specifically, voxel-based morphometry (VBM), has 
been used to study many psychiatric constructs across stages of development. VBM 
allows the researcher to measure the volumes of the major tissue types of the brain, 
(Ashburner and Friston, 2000) thus providing a neurobiological framework to closely 
study a behavioral profile of interest. VBM has informed many adolescent psychiatric 
disorders related to dysregulation including anxiety, (Radua et al., 2010) 
depression,(Bora et al., 2012) and conduct disorder. (Fairchild et al., 2011) Regarding 
previous structural neuroimaging studies of dysregulation, Adleman and colleagues used 
VBM to uncover differences among children with SMD, bipolar disorder (BP), and 
controls, with the SMD group exhibiting the lowest gray matter volume (GMV) in 
bilateral pre-supplemental motor area, right insula and dorsolateral prefrontal cortex. 
(Adleman et al., 2012) Additionally, Gold and colleagues used VBM to study youths with 
anxiety, BP, ADHD, and DMDD, compared to controls. Gold found GMV differences 
specific to, and across psychiatric disorders, with dysregulated participants exhibiting 
lower GMV in the right dorsolateral and superior frontal cortex. (Gold et al., 2016) 
Therefore, for our primary analysis using whole-brain VBM data, we hypothesized 
dysregulated individuals would exhibit lower GMV relative to controls in cortical regions 
implicated in regulatory processes such as the bilateral insula, right-sided dorsolateral 
prefrontal cortex, and ventromedial/orbitofrontal cortex. (Adleman et al., 2012; Rogers 
and De Brito, 2016) 
 Regions uncovered from the primary anatomical analysis can be used as regions 




hoc analyses broadly test the hypothesis that differences in brain structure yields 
differences in brain function. Interrogating both structure and function with the same 
dataset maximizes the information gained about the neurobiological characteristics of 
dysregulation, and captures the brain’s trait-like features measured via structural 
neuroimaging, and state-like features measured during functional task demands. Follow-
up analyses on neuroimaging data can also be used to explain the relationship between 
candidate comorbidity diagnoses (Copeland et al., 2013) and dysregulation. For instance, 
an identified neurobiological correlate of dysregulation can be modeled as a mediator in a 
path analysis linking the likelihood of a psychiatric disorder to dysregulation. In doing so, 
we test the hypothesis that the brain mediates the relationship between a disorder and 
dysregulation in some linear fashion. As we only probe data from the age 14 assessment 
of the IMAGEN study, these mediation models infer correlation and not causation. 
 
Methods 
 Participants were drawn from the IMAGEN study of adolescent development. 
(Schumann et al., 2010) Comprehensive study details are available in the online Standard 
Operating Procedures (https://imagen-europe.com/). The IMAGEN study conformed to 
the ethical standards outlined by the Declaration of Helsinki and was approved by ethics 
committees at each site including King’s College, London; Central Institute of Mental 
Health, Mannheim; Charite, Universitatsmedizin Berlin; University Medical Center 
Hamburg-Eppendorf; University of Nottingham; Trinity College Dublin; Institut National 




participants and their parents, written informed consent was obtained. Individuals who 
provided assent were assessed at age 14. For this report, all data were taken from the 
baseline assessment only (age 14).  Participants with SDQ data (N=2,126) were used as 
the starting sample of the analysis (Age M=14.56, SD=.44; Females=1,081, 51%). 
Selected participants from the LCA analysis were then drawn from the sample who 
received an anatomical scan with GMV images passing quality control (N=2,024). 
 
Strengths and Difficulties Questionnaire 
 The SDQ is 25-item instrument designed to characterize children across five 
domains including emotional symptoms, conduct problems, hyperactive behavior, peer 
problems, and prosocial behaviors. (Goodman, 1997) Hence, the SDQ is especially suited 
to capture both the behavioral and emotional features related to dysregulation. 
Furthermore, the SDQ is widely used and has been shown to predict psychiatric 
diagnoses later in life. (Goodman and Goodman, 2011) Data included in the analysis 
were from the parent reporting on their child’s behavior in the past six months. SDQ data 
from N=2,126 participants were used in the latent class analysis. 
 Each SDQ item is measured on an ordinal scale: 0=Not True, 1=Somewhat True, 
2=Certainly True. While the majority of the instrument is negatively valenced (e.g., 
“Often unhappy”, “Often lies or cheats”), the few positively valenced items are reversed 
coded with the exception of the entire prosocial domain. Therefore, higher values within 
the emotional, conduct, hyperactive or peer domain reflect difficulties, whereas higher 




analysis, positively valenced items from the prosocial domain were recoded to match the 
overall pattern of the instrument.  
 Previous investigators have reported using the SDQ-Dysregulation Profile (SDQ-
DP) to measure the dysregulation construct based on the sum of five proposed items. 
(Holtmann et al., 2011) Rather than imposing the recommended SDQ-DP cutoff of scores 
≥5 as dysregulated, we used a data driven approach to characterize individuals based on 
patterns of similar problem behaviors. And while the SDQ-DP is based on five SDQ 
items spanning behavioral and affective problems, youths who score high on only the 
behavioral items may be categorized as dysregulated despite scoring low on the 
emotional items. The use of latent class analysis is hypothesized to overcome this 
limitation by identifying a class of individuals who are most likely to exhibit co-
occurring behavioral and affective problems. Nonetheless, the SDQ-DP was calculated 
and compared to the class probabilities returned from the latent class analysis.  
 
Latent Class Analysis 
 Latent class analysis (LCA) is an example of a mixture model used to estimate 
group membership of latent constructs. LCA is robust to the categorical data format of 
the SDQ and assigns probability scores to each participant reflecting the likelihood of 
class membership. Participants were categorized into the class with the highest 
probability score.  
 Latent class models were estimated using the software Mplus via an EM 




class solutions. The best-fitted model was identified using multiple measures of fit. The 
Bayesian Information Criterion (BIC) is a goodness-of-fit index that penalizes models 
with more classes. Lower BIC values indicate more parsimonious models. Because 
standard loglikelihood tests are biased in this analytic environment, two other 
examinations were used to compare a K class model to a K-1 class model, the Vuong-Lo-
Mendell-Rubin likelihood ratio test (VLMRT) and the bootstrap likelihood ratio test 
(BLRT). In each case, significance comparing a K class model to a K-1 class model 
indicates additional information is provided. If it is not significant, then the K-1 class 
model can be accepted. In addition, models with higher entropy (closer to 1) indicate a 
clearer delineation of classes. (Celeux and Soromenho, 1996) In this analysis, all indices 
other than the BLRT (which was not discriminating) indicated a 5-class model fit (see 
Table A3.1). These classes were then used to identify two groups of interest, a 
dysregulated group, and a low symptom comparison group (controls). Group 
identification was determined based on their respective patterns of item endorsement as 
further explained below.  
 
Structural Neuroimaging Methods 
 Across the eight acquisition sites, participants were scanned on 3T MRI scanners 
from various manufacturers (Phillips, General Electric, Bruker, and Siemens). 
Standardization and quality assurance efforts were made to insure all sites used the same 
MRI acquisition parameters and yielded comparable data. High-resolution anatomical 




prepared gradient echo sequence based on the ADNI protocol (http://adni.loni.usc.edu). 
The structural image was collected for nine minutes using the following parameters: 
TR=2300ms; TE=2.8ms; flip angle=8o; matrix size=240x256; voxel resolution=1.1mm3; 
and 160 contiguous slices at a thickness of 1.1mm. 
 Whole-brain gray matter volume (GMV) images were generated using optimized 
voxel-based morphometry procedures in SPM8. (Ashburner and Friston, 2000) High-
resolution anatomical magnetic resonance images were acquired, including a 3D T1-
weighted magnetization prepared gradient echo sequence based on the ADNI protocol 
(http://adni.loni.usc.edu). Structural MRI preprocessing included segmenting and 
normalizing the images into Montreal Neurological Institute template space. The gray 
matter segmentation images were then modulated to obtain volumetric images, rather 
than tissue concentration images. N=2,024 participants received a structural MRI and had 
GMV images passing quality control.  
 In preparation for the between-group GMV comparison, variables potentially 
influencing adolescent GMV (age, sex, site of imaging acquisition, handedness, puberty 
status, (Carskadon and Acebo, 1993) verbal and performance IQ, (Wechsler, 2003) and 
total GMV) were partialled out of the images. To do so, all participants from the baseline 
IMAGEN sample with preprocessed GMV images (N=2,024) were submitted to a 
multiple regression with only the confounding variables included in the design matrix. 
The residual GMV image for each participant was then used in the permutation test 
described below. This procedure was used because including nuisance covariates in the 




 In light of recent criticisms related to the proper correction for multiple 
comparisons in neuroimaging research, (Eklund et al., 2016) permutation analyses have 
been advocated as a non-parametric approach to closely control the number of false-
positives in a statistical analysis. (Winkler et al., 2014) Here, we used a random label 
permutation test applied to the residual output of the aforementioned nuisance regression. 
Each participant’s group membership was randomly shuffled and a whole-brain two-
group t-test using a general linear model was fitted to the residualized images. Random 
label shuffling was repeated 10,000 times, thus building a null distribution at each voxel, 
to which the originally labeled results were compared. Threshold-free cluster 
enhancement correction (TFCE)(Smith and Nichols, 2009) was then used to control the 
family-wise error rate for identifying clusters of residual gray matter that exhibit 
significant group differences. Regions of interest (ROI) surviving a TFCE corrected α < 
.05 were then probed for fMRI group differences, as well as being modeled as the 
mediator in candidate path analyses linking the likelihood of psychopathology to 
dysregulation. Permutation analyses were conducted using FSL’s Permutation Analysis 
of Linear Models (Winkler et al., 2014) on the University of Vermont’s Advanced 
Computing Core.  
 
Functional Neuroimaging Methods 
 Three fMRI tasks commonly used in psychiatric neuroimaging were administered, 
including the stop signal task, monetary-incentive delay task, and a face-processing task. 




response. (Rubia et al., 2007) Motor inhibitory control performance during this task is 
commonly measured using the stop signal reaction time (SSRT), an estimate of the speed 
of the inhibitory process, calculated from the average latency period between the “go” 
and “stop signal” during successful inhibition trials. (Logan and Cowan, 1984) The 
monetary-incentive delay task measures the processing of both anticipation and receipt of 
monetary rewards. (Knutson et al., 2000) The face-processing task involves the passive 
viewing of angry faces, neutral faces, and control images. (Grosbras, 2005) See 
Supplement 1, available online, for full details on the fMRI tasks. 
 All fMRI data were submitted to standard preprocessing methods and whole-brain 
contrast images specific to each task were estimated using a general linear model (see 
Supplement 1, available online, for fMRI processing details). Specifically, unsuccessful 
and successful inhibitory control, monetary reward anticipation and receipt, angry faces, 
neutral faces, and the differential activation for angry minus neutral faces, were each used 
to explore any functional differences between the groups. For each contrast image, the 
mean value within a region of interest (ROI) was extracted and analyzed using two-group 
ANCOVA models with a Bonferroni corrected alpha based on the number of contrasts 
tested for each task modality. 
 
Likelihood of Psychiatric Diagnoses 
 Psychopathology was determined using the Developmental and Well-Being 
Assessment (DAWBA; http://www.dawba.info/a0.html), a set of computer-administered 




5-17. Based on the child and parent responses, a computer algorithm generates scores to 
predict the likelihood of meeting criteria for DSM-IV diagnoses (“band scores”). These 
band scores range from 1 to 5, representing a probability of <0.1% to >70%. DAWBA 
band scores have been shown to yield prevalence estimates that broadly compare to 
clinician-rated diagnoses. (Goodman and Goodman, 2011)  
 
Mediation Analyses 
 Mediation was conducted in Mplus using a robust weighted least squares 
estimator to estimate direct and indirect effects, with bias-corrected 95% confidence 
intervals generated from 1000 bootstrapped samples. The use of bootstrapping the 
indirect effects is a more powerful method of inferring mediation compared to the 
traditional five-step procedure. (Hayes, 2009) The independent variables for the five 
separate mediation analyses included the full range of DAWBA band scores, representing 
the likelihood of receiving a DSM-IV diagnosis for anxiety, depression, conduct disorder 
(CD), oppositional defiance disorder (ODD), and attention deficit hyperactivity disorder 
(ADHD). These five constructs were informed by Copeland and colleagues who assessed 
the prevalence rates of DMDD comorbidity with these disorders. (Copeland et al., 2013) 
Furthermore, these disorders broadly capture the co-occurring internalizing and 
externalizing problems exhibited by dysregulated individuals.  
 The identified GMV features were modeled as a mediator between each band 
score and the binary dysregulation status as the dependent variable. Hence, models were 




relationship between a related psychiatric disorder and the dysregulated phenotype. As 
the initial neuroimaging analysis here tests for a biomarker of dysregulation in isolation, 
follow up path analyses assessed the involvement of brain structure with dysregulation in 
the context of affiliated psychiatric diagnoses reported by Copeland and colleagues. Any 
significant indirect effects uncovered by these path models provides evidence indicating 
the correlation between the likelihood of a related disorder and being dysregulated is 
driven, in part, through changes in focal brain structure.  
 
Results 
Latent Class Analysis Results 
 The best-fitting LCA model returned a five-class solution (see Table A3.1 for fit 
statistics). Here, we describe each class and offer a label to characterize their profile. 
Class 1, the “defiant class” (18% of the sample), contained individuals with low prosocial 
traits and slightly elevated conduct problems and hyperactivity. Class 2, the “emotional 
difficulties” class (16% of the sample), contained individuals with the highest emotional 
difficulties. Class 3, the “dysregulated class” (12% of the sample), contained individuals 
with very high levels of difficulties across all five domains. Class 4, the “hyperactive 
class” (25% of the sample), contained individuals with elevated hyperactivity. Class 5, 
the “low symptom class” (29% of the sample), contained individuals with very low levels 
of problem behaviors across all domains. And while class 5 is labeled “low symptoms”, 
we note that the defiant, emotional difficulties, and hyperactive classes also exhibit low 




studies reporting high prevalence rates of any level of psychiatric symptomatology in 
adolescence. (Copeland et al., 2011) See Figure A3.1 for the average item-endorsement 
for each class and Table 2 for the five SDQ summary scores for each class. 
 While other classes exhibited elevations in a single domain (i.e., emotional 
difficulties class; hyperactive class), the dysregulated class distinctly exhibited co-
occurring behavioral and affective problems. These individuals exhibited the highest 
probability of endorsing conduct problems, hyperactivity, peer problems, and the second 
highest probability of endorsing emotional problems (closely following the emotional 
difficulties class), and prosocial problems (closely following the defiant class). The low 
symptom class (the largest sample) was selected as the comparison group as they 
exhibited the lowest probability of endorsing all problematic behaviors. See Table S1, 
available online, for comparison of the dysregulated class to the full sample on 
descriptive characteristics. 
 Next, the SDQ-DP was calculated to compare to the LCA results using bivariate 
correlations between the SDQ-DP sum score and the probability of each class 
membership. Results indicated the SDQ-DP was most positively associated with the 
dysregulated class (r2126=.61, p<.001) and most negatively associated with the low 
symptom class (r2126=-.44, p<.001), thus providing support for the dysregulated 
phenotype captured by class 3 and the low symptom group captured by class 5.  
However, these correlations may be inflated as both measures were estimated from 
similar items on the same dataset. Nonetheless, Holtmann and colleagues report 




(CBCL-DP) binary score at r=.45 and CBCL-DP sum score at r=.75. Therefore, the LCA 
results reported here are in line with these other measurement instruments.  
 There were 184 participants included in the LCA who did not provide anatomical 
scan data (for reasons including failing quality control, MRI safety issues, etc.). 
However, chi-square tests indicated there was no difference in LCA class membership in 
this subsample relative to the larger sample with anatomical scan data (Χ24,2126 =2.2, 
p>.05). Thus, we do not believe there was any skew in the LCA class assignment by the 
participants who did not provide anatomical scan data. 
 
Neuroimaging Sample Characteristics 
 Of the 261 dysregulated and 613 low symptom comparison individuals identified 
from the LCA, 233 dysregulated and 564 comparison individuals provided useable GMV 
data. For the sample of 233 dysregulated individuals, an equal size subset of comparison 
individuals was selected from the low symptom class. This control group was pseudo-
randomly selected so as to match to the dysregulated group by containing an equal 
number of males and females who showed no differences on total GMV, pubertal 
development, performance and verbal IQ, or age, and contained similar distributions for 
handedness and site of acquisition (see Table S2, available online, for group 
comparisons). And while site was included in the initial nuisance regression of the full 
IMAGEN dataset, it is difficult to precisely account for site when there are unequal 
representations at each site. Hence, a pseudo-random sampling of the two groups was 




Results using this perfectly site-matched subsample were consistent with the main 
findings reported below. See Supplement 1, available online, for more information.  
 
Whole-brain Residual Gray Matter Volume Comparison 
 After running a two-sample t-test using a general linear model with 10,000 
random label permutations, a single cluster survived TFCE-correction for multiple 
comparisons (PFWE-corr<.05, k=48 voxels). This cluster was found in the right orbitofrontal 
cortex (OFC), center of mass at (MNI: 24, 30, -16), spanning the orbital sulcus with 
extent into the posterior orbital gyrus. In this region, dysregulated individuals exhibited 
lower residual GMV relative to their peers with low symptoms (see Figure A3.2).  
 
Laterality Test 
 As only one hemisphere survived strict correction, and there is growing interest in 
prefrontal asymmetry, a contralateral region of interest analysis was performed post-hoc. 
To perform this test, we translated the right-sided region of interest onto the left 
hemisphere and extracted regional GMV for all subjects. Two-sample t-tests indicated the 
left OFC ROI yielded significant differences (L.OFC: t462=-3.32, p<1.0x10-3), similar to 
the findings in the right OFC, albeit at a relatively lower magnitude of effect (R.OFC: 






  The identified sample for GMV analyses (n=466) was selected on the basis of the 
quality of their anatomical image, meaning some of these participants did not have fMRI 
data available. See Table S3 and Supplement 1, available online, for full details regarding 
these reduced samples, and reasons for missingness. In preparation for the ROI-level 
between-group comparisons using the fMRI data, we first examined the amount of head 
motion in the images. For each subject, the mean framewise displacement (mean FD) was 
calculated for each of the three fMRI tasks. Based on prior developmental neuroimaging 
studies,(Silvers et al., 2016) a head motion exclusionary criterion of mean FD > .9mm 
was used. For the stop signal task, 3 dysregulated participants were excluded. For the 
faces task, 1 dysregulated participant was excluded. For the MID task, 5 dysregulated and 
1 low symptom participants were excluded. Importantly, these reduced samples for fMRI 
comparisons retained critical between-group similarities as the starting samples for 
anatomical comparisons. Chi-square (for categorical measures) and t-tests indicated that 
after excluding subjects, the reduced samples retained their best-matched characteristics 
and did not differ on age, sex, handedness, IQs, or total GMV (p> .05).  
 Data were then submitted to standard two-sample t-tests to determine any group 
differences in head motion for a given task. Results indicated that while mean FD did not 
exceed thresholds previously reported as problematic, (Power et al., 2012; Siegel et al., 
2014) the dysregulated sample exhibited significantly more head motion during each 
fMRI acquisition (see Table S4, available online). Although participants’ head motion 
parameters were included in the design matrix during their fMRI contrast estimation, we 




 For the stop signal task, results indicated a significant between-group difference 
during successful inhibitory control trials F1,377=5.61, pcorr<.05, such that the dysregulated 
group showed higher activation (n=186, M=.15, SD=1.2) than the low symptom group 
(n=194, M=-.09, SD=.92). To ensure these findings were not driven by the difference in 
head motion, similar ANCOVA models were estimated on 5,000 pseudo-random 
subsamples of the data matched on head motion. Results were consistent, leading to a 
mean F1,307=4.9, p<.05, suggesting the between-group difference on successful inhibitory 
control activations were not driven by head motion. See Supplement 1, available online, 
for more information.  
 Due to problems with the behavioral task performance adaptive algorithm, stop 
signal reaction time (SSRT) scores were available on only a subset of participants. A 
between-group comparison on those individuals with useable SSRT behavioral data 
(Dysregulated n=97; Controls n=107) yielded no significant differences on SSRT 
(t202=0.38, p=.71). Given the reduced sample sizes of participants with SSRT data, no 
imputations were performed for SSRT, and it is unknown the degree to which the effects 
might generalize to the starting samples. No between-group activation differences were 
detected for unsuccessful inhibitory control trials, or on any of the remaining fMRI 
contrasts (reward and face processing tasks).  
  
Mediation Analyses 
 The likelihood of having any of the five psychopathologies exhibited a significant 




dysregulation. (Copeland et al., 2013) Bias-corrected confidence intervals around the 
indirect effect of the right OFC GMV ROI indicated this region partially mediated the 
likelihood of an anxiety disorder diagnosis (c=.023, 95% CI [0.003, 0.043]) or conduct 
disorder diagnosis (c=.018, 95% CI [.003, .033]) to dysregulation status (see Figure 
A3.3). No significant indirect effects were detected to link the brain between the 
likelihood of depression, ODD, or ADHD with dysregulation. Additionally, regional 
fMRI brain activation during successful inhibitory control did not yield any significant 
mediation effects.  See Table A3.3 for mediation model results.  
 
Discussion 
 We report that emotionally and behaviorally dysregulated adolescents exhibited 
lower GMV in the right OFC relative to their non-dysregulated peers. These findings 
were identified by a conservative permutation analysis between two large samples of 
closely matched groups. Secondary analyses indicated that within this same region, the 
dysregulated group exhibited higher functional brain activation when executing 
successful inhibitory control behaviors. These fMRI results provide some specificity on 
the psychological correlates of the GMV effect, such that the anatomical difference 
associated with dysregulation was related to inhibitory control but not to face or reward 
processing. Taken together, these results suggest dysregulation is characterized by 
differences in cortical regions involved with executive functioning. Lastly, the volume of 
the right OFC region partially mediated relationships between the likelihoods of an 




 It is interesting that the right OFC was uncovered from a conservative whole-
brain analysis and also exhibited differences on the stop signal task, as there is a body of 
research implicating the OFC in behavioral and emotional regulation. For example, 
previous research on the IMAGEN sample identified this region as participating in a 
network of brain activity during successful inhibitory control trials. (Whelan et al., 2012) 
As the dysregulated and low symptoms groups exhibited similar task performance, the 
greater activity in the right OFC of the dysregulated group may reflect greater effort or 
cognitive resources needed to execute inhibitory behaviors equal to that of their peers. 
Therefore, dysregulation may be partly dependent on a neurobiological inhibitory control 
network compromised in its ability to efficiently regulate behavior.  
 The OFC is also putatively involved in integrating attention and emotion by 
assigning a signal of affective value to stimuli. Previous work using event-related 
potentials (ERP) during an affective go/no-go task was conducted on children with co-
occuring internalizing and externalizing disorders.  One set of results identified higher 
ventral prefrontal activations during inhibitory control trials in children with poor self-
regulatory abilities as measured via parent-child observations. (Granic et al., 2012) In a 
related treatment study of similar children, treatment success was characterized by 
attenuation of activation levels in the ventral prefrontal region during inhibitory control 
trials. (Lewis et al., 2008) Hence, our findings are in line with these reports and suggest 
the OFC as both a potential biomarker and candidate region for targeted clinical 




 In terms of the mediation results, the investigated psychopathologies all exhibited 
a significant and large total effect on dysregulation, indicating that the likelihood of 
having an internalizing or externalizing disorder was associated with an increased 
likelihood of being dysregulated. These findings are consistent with previous reports 
identifying similar patterns of comorbidity from three datasets of child psychopathology. 
(Copeland et al., 2013) Moreover, the direct effects were also large, accounting for nearly 
98% of the total effect for all disorders (see Table A3.3). Given these relationships, the 
significant partial mediation results are notable as little variance is left to be explained by 
the indirect paths. Yet despite these relatively weak indirect effects, the significant 
findings highlight the transdiagnostic nature of the right OFC region insofar as it is a 
mediator to dysregulation for the likelihood of anxiety and conduct disorder. Although a 
significant mediation was not observed for depression, ODD, or ADHD it would be 
incautious to conclude that the mediation effect has specificity for anxiety and conduct 
disorder as effects in similar directions were observed for depression (p=.065) and ODD 
(p=.070; see Table A3.3). On the whole, the data suggest a small but potentially 
important role for the OFC in linking internalizing and externalizing disorder to 
dysregulation. Lastly, we reiterate the path models should not be misinterpreted as 
implying the likelihood of an anxiety, conduct disorder, or the brain feature caused 
dysregulation as the models are restricted to age 14 data only. 
 Limitations of this study include the lack of DSM-5 diagnostic measures, as it is 
unclear if the individuals contained in the dysregulation group meet DMDD diagnostic 




individuals who receive a DSM-5 DMDD diagnosis following a clinical interview. 
Likewise, measurement studies are also needed to determine the correlation between 
popular measurement methods like SDQ-LCA, SDQ-DP and CBCL-DP, and their 
correlation with clinical ratings. Additionally, recent work taking a factor analytic 
approach to the SDQ has identified a dysregulation factor using just three of the five 
domains, omitting the prosocial and peer problem domains. (Deutz et al., 2018) However, 
given that elevations in the CBCL Social Problems domain frequently accompany the 
CBCL-DP, (Althoff et al., 2010a) this approach risks omitting relevant features of the 
dysregulation construct.  
 In considering dysregulation measurement inconsistencies, differences in the 
precise brain region uncovered here with the previous regions uncovered by Adleman and 
by Gold and colleagues are likely attributed to differing measurement approaches. 
Nonetheless, the right-sided prefrontal anatomical finding is broadly consistent with these 
prior results. Although earlier fMRI studies of inhibitory control in dysregulation failed 
to detect significant group differences (Deveney et al., 2012) this is likely due to our 
fMRI analysis, by design, being restricted to a single anatomically defined region of 
interest. Another important consideration in interpreting the present fMRI results and 
integrating them with past findings is the potential confounding role of head motion. 
Despite including mean framewise displacement as a covariate, ANCOVA models are 
generally unable to completely control for a significant between-group difference in that 




procedure in which the group differences were recapitulated with subsamples chosen not 
to differ on head motion.  
 A caveat regarding the mediation results is that the path models were estimated 
using DAWBA band scores. As the DAWBA contains many skip rules leading some 
participants to “screen in” for extra items, these skips rules are sometimes related to high 
SDQ domain scores. Estimating paths between band scores and a binary dysregulation 
score determined via an SDQ-LCA consequently may contain a degree of circularity. 
Another limitation of the present study is the use of single informant data, although 
previous studies suggest agreements among multi-informants are generally low. (De Los 
Reyes and Kazdin, 2005) Finally, given the neurodevelopmental changes underway at 
age 14, it is unknown if the neuroanatomical difference identified here persists 
throughout the lifespan. Future longitudinal studies on dysregulated individuals are 
needed to determine the psychosocial and neurobiological antecedents of dysregulation, 
as well as the developmental effect of neural maturation on the persistence of 
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1 -39030.3 78443.79 NA NA 1 
2 -36850.3 74474.39 <0.001 <0.001 0.82 
3 -36188.3 73541.19 <0.001 <0.001 0.80 
4 -35664.2 72883.75 0.0046 <0.001 0.79 
5 -35252 72450.08 0.0028 <0.001 0.81 
6 -35067.2 72471.34 0.3346 <0.001 0.81 
7 -34893.2 72514.15 0.7601 <0.001 0.81 
 
BIC = Bayesian Information Criterion; BLRT=Bootstrap Likelihood Ratio Test; NA=Not 




Table A3.2: Strengths and Difficulties Questionnaire Summary Scores For Each Latent 
Class 
 
Class 3 comprised the “dysregulated” group who exhibited highest levels of impairment 
across all dimensions. Class 5 comprised the “low symptom” control group who 
exhibited the lowest levels of impairment. Summary scores were calculated by the sum of 
five items related to each dimension.(Goodman, 1997) Higher values signify more 
difficulty except within the prosocial domain. M=Mean; SD=Standard Deviation; SDQ = 





















1 (373) 1.36, 1.30 1.98, 1.29 2.52, 1.51 1.66, 1.57 5.81, 1.36 
2 (340) 4.20, 1.76 1.37, 1.19 3.16, 1.84 2.51, 1.71 8.99, 1.02 
3 (261) 4.15, 2.23 4.32, 1.58 6.44, 1.98 2.91, 2.08 6.31, 1.97 
4 (539) 1.20, 1.10 1.57, 1.17 3.99, 1.43 0.57, 0.80 8.59, 1.02 




Table A3.3: Summary of Mediation Models 
 
Total effects reflect association between the likelihood of disorder and dysregulation. 
Direct effects reflect the association between the likelihood of a disorder and 
dysregulation while accounting for the GMV region of interest (mediator). Indirect 
effects are the difference in betas, and reflect the magnitude of mediation through the 
region of interest. Significant indirect effects (95%CI >0) in bold. ADHD=Attention 
Deficit Hyperactivity Disorder; GMV=Gray Matter Volume; ODD=Oppositional Defiant 











    Lower Upper 
      
Anxiety to Dysregulation      
Total Effect .690 .055 .001 .582 .799 
Direct Effect .667 .058 .001 .554 .780 
Indirect Effect .023 .010 .025 .003 .043 
 
Depression to Dysregulation      
Total Effect .700 .044 .001 .613 .788 
Direct Effect .683 .045 .001 .595 .772 
Indirect Effect .017 .009 .065 -.001 .035 
 
 
Conduct Disorder to Dysregulation      
Total Effect .780 .035 .001 .712 .848 
Direct Effect .762 .036 .001 .692 .833 
Indirect Effect .018 .008 .022 .003 .033 
 
ODD to Dysregulation      
Total Effect .841 .024 .001 .794 .888 
Direct Effect .826 .025 .001 .776 .876 
Indirect Effect .015 .008 .070 -.001 .031 
 
ADHD to Dysregulation       
Total Effect .919 .019 .001 .882 .957 
Direct Effect .909 .021 .001 .867 .951 






Figure A3.1: Average Strengths and Difficulties Questionnaire Item Endorsement for 
Five Classes
 
 Each SDQ item present on the x-axis, ordered by the five respective SDQ domains to aid 
in interpretability. Average item endorsement on y-axis, from 0-2 (Not true, somewhat 
true, certainly true). Items with asterisks indicate reverse coding. Dysregulated class (3) 
in green line; low symptom class (5) in black line. SDQ=Strengths and Difficulties 
Questionnaire. 
 
Figure A3.2: Right Orbitofrontal Cortex Region of Interest 
  
Cluster (k=48 voxels; center of mass MNI coordinates: 3), identified as passing TFCE-
correction (p < .05) from a two-sample residual gray matter volume permutation analysis. 
This cluster was also present in a two-group permutation analysis estimated without 
residualized images or nuisance covariates. MNI=Montreal Neurological Institute; 























































































































































Figure A3.3: Mediation Models with Significant Indirect Effects 
 
 
Path models of the relationship between the likelihood of anxiety disorder (left), or, 
conduct disorder (right), to dysregulation, mediated by the right orbitofrontal cortex gray 
matter volume ROI. All coefficients are standardized and pass a null-hypothesis 
significance test at p<.05. The indirect effects (dotted line, c paths) reflect the magnitude 
of mediation through the ROI, with significance determined by 95% confidence intervals 
generated from 1000 bootstrapped samples (see Table 3). Total effects (c’ paths) reflect 
the bivariate correlation between a disorder and dysregulation when the mediator is 
excluded. The negative parameter estimates for the paths into and out of the ROI (a and b 
paths) are in line with the lower GMV exhibited by the dysregulated group. GMV=Gray 
Matter Volume; ROI=Region of Interest. 
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